
<html lang="en"     class="pb-page"  data-request-id="7eeaf888-8251-47b9-b286-d590e143c22a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm9006559;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-16;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor" /></meta><meta name="dc.Creator" content="Maria Gabriella  Brasca" /></meta><meta name="dc.Creator" content="Nadia  Amboldi" /></meta><meta name="dc.Creator" content="Dario  Ballinari" /></meta><meta name="dc.Creator" content="Alexander  Cameron" /></meta><meta name="dc.Creator" content="Elena  Casale" /></meta><meta name="dc.Creator" content="Giovanni  Cervi" /></meta><meta name="dc.Creator" content="Maristella  Colombo" /></meta><meta name="dc.Creator" content="Francesco  Colotta" /></meta><meta name="dc.Creator" content="Valter  Croci" /></meta><meta name="dc.Creator" content="Roberto  D’Alessio" /></meta><meta name="dc.Creator" content="Francesco  Fiorentini" /></meta><meta name="dc.Creator" content="Antonella  Isacchi" /></meta><meta name="dc.Creator" content="Ciro  Mercurio" /></meta><meta name="dc.Creator" content="Walter  Moretti" /></meta><meta name="dc.Creator" content="Achille  Panzeri" /></meta><meta name="dc.Creator" content="Wilma  Pastori" /></meta><meta name="dc.Creator" content="Paolo  Pevarello" /></meta><meta name="dc.Creator" content="Francesca  Quartieri" /></meta><meta name="dc.Creator" content="Fulvia  Roletto" /></meta><meta name="dc.Creator" content="Gabriella  Traquandi" /></meta><meta name="dc.Creator" content="Paola  Vianello" /></meta><meta name="dc.Creator" content="Anna  Vulpetti" /></meta><meta name="dc.Creator" content="Marina  Ciomei" /></meta><meta name="dc.Description" content="The discovery of a novel class of inhibitors of cyclin dependent kinases (CDKs) is described. Starting from compound 1, showing good potency as inhibitor of CDKs but being poorly selective against ..." /></meta><meta name="Description" content="The discovery of a novel class of inhibitors of cyclin dependent kinases (CDKs) is described. Starting from compound 1, showing good potency as inhibitor of CDKs but being poorly selective against ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 15, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9006559" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9006559" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9006559" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9006559" /></link>
        
    
    

<title>Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9006559" /></meta><meta property="og:title" content="Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0011.jpeg" /></meta><meta property="og:description" content="The discovery of a novel class of inhibitors of cyclin dependent kinases (CDKs) is described. Starting from compound 1, showing good potency as inhibitor of CDKs but being poorly selective against a panel of serine−threonine and tyrosine kinases, new analogues were synthesized. Enhancement in selectivity, antiproliferative activity against A2780 human ovarian carcinoma cells, and optimization of the physical properties and pharmacokinetic profile led to the identification of highly potent and orally available compounds. Compound 28 (PHA-848125), which in the preclinical xenograft A2780 human ovarian carcinoma model showed good efficacy and was well tolerated upon repeated daily treatments, was identified as a drug candidate for further development. Compound 28 is currently undergoing phase I and phase II clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9006559"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9006559">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9006559&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9006559&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9006559&amp;href=/doi/10.1021/jm9006559" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 5152-5163</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900277z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900473p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor<a class="ref internalNav" href="#pdb" aria-label=""></a><a class="ref internalNav" href="#ded" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Gabriella++Brasca">Maria Gabriella Brasca</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nadia++Amboldi">Nadia Amboldi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dario++Ballinari">Dario Ballinari</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Cameron">Alexander Cameron</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Casale">Elena Casale</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Cervi">Giovanni Cervi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maristella++Colombo">Maristella Colombo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Colotta">Francesco Colotta</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valter++Croci">Valter Croci</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++D%E2%80%99Alessio">Roberto D’Alessio</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Fiorentini">Francesco Fiorentini</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonella++Isacchi">Antonella Isacchi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ciro++Mercurio">Ciro Mercurio</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Moretti">Walter Moretti</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Achille++Panzeri">Achille Panzeri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wilma++Pastori">Wilma Pastori</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Pevarello">Paolo Pevarello</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesca++Quartieri">Francesca Quartieri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fulvia++Roletto">Fulvia Roletto</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriella++Traquandi">Gabriella Traquandi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Vianello">Paola Vianello</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Vulpetti">Anna Vulpetti</a></span><span class="author-xref-symbol "><sup>∞</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Ciomei">Marina Ciomei</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39-0331-581533. Fax: +39-0331-581347. E-mail: <a href="/cdn-cgi/l/email-protection#4e292f2c3c272b22222f602c3c2f3d2d2f0e202b3c38272f2021233d602d2123"><span class="__cf_email__" data-cfemail="8fe8eeedfde6eae3e3eea1edfdeefceceecfe1eafdf9e6eee1e0e2fca1ece0e2">[email protected]</span></a></div><div class="corresp-fn" id="fn2">∥Present address: Diamond Light Source, Chilton, Didcot, Oxfordshire, U.K</div><div class="corresp-fn" id="fn4">‡Accelera Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</div><div class="corresp-fn" id="fn5">§Present address: Genextra Group, Milano, Italy</div><div class="corresp-fn" id="fn6">⊥Present address: Newron, Milano, Italy</div><div class="corresp-fn" id="fn7">∞Present address: Novartis Pharma AG, Basel, Switzerland</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9006559&amp;href=/doi/10.1021%2Fjm9006559" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 5152–5163</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 15, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 May 2009</li><li><span class="item_label"><b>Published</b> online</span>15 July 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 August 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9006559" title="DOI URL">https://doi.org/10.1021/jm9006559</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5152%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaria%2BGabriella%2BBrasca%252C%2BNadia%2BAmboldi%252C%2BDario%2BBallinari%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D16%26contentID%3Djm9006559%26title%3DIdentification%2Bof%2BN%252C1%252C4%252C4-Tetramethyl-8-%257B%255B4-%25284-methylpiperazin-1-yl%2529phenyl%255Damino%257D-4%252C5-dihydro-1H-pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2B%2528PHA-848125%2529%252C%2Ba%2BPotent%252C%2BOrally%2BAvailable%2BCyclin%2BDependent%2BKinase%2BInhibitor%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5163%26publicationDate%3DAugust%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9006559"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4290</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">77</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9006559" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Gabriella Brasca&quot;},{&quot;first_name&quot;:&quot;Nadia&quot;,&quot;last_name&quot;:&quot;Amboldi&quot;},{&quot;first_name&quot;:&quot;Dario&quot;,&quot;last_name&quot;:&quot;Ballinari&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Cameron&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Casale&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Cervi&quot;},{&quot;first_name&quot;:&quot;Maristella&quot;,&quot;last_name&quot;:&quot;Colombo&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Colotta&quot;},{&quot;first_name&quot;:&quot;Valter&quot;,&quot;last_name&quot;:&quot;Croci&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;D’Alessio&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Fiorentini&quot;},{&quot;first_name&quot;:&quot;Antonella&quot;,&quot;last_name&quot;:&quot;Isacchi&quot;},{&quot;first_name&quot;:&quot;Ciro&quot;,&quot;last_name&quot;:&quot;Mercurio&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Moretti&quot;},{&quot;first_name&quot;:&quot;Achille&quot;,&quot;last_name&quot;:&quot;Panzeri&quot;},{&quot;first_name&quot;:&quot;Wilma&quot;,&quot;last_name&quot;:&quot;Pastori&quot;},{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Pevarello&quot;},{&quot;first_name&quot;:&quot;Francesca&quot;,&quot;last_name&quot;:&quot;Quartieri&quot;},{&quot;first_name&quot;:&quot;Fulvia&quot;,&quot;last_name&quot;:&quot;Roletto&quot;},{&quot;first_name&quot;:&quot;Gabriella&quot;,&quot;last_name&quot;:&quot;Traquandi&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Vianello&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Vulpetti&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Ciomei&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;5152-5163&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9006559&quot;},&quot;abstract&quot;:&quot;The discovery of a novel class of inhibitors of cyclin dependent kinases (CDKs) is described. Starting from compound 1, showing good potency as inhibitor of CDKs but being poorly selective against a panel of serine−threonine and tyrosine kinases, new analogues were synthesized. Enhancement in selectivity, antiproliferative activity against A2780 human ovarian carcinoma cells, and optimization of the physical properties and pharmacokinetic profile led to the identification of highly potent and orally available compounds. Compound 28 (PHA-848125), which in the preclinical xenograft A2780 human ovarian carcinoma model showed good efficacy and was well tolerated upon repeated daily treatments, was identified as a drug candidate for further development. Compound 28 is currently undergoing phase I and phase II clinical trials.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9006559&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9006559" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9006559&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9006559" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9006559&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9006559" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9006559&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9006559&amp;href=/doi/10.1021/jm9006559" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9006559" /></input><a href="/doi/pdf/10.1021/jm9006559" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9006559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9006559%26sid%3Dliteratum%253Aachs%26pmid%3D19603809%26genre%3Darticle%26aulast%3DBrasca%26date%3D2009%26atitle%3DIdentification%2Bof%2BN%252C1%252C4%252C4-Tetramethyl-8-%257B%255B4-%25284-methylpiperazin-1-yl%2529phenyl%255Damino%257D-4%252C5-dihydro-1H-pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2B%2528PHA-848125%2529%252C%2Ba%2BPotent%252C%2BOrally%2BAvailable%2BCyclin%2BDependent%2BKinase%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D16%26spage%3D5152%26epage%3D5163%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of a novel class of inhibitors of cyclin dependent kinases (CDKs) is described. Starting from compound <b>1</b>, showing good potency as inhibitor of CDKs but being poorly selective against a panel of serine−threonine and tyrosine kinases, new analogues were synthesized. Enhancement in selectivity, antiproliferative activity against A2780 human ovarian carcinoma cells, and optimization of the physical properties and pharmacokinetic profile led to the identification of highly potent and orally available compounds. Compound <b>28</b> (PHA-848125), which in the preclinical xenograft A2780 human ovarian carcinoma model showed good efficacy and was well tolerated upon repeated daily treatments, was identified as a drug candidate for further development. Compound <b>28</b> is currently undergoing phase I and phase II clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>#</span> </h4><p class="last">Coordinates of the CDK2 complexes with compounds <b>2</b> and <b>28</b> have been deposited in the Protein Data Base under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIP">2WIP</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIH">2WIH</a>, together with the corresponding structure factor files.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> </h4><p class="last">This paper is dedicated to the memory of our colleague Valter Croci.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclin dependent kinases (CDKs<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: CDK, cyclin dependent kinase; CDK2/A, (cyclin dependent kinase 2)/(cyclin A); Aur-A, Aurora A; TRKA, thropomyosin receptor kinase A, catalytic receptor for the neurothrophin nerve growth factor; NGF, nerve growth factor; pRB, retinoblastoma protein; PPB, plasma protein binding; EDC, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride; HOBt, 1-hydroxybenzotriazole; HOBt·NH<sub>3</sub>, 1-hydroxybenzotriazole ammonium salt; (±)-BINAP, (±)-2,2′-bis(diphenylphosphino)-1,1′-binaphthalene.</p></div> are a family of serine/threonine kinases that, in concert with cyclins (positive regulators) and natural inhibitors (CDKI), play a crucial role in the cell cycle progression.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Deregulation of the activity of CDKs, due to alterations of expression and/or genetic mutations of cyclins, CDKs, CDKIs, and other components of the retinoblastoma protein (pRB) pathway, has been reported in more than 90% of human neoplasms. For example, cyclins E and A have been found overexpressed in 50% of breast and lung cancer whereas decreased levels of the inhibitor p27 indicate a poor prognosis in breast, prostate, colon, gastric, lung, and esophageal cancer.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The high frequency of alterations found in the core members of this pathway in human tumors led to the suggestion that its deregulation, leading to increased activity of CDK/cyclin complexes, is an obligatory event for the development of all human cancers. Despite recent genetic studies in mice indicating that normal cells are not dependent on interphase CDKs (CDK4 and CDK2) for their growth, certain tumor cells, depending on their origin and their pathogenic spectrum of mutation, may be sensitive to the inhibition of CDKs.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Several small molecules inhibitors of CDKs are in clinical development. Among the first generation of CDK inhibitors, flavopiridol has been granted orphan drug status for the treatment of chronic lymphocytic leukemia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A second generation of inhibitors with greater selectivity for CDKs such as roscovitine/CYC-202,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> BMS-387032/SNS-032<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (both mainly CDK2 but also CDK7 and CDK9 inhibitors), PD0332991<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (selective CDK4 and CDK6 inhibitor), and recently R547<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (CDK1, -2, -4 inhibitor), SCH-727965<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (CDK1, -2, -5, -9 inhibitor), AT7519<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (CDK1, -2, -4, -5 inhibitor), and AZD5597<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (CDK1, -2, and -9 inhibitor) suggest that agents that inhibit the function of multiple CDKs may be clinically more successful than very selective inhibitors of CDKs.</div><div class="NLM_p">We recently reported on a series of benzodipyrazoles<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> as CDK2 inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). As a further development of the fused pyrazole ring systems, we identified a novel series of pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamides as CDK inhibitors. Preliminary expansion of this class led to compound <b>1</b> that, notwithstanding being a potent inhibitor of CDKs, was poorly selective against a panel of serine−threonine and tyrosine kinases (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Session">Experimental Session</a>, <a class="ref internalNav" href="#sec5_51" aria-label="Kinase Assays">Kinase Assays</a>). The remarkable antiproliferative activity of this compound against A2780 human ovarian carcinoma cells and the potency on CDKs prompted us to start a medicinal chemistry program with the aim of optimizing its profile with respect to selectivity, physicochemical properties, and pharmacokinetic profile.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. From benzodipyrazole series to hit compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Structural information was used to support the development of this class. Specifically, the crystal structure of CDK2/cyclin A complexed with carboxylic acid <b>2</b> was solved (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This compound, which shows a similar potency but is more soluble than compound <b>1</b>, binds in the ATP pocket of the active conformation of the kinase: the pyrazoloquinazoline ring system occupies the adenine region of the ATP pocket, while the phenyl moiety points toward the solvent accessible region. Compound <b>2</b> makes two hydrogen bonds with the protein backbone of the hinge region: the N atom at position 7 of the pyrazoloquinazoline core interacts with the backbone NH of Leu83, while the adjacent amino group binds to the carbonyl oxygen of Leu83. In addition, the carboxylate group of the ligand is within hydrogen bonding distance of the conserved lysine (Lys33).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylic acid derivative <b>2</b> in complex with CDK2/cyclin A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIP">2WIP</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic approach to this class of compounds<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) started from commercially available 1,2-cyclohexanedione that, after conversion into enol ether <b>3</b>, was condensed with diethyl oxalate to provide diketoester <b>4</b> that further reacted with methylhydrazine to form regioselectively the pyrazole <b>5.</b> Condensation with <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal gave rise to enaminone <b>6a</b>. The preparation of intermediate <b>6b</b> was accomplished by using dimedone as starting material. The formation of enol ether <b>7</b> was followed by a reaction sequence encompassing reduction of the conjugated double bond, elimination, and epoxidation to give intermediate <b>8</b>. Oxirane ring-opening by methanol led to enol ether <b>9</b>, regioisomer of <b>7</b>. Subsequent condensation with diethyl oxalate and reaction of resulting 1,3-diketone intermediate with methylhydrazine regioselectively gave rise to the pyrazole derivative <b>10</b>. Condensation with <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal afforded the enaminone <b>6b</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Adducts <b>6a</b> and <b>6b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>p-</i>TSA cat., toluene, EtOH, reflux, 48 h, 66%; (b) 1 M LiN(TMS)<sub>2</sub> in THF, diethyl oxalate, Et<sub>2</sub>O, −50 °C to room temp, 76%; (c) methylhydrazine, CH<sub>3</sub>COOH, room temp, 6 h, 63%; (d) <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal, DMF, 60 °C, 8 h, 90%; (e) TiCl<sub>4</sub>, MeOH, room temp, 1 h, 92%; (f) 1 M LiAlH<sub>4</sub> in THF, 0 °C to room temp, 4 h; 2 M H<sub>2</sub>SO<sub>4</sub>; H<sub>2</sub>O<sub>2</sub>, 2% NaOH, MeOH, 0−4 °C, 20 h, 78%; (g) KOH, MeOH, room temp, 20 h, 68%; (h) NaH, diethyl oxalate, THF, reflux, 1 h; methylhydrazine, CH<sub>3</sub>COOH, room temp, 12 h, 48%; (i) <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal, DMF, 60 °C, 2 h, 87%.</p></p></figure><div class="NLM_p">The two enaminones <b>6a</b> and <b>6b</b> were condensed with phenylguanidine carbonate in DMF to afford the arylamino derivatives <b>11a</b> and <b>11b</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Hydrolysis of carboxylic esters gave the corresponding acids, which were submitted to the coupling with amines to provide amides <b>1</b>, <b>16</b>−<b>21</b>, and <b>26</b>. Alternatively, the two enaminones <b>6a</b> and <b>6b</b> were condensed with guanidine hydrochloride in DMF to afford the fused pyrimidine derivatives <b>12a</b> and <b>12b</b>, which were converted into the corresponding iodo derivatives <b>13a</b> and <b>13b</b>. Hydrolysis of carboxylic esters gave the corresponding acids, which were submitted to the coupling with amines to provide amides <b>14a</b>,<b>15a</b> and <b>14b</b>,<b>15b</b>. Palladium catalyzed coupling with substituted anilines furnished the arylamino derivatives <b>22</b>−<b>25</b> and <b>27</b>−<b>41</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Final Compounds <b>1</b> and <b>16</b>−<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) phenylguanidine carbonate, DMF, 110 °C, 6 h, 72−90%; (b) 1.5 N KOH in 95% EtOH, room temp; HOBt·NH<sub>3</sub>, EDC, DIPEA, DMF, room temp or R<sup>1</sup>NH<sub>2</sub>, EDC, HOBt, DIPEA, DMF, room temp, 46−83%; (c) guanidine hydrochloride, K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C, 92−93%; (d) isopentyl nitrite, CsI, I<sub>2</sub>, CuI, DME, 65 °C, 40−46%; (e) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, dioxane, reflux; HOBt·NH<sub>3</sub>, EDC, DIPEA, DMF, room temp or R<sup>1</sup>NH<sub>2</sub>, EDC, HOBt, DIPEA, DMF, room temp, 56−65%; (f) substituted aniline, Pd(OAc)<sub>2</sub>, (±)-BINAP, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 30−71%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An initial set of amides <b>1</b> and <b>16</b>−<b>21</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was synthesized in order to explore the phosphate region of the ATP binding site of the CDK2/cyclin A, which accommodates the carboxamide groups. The primary carboxamide <b>1</b> proved to be the most active compound. Analogously, secondary amides bearing small substituents such as methyl, cyclopropyl, and hydroxyethyl (<b>16</b>−<b>18</b>) displayed interesting enzymatic activity as CDK2/cyclin A inhibitors, whereas bulkier residues such as cyclopentyl, phenyl, and benzyl (<b>19</b>−<b>21</b>) caused a marked decrease in activity on CDK2/cyclin A. However, no particular improvement in terms of selectivity vs the serine−threonine kinase Aurora A (used as indicator of compound selectivity) and of cellular antiproliferative activity was achieved moving from the primary amide <b>1</b> to the most interesting secondary amides <b>16</b>−<b>18</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. R<sup>1</sup> Modification<a class="ref internalNav" href="#t1fn8" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center"> </th><th class="colsep1" colspan="3" align="center" char=".">IC<sub>50</sub>, μM</th><th align="center" char="."> </th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd</th><th class="rowsep1" align="center">R<sup>1</sup></th><th class="rowsep1" align="center" char=".">CDK2/A</th><th class="rowsep1" align="center" char=".">Aur-A</th><th class="rowsep1" align="center" char=".">A2780</th><th class="rowsep1" align="center" char=".">solubility at pH 7, μM</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left">H</td><td align="char" char=".">0.002</td><td align="char" char=".">0.050</td><td align="char" char=".">0.50</td><td align="char" char=".">3</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="left">CH<sub>3</sub></td><td align="char" char=".">0.019</td><td align="char" char=".">0.312</td><td align="char" char=".">2.63</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="left">cyclopropyl</td><td align="char" char=".">0.081</td><td align="char" char=".">0.213</td><td align="char" char=".">3.82</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OH</td><td align="char" char=".">0.074</td><td align="char" char=".">0.364</td><td align="char" char=".">2.38</td><td align="char" char=".">7</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="left">cyclopentyl</td><td align="char" char=".">3.90</td><td align="char" char=".">>10</td><td align="char" char=".">>10</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="left">phenyl</td><td align="char" char=".">0.574</td><td align="char" char=".">>10</td><td align="char" char=".">>10</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="left">benzyl</td><td align="char" char=".">1.053</td><td align="char" char=".">0.374</td><td align="char" char=".">0.58</td><td align="char" char=".">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn8"><div class="footnote" id="t1fn8"><sup>a</sup><p class="last">Values are the mean of two or more experiments.</p></div></div></div><div class="NLM_p">Exploration of the solvent accessible region of the ATP binding site of CDK2/cyclin A was realized by introducing solubilizing moieties on the phenyl ring to give arylamines <b>22</b>−<b>25</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup> Modifications<a class="ref internalNav" href="#t2fn8" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th class="colsep1" colspan="3" align="center" char=".">IC<sub>50</sub>, μM</th><th align="center" char="."> </th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd</th><th class="rowsep1" align="center">R<sup>1</sup></th><th class="rowsep1" align="center">R<sup>2</sup></th><th class="rowsep1" align="center">R<sup>3</sup></th><th class="rowsep1" align="center" char=".">CDK2/A</th><th class="rowsep1" align="center" char=".">Aur-A</th><th class="rowsep1" align="center" char=".">A2780</th><th class="rowsep1" align="center" char=".">solubility at pH 7, μM</th></tr></thead><tbody><tr valign="top"><td align="left"><b>22</b></td><td align="left">H</td><td align="left">4-methylpiperazin-1-yl</td><td align="left">H</td><td align="char" char=".">0.002</td><td align="char" char=".">0.053</td><td align="char" char=".">0.03</td><td align="char" char=".">156</td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="left">CH<sub>3</sub></td><td align="left">4-methylpiperazin-1-yl</td><td align="left">H</td><td align="char" char=".">0.045</td><td align="char" char=".">0.175</td><td align="char" char=".">0.19</td><td align="char" char=".">211</td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="left">H</td><td align="left">H</td><td align="left">4-methylpiperazin-1-yl</td><td align="char" char=".">0.001</td><td align="char" char=".">0.030</td><td align="char" char=".">0.03</td><td align="char" char=".">47</td></tr><tr valign="top"><td align="left"><b>25</b></td><td align="left">H</td><td align="left">morpholin-4-yl</td><td align="left">H</td><td align="char" char=".">0.014</td><td align="char" char=".">0.051</td><td align="char" char=".">0.12</td><td align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn8"><div class="footnote" id="t2fn8"><sup>a</sup><p class="last">Values are the mean of two or more experiments.</p></div></div></div><div class="NLM_p">Early comparison of analogues <b>22</b> and <b>23</b> with parent compounds <b>1</b> and <b>16</b>, respectively, indicated that introduction of the 4-methylpiperazinyl moiety on the phenyl ring para position afforded potent enzyme inhibitors with an improvement of the antiproliferative activity in A2780 human ovarian carcinoma cells as well as solubility in neutral buffer. Introduction of the 4-methylpiperazinyl group in the meta position (<b>24</b>) or of the morpholin-4-yl group in the para position of the phenyl ring (<b>25</b>) was compatible with the maintenance of the CDK2 inhibitory activity and potency in the cellular antiproliferative assay, albeit solubility in neutral buffer was diminished. Unfortunately, improvement in the selectivity vs Aurora A, as well as vs many of the kinases in our panel, was not achieved with this series, and the exploration of the small CDK2 cavity at the back of the pocket (buried region) was considered. Size and shape of this cavity vary among the different kinases and are often exploited for improving selectivity. The buried region of CDK2, defined by Ala31, Val64, Phe80, and Ala144,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> is small mainly because of the presence of a hindered and rigid gatekeeper residue such as Phe80. Structure−activity relationship (SAR) data generated by us<a onclick="showRef(event, 'ref11 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref14">(11, 13, 14)</a> and others<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> on multiple chemical classes have shown that occupation of this buried area by small hydrophobic moieties is beneficial to CDK2 binding. By visual inspection and modeling experiments, position 4 of the pyrazoloquinazoline skeleton was identified as suitable for placing a moiety such as a dimethyl group that could increase the hydrophobic contact in the CDK2 buried region. Compound <b>26</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) showed interesting CDK2 inhibitory activity and potency in the A2780 cells assay. Moreover, incorporation of the dimethyl moiety at the 4-position resulted in a significant improvement of selectivity against Aurora A for compound <b>26</b> when compared to compound <b>1</b>, supporting the working hypothesis.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup> Modifications<a class="ref internalNav" href="#t3fn8" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th class="colsep1" colspan="3" align="center" char=".">IC<sub>50</sub>, μM</th><th align="center" char="."> </th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd</th><th class="rowsep1" align="center">R<sup>1</sup></th><th class="rowsep1" align="center">R<sup>2</sup></th><th class="rowsep1" align="center">R<sup>3</sup></th><th class="rowsep1" align="center" char=".">CDK2/A</th><th class="rowsep1" align="center" char=".">Aur-A</th><th class="rowsep1" align="center" char=".">A2780</th><th class="rowsep1" align="center" char=".">solubility at pH 7, μM</th></tr></thead><tbody><tr valign="top"><td align="left"><b>26</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="char" char=".">0.024</td><td align="char" char=".">>10</td><td align="char" char=".">0.17</td><td align="char" char="."><1</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">H</td><td align="left">4-methylpiperazin-1-yl</td><td align="left">H</td><td align="char" char=".">0.017</td><td align="char" char=".">0.582</td><td align="char" char=".">0.05</td><td align="char" char=".">98</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="left">CH<sub>3</sub></td><td align="left">4-methylpiperazin-1-yl</td><td align="left">H</td><td align="char" char=".">0.045</td><td align="char" char=".">1.051</td><td align="char" char=".">0.20</td><td align="char" char=".">191</td></tr><tr valign="top"><td align="left"><b>29</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">4-methylpiperazin-1-yl</td><td align="char" char=".">0.031</td><td align="char" char=".">1.00</td><td align="char" char=".">0.53</td><td align="char" char=".">182</td></tr><tr valign="top"><td align="left"><b>30</b></td><td align="left">CH<sub>3</sub></td><td align="left">morpholin-4-yl</td><td align="left">H</td><td align="char" char=".">0.137</td><td align="char" char=".">0.649</td><td align="char" char=".">0.37</td><td align="char" char=".">46</td></tr><tr valign="top"><td align="left"><b>31</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">morpholin-4-yl</td><td align="char" char=".">0.248</td><td align="char" char=".">0.625</td><td align="char" char=".">0.70</td><td align="char" char=".">51</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="left">CH<sub>3</sub></td><td align="left">1-methylpiperidin-4-yloxy</td><td align="left">H</td><td align="char" char=".">0.029</td><td align="char" char=".">1.343</td><td align="char" char=".">0.17</td><td align="char" char=".">183</td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">1-methylpiperidin-4-yloxy</td><td align="char" char=".">0.047</td><td align="char" char=".">1.584</td><td align="char" char=".">0.39</td><td align="char" char=".">160</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left">CH<sub>3</sub></td><td align="left">4-methylpiperazin-1-ylmethyl</td><td align="left">H</td><td align="char" char=".">0.055</td><td align="char" char=".">1.615</td><td align="char" char=".">0.24</td><td align="char" char=".">170</td></tr><tr valign="top"><td align="left"><b>35</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">4-methylpiperazin-1-ylmethyl</td><td align="char" char=".">0.059</td><td align="char" char=".">1.184</td><td align="char" char=".">0.57</td><td align="char" char=".">162</td></tr><tr valign="top"><td align="left"><b>36</b></td><td align="left">CH<sub>3</sub></td><td align="left">morpholin-4-ylmethyl</td><td align="left">H</td><td align="char" char=".">0.036</td><td align="char" char=".">0.535</td><td align="char" char=".">0.35</td><td align="char" char=".">133</td></tr><tr valign="top"><td align="left"><b>37</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">morpholin-4-ylmethyl</td><td align="char" char=".">0.160</td><td align="char" char=".">0.638</td><td align="char" char=".">0.87</td><td align="char" char=".">121</td></tr><tr valign="top"><td align="left"><b>38</b></td><td align="left">CH<sub>3</sub></td><td align="left">dimethylamino</td><td align="left">H</td><td align="char" char=".">0.059</td><td align="char" char=".">0.855</td><td align="char" char=".">0.50</td><td align="char" char=".">56</td></tr><tr valign="top"><td align="left"><b>39</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">dimethylamino</td><td align="char" char=".">0.220</td><td align="char" char=".">1.437</td><td align="char" char=".">3.01</td><td align="char" char=".">41</td></tr><tr valign="top"><td align="left"><b>40</b></td><td align="left">CH<sub>3</sub></td><td align="left">dimethylaminomethyl</td><td align="left">H</td><td align="char" char=".">0.035</td><td align="char" char=".">>5</td><td align="char" char=".">0.11</td><td align="char" char=".">206</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">dimethylaminomethyl</td><td align="char" char=".">0.083</td><td align="char" char=".">2.940</td><td align="char" char=".">0.5</td><td align="char" char=".">193</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn8"><div class="footnote" id="t3fn8"><sup>a</sup><p class="last">Values are the mean of two or more experiments.</p></div></div></div><div class="NLM_p">With the aim of improving solubility in neutral buffer, an expansion on the 4,4-dimethylsubstituted pyrazoloquinazoline skeleton was performed by keeping the 3-substituent fixed as primary or <i>N</i>-methylamide and varying the arylamines at position 8. Introduction of the 4-methylpiperazinyl moiety in the para position of the phenyl ring (<b>27</b> and <b>28</b>) provided compounds with good activity against CDK2/cyclin A and in A2780 cell proliferation assay as well as good solubility in neutral buffer. Selectivity toward Aurora A was reasonably improved by the presence of the 4,4-dimethyl moiety, in particular when comparing <b>28</b> with <b>23</b>. As far as buffer solubility is concerned, compound <b>28</b>, albeit less potent than compound <b>27</b>, displayed higher solubility. The binding mode of the 4,4-dimethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline skeleton was confirmed by the crystal structure of compound <b>28</b> in complex with CDK2/cyclin A (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of compound <b>28</b> (PHA-848125) in complex with CDK2/cyclin A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIH">2WIH</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>28</b> is anchored, in a similar manner as compound <b>2</b>, to the ATP pocket of CDK2/cyclin A by three hydrogen bonds to the protein backbone of the hinge region (Leu83) and to the conserved Lys33. Selectivity enhancement of compound <b>28</b> with respect to <b>23</b> could be explained by the more favorable hydrophobic interactions of the 4,4-dimethyl group with the CDK2 gatekeeper residue Phe80 (compared with the Aurora A gatekeeper Leu210) and by the presence of the smaller side chain of CDK2-Val64 (Aurora A-Leu194).</div><div class="NLM_p">CDK2/cyclin A inhibitory activity was retained by introduction of the 4-methylpiperazinyl group in the meta position, as in compound <b>29</b>, but a lower potency in the cellular antiproliferative assay was observed with respect to compound <b>28</b>. Introduction of the morpholin-4-yl group in the para and meta positions of the phenyl ring led to compounds <b>30</b> and <b>31</b>, respectively, that were less potent on the enzyme and in the cellular antiproliferative assays and less soluble in neutral buffer than compound <b>28</b>. The role of the 4-methylpiperazinyl moiety, as far as potency and solubility are concerned, was explored by replacement with different solubilizing groups attached to the phenyl ring in the para and meta positions (<b>32</b>−<b>41</b>). All these compounds, with the exception of <b>37</b> and <b>39</b>, displayed good activity on CDK2/cyclin A and from moderate to good selectivity vs Aurora A. In particular, the para substituted compounds were endowed with a higher potency in the antiproliferative assay than the corresponding meta derivatives (compare <b>32</b>, <b>34</b>, <b>36</b>, <b>38</b>, <b>40</b> to <b>33</b>, <b>35</b>, <b>37</b>, <b>39</b>, <b>41</b>). All compounds of this series showed good solubility except for the dimethylamino derivatives <b>38</b> and <b>39</b>.</div><div class="NLM_p">Compounds <b>27</b>, <b>28</b>, <b>32</b>, <b>34</b>, <b>40</b> were selected for further assessment on the basis of their potency on the enzyme, antiproliferative activity, and preliminary solubility in neutral buffer. Further selection criteria were applied using preliminary in vitro physicochemical ADME properties (solubility in 5% dextrose, stability to human CYP4503A4, human plasma protein binding) and in vivo pharmacokinetic data as key parameters. As reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, compound <b>28</b> emerged among these because of its high stability to human CYP4503A4 (85% remaining), acceptable plasma protein binding (98% bound), and good solubility (10 mg/mL in 5% dextrose as hydrochloride salt).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Physicochemical ADME Properties of Selected Compounds<a class="ref internalNav" href="#t4fn8" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="rowsep1" colspan="3" align="center" char=".">in vitro ADME properties</th></tr><tr valign="top"><th align="center">compd</th><th align="center" char=".">solubility in 5% dextrose, mg/mL</th><th align="center" char=".">CYP4503A4, % remaining</th><th align="center" char=".">PPB, %</th></tr></thead><tbody><tr valign="top"><td align="left"><b>27</b></td><td align="char" char=".">3.4</td><td align="char" char=".">82</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="char" char=".">10</td><td align="char" char=".">85</td><td align="char" char=".">98</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="char" char=".">10</td><td align="char" char=".">63</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="char" char=".">10</td><td align="char" char=".">50</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>40</b></td><td align="char" char=".">10</td><td align="char" char=".">77</td><td align="char" char=".">95</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn8"><div class="footnote" id="t4fn8"><sup>a</sup><p class="last">Dosed in 5% dextrose as hydrochloride salt.</p></div></div></div><div class="NLM_p">In addition, <b>28</b> possessed better pharmacokinetic parameters than the other compounds tested so far (<b>32</b>, <b>34</b>, and <b>40</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In vivo results in healthy nude mouse (10 mg/kg by iv administration) suggested a half-life of 2.6 h, with a moderate clearance (about 36% of the hepatic blood flow). The volume of distribution (<i>V</i><sub>ss</sub> about 7-fold of the total body water) pointed toward a high tissue distribution. Compound <b>28</b>, after oral administration at a dose of 10 mg/kg, showed the highest oral bioavailability (85%) with an AUC of 8.29 μM·h, a <i>C</i><sub>max</sub> of 2.35 μM, and a half-life of 2.9 h.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo Pharmacokinetic Parameters of Selected Compounds<a class="ref internalNav" href="#t5fn8" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="rowsep1" colspan="3" align="center" char=".">in vivo PK (mouse), 10 mg/kg iv</th><th class="rowsep1" colspan="4" align="center" char=".">in vivo PK (mouse), 10 mg/kg os</th></tr><tr valign="top"><th align="center">compd</th><th align="center" char="."><i>t</i><sub>1/2</sub>, h</th><th align="center" char=".">CL, (mL/h)/kg</th><th align="center" char="."><i>V</i><sub>ss</sub>, mL/kg</th><th align="center" char="."><i>t</i><sub>1/2</sub>, h</th><th align="center" char="."><i>C</i><sub>max</sub>, μM</th><th align="center" char=".">AUC, μM·h</th><th align="center" char="."><i>F</i>, %</th></tr></thead><tbody><tr valign="top"><td align="left"><b>28</b></td><td align="char" char=".">2.6</td><td align="char" char=".">1873</td><td align="char" char=".">4822</td><td align="char" char=".">2.9</td><td align="char" char=".">2.35</td><td align="char" char=".">8.29</td><td align="char" char=".">85</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="char" char=".">1.9</td><td align="char" char=".">2621</td><td align="char" char=".">5273</td><td align="char" char=".">3.9</td><td align="char" char=".">0.60</td><td align="char" char=".">2.51</td><td align="char" char=".">38</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="char" char=".">1.8</td><td align="char" char=".">1898</td><td align="char" char=".">3227</td><td align="char" char=".">4.2</td><td align="char" char=".">0.77</td><td align="char" char=".">3.37</td><td align="char" char=".">42</td></tr><tr valign="top"><td align="left"><b>40</b></td><td align="char" char=".">1.4</td><td align="char" char=".">3200</td><td align="char" char=".">4040</td><td align="char" char=".">3.4</td><td align="char" char=".">0.57</td><td align="char" char=".">1.97</td><td align="char" char=".">28</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn8"><div class="footnote" id="t5fn8"><sup>a</sup><p class="last">Dosed in 5% dextrose as hydrochloride salt.</p></div></div></div><div class="NLM_p">Compound <b>28</b> displayed a combination of cellular potency and physicochemical properties that made it suitable for further profiling as an orally active CDK inhibitor. It was subsequently screened against a panel of 43 serine−threonine and tyrosine kinases. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, among the members of the CDK family that were assessed, <b>28</b> turned out to be a potent inhibitor of CDK2/cyclin A but also, albeit less potent, an inhibitor of CDK4/cyclin D1 (ratio vs CDK2/cyclin A of 3.5×), CDK5/p35 (6×), CDK2/cyclin E (8×), CDK1/cyclin B (8.5×), and CDK7/cyclin H (3×). Among all the other enzymes in the panel, only TRKA was inhibited in the same nanomolar range by compound <b>28</b>. It is worth noting that overexpression of TRKA correlates with an aggressive phenotype and poor clinical outcome in malignant solid tumors such as prostate,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> pancreatic,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and breast cancer.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selectivity Profile of Compound <b>28</b><a class="ref internalNav" href="#t6fn8" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th class="colsep1" colspan="7" align="center" char=".">IC<sub>50</sub>, μM</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" char=".">CDK2/A</th><th class="rowsep1" align="center" char=".">CDK4/D1</th><th class="rowsep1" align="center" char=".">CDK5/p35</th><th class="rowsep1" align="center" char=".">CDK2/E</th><th class="rowsep1" align="center" char=".">CDK1/B</th><th class="rowsep1" align="center" char=".">CDK7/H</th><th class="rowsep1" align="center" char=".">TRKA</th></tr></thead><tbody><tr valign="top"><td align="char" char=".">0.045</td><td align="char" char=".">0.160</td><td align="char" char=".">0.265</td><td align="char" char=".">0.363</td><td align="char" char=".">0.398</td><td align="char" char=".">0.150</td><td align="char" char=".">0.053</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn8"><div class="footnote" id="t6fn8"><sup>a</sup><p class="last">Values are the mean of two or more experiments.</p></div></div></div><div class="NLM_p">The effects of compound <b>28</b> on the cell cycle progression and DNA synthesis (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) were analyzed using flow cytometry analysis and BrdU incorporation, respectively, on A2780 ovarian carcinoma cells in exponential growth in the presence or absence of compound, for 24 h at 1 μM. At this concentration, the compound was able to show a clear reduction of S phase population, which was associated with an increase of G1 population as expected for a CDK2/cyclin A inhibitor. The reduction of S phase population was linked to a strong reduction of the percentage of BrdU incorporating cell, meaning that DNA synthesis in these cells was impaired.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Effects on Cell Cycle Progression and DNA Synthesis of Compound <b>28</b> at 1 μM<a class="ref internalNav" href="#t7fn8" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" char=".">G0/G1, %</th><th class="rowsep1" align="center" char=".">S, %</th><th class="rowsep1" align="center" char=".">G2/M, %</th><th class="rowsep1" align="center" char=".">BrdU incorporation, %</th></tr></thead><tbody><tr valign="top"><td align="char" char=".">+49</td><td align="char" char=".">−68</td><td align="char" char=".">−40</td><td align="char" char=".">−75</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn8"><div class="footnote" id="t7fn8"><sup>a</sup><p class="last">Versus control cells.</p></div></div></div><div class="NLM_p">In addition, the effect on the phosphorylation status of a known CDK substrate such as retinoblastoma protein (pRb) was analyzed in cells treated with compound <b>28</b> at 1 and 3 μM. A clear reduction of the hyperphosphorylated form of pRb and an accumulation of the hypophosphorylated form of pRb were observed in the extracts of treated cells in comparison with the untreated cells, indicative of an effect on the activity of CDK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>28</b> decreases the amount of pRB phosphorylation in treated cells in comparison with untreated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the data presented above, compound <b>28</b> was prioritized for further in vivo characterization in the human ovarian A2780 xenograft mouse model. The doses of 20, 30, and 40 mg/kg were selected and administered orally twice a day for 10 consecutive days on the basis of the plasma levels reached in the preliminary in vivo PK study. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> illustrates the results from this study. Compound <b>28</b> caused a dose-dependent inhibition of A2780 tumor growth up to 91% at a dose of 40 mg/kg.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>28</b> shows 53%, 76%, and 91% tumor growth inhibition (TGI) against a human ovarian cancer model (A2780) transplanted into nude mice when orally administered respectively at doses of 20 (◼), 30 (▲), and 40 (×) mg/kg b.i.d. for 10 consecutive days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from compound <b>1</b>, showing good potency as CDK inhibitor but being poorly selective against a panel of serine−threonine and tyrosine kinases, a series of new analogues was synthesized. A remarkable enhancement in selectivity toward Aurora A was achieved through the incorporation of the dimethyl group at the 4-position of the skeleton. Several of the prepared compounds showed antiproliferative activity against A2780 human ovarian carcinoma cells mediated by CDK2 inhibition. Optimization of the physical properties and pharmacokinetic profile led to the identification of the highly potent, orally available compound <b>28</b> (PHA-848125). The inhibition of TRKA highlighted the value of <b>28</b> due to the involvement of this kinase in the development of solid tumors such as prostate, pancreatic, and breast cancer. The evaluation of this aspect will be reported elsewhere. Compound <b>28</b> is currently undergoing phase I and phase II clinical trials.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p last">All solvents and reagents, unless otherwise stated, were commercially available, were of the best grade, and were used without further purification. All experiments dealing with moisture-sensitive compounds were conducted under dry nitrogen or argon. Organic solutions were evaporated using a Heidolph WB 2001 rotary evaporator at 15−20 mmHg. Thin-layer chromatography was performed on Merck silica gel 60 F<sub>254</sub> precoated plates. Column chromatography was conducted either under medium pressure on silica (Merck silica gel 40−63 μm) or on prepacked silica gel cartridges (Biotage). Components were visualized by UV light (λ = 254 nm) and by iodine vapor. <sup>1</sup>H NMR spectra were recorded at 28 °C on a Varian Inova 400 spectrometer in DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> using the residual solvent signal as reference. Chemical shifts (δ) are reported in parts per million (ppm) and coupling constants (<i>J</i>) in Hz. The following abbreviations are used for multiplicities: s = singlet; bs = broad signal; d = doublet; t = triplet; m = multiplet; dd = doublet of doublets. Electrospray (ESI) mass spectra were obtained on a Finnigan LCQ ion trap. Unless otherwise specified, all final compounds were homogeneous (purity of not less than 95%), as determined by high-performance liquid chromatography (HPLC). HPLC−UV−MS analyses, used to assess compound purity, were carried out combining the ion trap MS instrument with HPLC system SSP4000 (Thermo Separation Products) equipped with an autosampler LC Pal (CTC Analytics) and UV6000LP diode array detector (UV detection at 215−400 nm). Instrument control, data acquisition, and processing were performed by using Xcalibur 1.2 software (Finnigan). HPLC chromatography was run at room temperature and 1 mL/min flow rate using a Waters X Terra RP 18 column (4.6mm × 50 mm, 3.5 μm). Mobile phase A was 5 mM ammonium acetate buffer (pH 5.5 with acetic acid)/acetonitrile, 90:10, and mobile phase B was 5 mM ammonium acetate buffer (pH 5.5 with acetic acid)/acetonitrile, 10:90. The gradient was from 0 to 100% B in 7 min and then held at 100% B for 2 min before requilibration. ESI(+) high resolution mass spectra (HRMS) were obtained on a Waters Q-Tof Ultima directly connected to a micro-HPLC 1100 Agilent as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Elemental analyses were performed on a Carlo Erba 1110 instrument, and C, H, and N results were within ±0.4% of theoretical values unless otherwise specified. Melting points are uncorrected.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-Ethoxycyclohex-2-en-1-one (<b>3</b>)</h3><div class="NLM_p last">1,2-Cyclohexandione (50.0 g, 0.445 mol) was dissolved in a mixture of toluene (1.0 L) and ethanol (0.5 L). <i>p</i>-Toluenesulfonic acid (10.0 g, 52 mmol) was added and the solution heated under reflux for 2 days. The solvent was then evaporated and the residue dissolved with dichloromethane and washed with a saturated solution of NaHCO<sub>3</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude was purified by chromatography on a silica gel column (cyclohexane/ethyl acetate, 98/2) to give <b>3</b> as an oil (41.41 g, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.99 (t, <i>J</i> = 4.5 Hz, 1H), 3.67 (q, <i>J</i> = 6.8 Hz, 2H), 2.33−2.39 (m, 4H), 1.82−1.88 (m, 2H) 1.20 (t, <i>J</i> = 6.8 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 141 (M + H)<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Ethyl (3-Ethoxy-2-oxocyclohex-3-en-1-yl)(oxo)acetate (<b>4</b>)</h3><div class="NLM_p last">LiN(TMS)<sub>2</sub> (1 M in THF, 325 mL) was added dropwise at −50 °C to a solution of <b>3</b> (41.40 g, 0.29 mol) in diethyl ether (310 mL). After 30 min at the same temperature, diethyl oxalate (44.2 mL, 0.325 mol) was added. The solution was kept at room temperature overnight. Water (300 mL) was added, the pH adjusted to 4−5 by adding 1 N HCl, and the resulting solution extracted with ethyl acetate. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness. The crude was purified by chromatography on a silica gel column (dichloromethane) to yield <b>4</b> as an oil (52.9 g, 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) <i>δ 5</i>.93 (m, 1H), 4.23 (q, <i>J</i> = 7.1 Hz, 2H), 3.70 (q, <i>J</i> = 6.9 Hz, 2H), 3.27 (m, 1H), 2.06−2.58 (m, 4H), 1.25 (t, <i>J</i> = 7.1 Hz, 3H), 1.20 (t, <i>J</i> = 6.9 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 241 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>12</sub>H<sub>16</sub>O<sub>5</sub> + H<sup>+</sup> 241.1070, found 241.1072.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Ethyl 1-Methyl-7-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>5</b>)</h3><div class="NLM_p last">Compound <b>4</b> (30.0 g, 0.125 mol) was dissolved in glacial acetic acid (150 mL), and methylhydrazine (6.6 mL, 0.125 mol) was added. The mixture was stirred at room temperature for 6 h. The solvent was evaporated, the crude dissolved with water, the solution made basic with 30% NH<sub>4</sub>OH and extracted with dichloromethane. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was purified by chromatography on a silica gel column (dichloromethane) and crystallized from a mixture <i>n</i>-hexane/diethyl ether to give <b>5</b> as a white solid (17.5 g, 63%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.33 (q, <i>J</i> = 6.9 Hz, 2H), 4.15 (s, 3H), 2.90 (t, <i>J</i> = 6.2 Hz, 2H), 2.51−2.53 (m, 2H), 2.03−2.07 (m, 2H), 1.33 (t, <i>J</i> = 6.9 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 223 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>11</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub> + H<sup>+</sup> 223.1077, found 223.1077.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Ethyl (6<i>E</i>)-6-[(Dimethylamino)methylidene]-1-methyl-7-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>6a</b>)</h3><div class="NLM_p last">Compound <b>5</b> (16.0 g, 0.072 mol) was dissolved in DMF (100 mL), and <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal (32 mL, 0.13 mol) was added. The mixture was stirred at 60 °C for 8 h. The solvent was evaporated and the solid crystallized from ethanol to give <b>6a</b> as a white solid (17.9 g, 90%). <sup>1</sup>H NMR (400 MHz), DMSO-<i>d</i><sub>6</sub>) δ 7.48 (s, 1H), 4.26 (q, <i>J</i> = 6.9 Hz, 2H), 4.12 (s, 3H), 3.12 (s, 6H), 2.88−2.92 (m, 2H), 2.79−2.83 (m, 2H), 1.29 (t, <i>J</i> = 6.9 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 278 (M + H)<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-Methoxy-5,5-dimethyl-cyclohex-2-en-1-one (<b>7</b>)</h3><div class="NLM_p last">A solution of 5,5-dimethyl-1,3-cyclohexanedione (80.0 g, 0.57 mol) in anhydrous methanol (600 mL) was treated with 1 M solution of titanium chloride (TiCl<sub>4</sub>) in dichloromethane (17.2 mL). After being stirred for 1 h at room temperature, the mixture was slowly poured into a cold 5% NaHCO<sub>3</sub> solution and extracted with diethyl ether (450 mL × 6). The organic layers were collected, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness, affording <b>7</b> (80.7 g, 92%) as a pale-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.35 (s, 1H), 3.68 (s, 3H), 2.26 (s, 2H), 2.19 (s, 2H), 1.05 (s, 6H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4,4-Dimethyl-7-oxa-bicyclo[4.1.0]heptan-2-one (<b>8</b>)</h3><div class="NLM_p last">A solution of <b>7</b> (80.0 g, 0.519 mol) in anhydrous THF (270 mL) was treated dropwise with a 1 M solution of LiAlH<sub>4</sub> in THF (182 mL) under argon atmosphere and keeping the temperature of the reaction between 0 and 5 °C. The temperature was allowed to rise to 25 °C, and the mixture was stirred for 4 h. The resulting slurry was cooled in an ice bath, quenched with ethyl acetate (30 mL), and poured with caution into a cooled 2 M H<sub>2</sub>SO<sub>4</sub> solution. The aqueous solution was then extracted with diethyl ether (300 mL × 3), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to remove most of the solvent. The crude material was dissolved in methanol (500 mL), cooled to 0 °C, and treated with 30% hydrogen peroxide (265 mL, 2.6 mol). The resulting solution was treated dropwise with a 2% NaOH solution (142 mL, 0.067 mol), keeping the reaction temperature around 0 °C. The mixture was allowed to stay at 4 °C for 20 h and was then diluted with water (900 mL) and extracted with ethyl ether (450 mL × 4). The extracts were collected, washed with 5% sodium metabisulfite solution and with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by distillation under vacuum to obtain <b>8</b> (56.7 g, 78%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.59 (t, <i>J</i> = 4.6 Hz, 1H), 3.20 (d, <i>J</i> = 3.8 Hz, 1H), 2.54 (d, <i>J</i> = 13.1 Hz, 1H), 1.91 (part of AB system, <i>J</i> = 14.6 Hz, 1H), 1.87 (part of AB system, <i>J</i> = 14.6, 4.3, 2.1, 1H), 1.74 (d, <i>J</i> = 13.1, 2.1, 1.1 Hz, 1H), 0.97 (s, 3H), 0.85 (s, 3H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Methoxy-5,5-dimethyl-cyclohex-2-en-1-one (<b>9</b>)</h3><div class="NLM_p last">A solution of <b>8</b> (44.0 g, 0.31 mol) in methanol (150 mL) was added to a solution of 85% potassium hydroxide (20.7 g, 0.31 mol) in methanol (450 mL) at room temperature. The mixture was kept at this temperature for 20 h. After cooling, the solution was diluted with water (1.2 L) and extracted with diethyl ether (350 mL × 5). The organic extracts were collected, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under vacuum to remove most of the solvent. The crude material was purified by distillation to obtain <b>9</b> (32.8 g, 68%) as an oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.83 (t, <i>J</i> = 4.4 Hz, 1H), 3.49 (s, 3H), 2.29 (s, 2H), 2.28 (d, <i>J</i> = 4.4 Hz, 2H), 0.98 (s, 6H).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Ethyl 1,4,4-Trimethyl-7-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>10</b>)</h3><div class="NLM_p last">A sample of 60% sodium hydride in mineral oil (2.41 g, 60.3 mmol) was suspended in anhydrous THF (60 mL) under argon atmosphere and treated with a solution of <b>9</b> (6.2 g, 40.2 mmol) in anhydrous THF (50 mL). After 15 min, a solution of diethyl oxalate (8.17 mL, 60.3 mmol) in anhydrous THF (50 mL) was added and the mixture was refluxed for 1 h. The slurry was diluted with water (800 mL), acidified with 1 N HCl (50 mL), and extracted with ethyl acetate (500 mL × 2). The organic layers were collected, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness to obtain an orange oil, which was dissolved in acetic acid (65 mL) and treated dropwise with a solution of methylhydrazine (2.14 mL, 40.2 mmol) in acetic acid (20 mL). The solution was stirred at room temperature overnight. The mixture was then diluted with water (800 mL) and extracted with ethyl acetate (500 mL × 2). The organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness. The crude material was chromatographed on silica gel (dichloromethane/ethyl acetate, 100/5) to obtain <b>10</b> (4.82 g, 48%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.43 (q, <i>J</i> = 7.0 Hz, 2H), 4.19 (s, 3H), 2.61 (t, <i>J</i> = 6.4 Hz, 2H), 1.98 (t, <i>J</i> = 6.4 Hz, 2H), 1.49 (s, 6H), 1.42 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Ethyl (6<i>E</i>)-6-[(Dimethylamino)methylidene]-1,4,4-trimethyl-7-oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>6b</b>)</h3><div class="NLM_p last">A solution of <b>10</b> (4.8 g, 19.2 mmol) in anhydrous DMF (30 mL) was treated with <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal (9.19 mL, 38.35 mmol) at 60 °C for 2 h. The mixture was evaporated to dryness, and the crude material was crystallized from <i>n</i>-hexane to give <b>6b</b> (5.1 g, 87%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.49 (s, 1H), 4.27 (q, <i>J</i> = 7.1 Hz, 1H), 4.09 (s, 3H), 3.11 (s, 6H), 2.76 (s, 2H), 1.32 (s, 6H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Ethyl 1-Methyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>11a</b>)</h3><div class="NLM_p last">Phenylguanidine carbonate (2.13 g, 13.31 mmol) was added to a suspension of compound <b>6a</b> (3.0 g, 10.81 mmol) in DMF (30 mL), and the mixture was stirred at 110 °C for 6 h. After the mixture was cooled, the solvent was evaporated and the residue was dissolved in dichloromethane and washed with water. The organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was triturated with diethyl ether and filtered to give <b>11a</b> as a white solid (2.72 g, 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.52 (s, 1H), 8.42 (s, 1H), 7.69−7.71 (m, 2H), 7.28−7.32 (m, 2H), 6.94−6.98 (m, 1H), 4.36 (s, 3H), 4.30 (q, <i>J</i> = 7.2 Hz, 2H), 2.98 (t, <i>J</i> = 7.7 Hz, 2H), 2.84 (t, <i>J</i> = 7.7 Hz, 2H), 1.31 (t, <i>J</i> = 7.2 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 350 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 350.1611, found 350.1614.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Ethyl 1,4,4-Trimethyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>11b</b>)</h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>6b</b>, compound <b>11b</b> was prepared. Yield, 90%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.53 (s, 1H), 8.41 (s, 1H), 7.68−7.70 (m, 2H), 7.28−7.32 (m, 2H), 6.94−6.98 (m, 1H), 4.34 (s, 3 H), 4.29 (q, <i>J</i> = 7.1 Hz, 2H), 2.73 (s, 2H), 1.32 (s, 6H), 1.31 (t, <i>J</i> = 7.15 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 378 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 378.1925, found 378.1919.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-Methyl-8-phenylamino-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylic Acid (<b>2</b>)</h3><div class="NLM_p last">To a suspension of <b>11a</b> (0.50 g, 1.43 mmol) in anhydrous ethanol (25 mL), 1.5 M KOH in 95% ethanol (3.7 mL, 5.55 mmol) was added under good stirring, and the mixture was left at room temperature overnight. After the mixture was cooled in an ice bath, 1 N HCl was added until neutral pH was attained. Water was added and the resulting precipitate collected by filtration to give <b>2</b> (390 mg, 85%) as a white solid: mp >250 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.68 (bs, 1H), 9.51 (s, 1H), 8.41 (s, 1H), 7.79−7.71 (m, 2H), 7.28−7.32 (m, 2H), 6.94−6.98 (m, 1H), 4.34 (s, 3H), 2.96 (t, <i>J</i> = 7.6 Hz, 2H), 2.83 (t, <i>J</i> = 7.6 Hz, 2H); LCMS (ESI) <i>m</i>/<i>z</i> 322 (M + H)<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-Methyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1</b>)</h3><div class="NLM_p last">A solution of <b>2</b> (150 mg, 0.46 mmol) in anhydrous DMF (5 mL) was treated with <i>N</i>,<i>N</i>-diisopropylethylamine (0.12 mL, 0.69 mmol) and EDC (131 mg, 0.69 mmol). The mixture was treated with 1-hydroxybenzotriazole ammonium salt<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (HOBt·NH<sub>3</sub>) (105 mg, 0.69 mmol). The mixture was kept at room temperature overnight and then was diluted with water, and the resulting precipitate was collected by filtration to afford <b>1</b> (132 mg, 90%): mp >250 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.48 (s, 1H), 8.40 (s, 1H), 7.68−7.71 (m, 2H), 7.45 (bs, 1H), 7.29 (m, 2H), 7.24 (bs, 1H), 6.93−6.97 (m, 1H), 4.32 (s, 3H), 2.98 (t, <i>J</i> = 7.8 Hz, 2H), 2.81 (t, <i>J</i> = 7.8 Hz, 2H); LCMS (ESI) <i>m</i>/<i>z</i> 321 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>17</sub>H<sub>16</sub>N<sub>6</sub>O + H<sup>+</sup> 321.1458, found 321.1458. Anal. (C<sub>17</sub>H<sub>16</sub>N<sub>6</sub>O) C, H, N.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>,1-Dimethyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>16</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (150 mg, 0.46 mmol) in anhydrous DMF (5 mL) were added <i>N,N</i>-diisopropylethylamine (0.12 mL, 0.69 mmol), HOBT (93 mg, 0.69 mmol), EDC (131 mg, 0.69 mmol), 2 M methylamine in THF (0.345 mL, 0.69 mmol), and the reaction mixture was stirred at room temperature overnight. The reaction mixture was poured into water (25 mL) and extracted with dichloromethane (4 × 25 mL). The combined organic extracts were washed with water and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude was purified by flash chromatography on silica gel (dichloromethane/methanol, 98/2) to afford <b>16</b> (141 mg, 92%): mp >250 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (s, 1H), 8.40 (s, 1H), 8.07 (q, <i>J</i> = 4.9 Hz, 1H), 7.69−7.71 (m, 2H), 7.30 (m, 2H), 6.96 (m, 1H), 4.33 (s, 3H), 2.99 (t, <i>J</i> = 7.9 Hz, 2H), 2.81 (t, <i>J</i> = 7.9 Hz, 2H), 2.73 (d, <i>J</i> = 4.9 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 335 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O + H<sup>+</sup> 335.1615, found 335.1627.</div></div><div id="sec17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Compounds <b>17</b>−<b>21</b></h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>2</b> and using suitable amines, compounds <b>17</b>−<b>21</b> were prepared.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-Cyclopropyl-1-methyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>17</b>)</h3><div class="NLM_p last">Yield, 55%; mp 186 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1H), 8.40 (s, 1H), 8.13 (d, <i>J</i> = 4.5 Hz, 1H), 7.68−7.70 (m, 2H), 7.27−7.31 (m, 2H), 6.93−6.98 (m, 1H), 4.32 (s, 3H), 2.98 (t, <i>J</i> = 7.8 Hz, 2H), 2.81 (t, <i>J</i> = 7.8 Hz, 2H), 2.78−2.84 (m, 1H), 0.57−0.71 (m, 4H); LCMS (ESI) <i>m</i>/<i>z</i> 361 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>20</sub>N<sub>6</sub>O + H<sup>+</sup> 361.1772, found 361.1779. Anal. (C<sub>20</sub>H<sub>20</sub>N<sub>6</sub>O) C, H, N.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(2-Hydroxyethyl)-1-methyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>18</b>)</h3><div class="NLM_p last">Yield, 68%; mp >250 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (s, 1H), 8.40 (s, 1H), 7.93 (t, <i>J</i> = 5.7 Hz, 1H), 7.69−7.71 (m, 2H), 7.28−7.32 (m, 2H), 6.94−6.98 (m, 1H), 4.73 (t, <i>J</i> = 5.4 Hz, 1H), 4.34 (s, 3H), 3.49 (m, 2H), 3.30 (m obscured by water signal, 2H), 2.99 (t, <i>J</i> = 7.9 Hz, 2H), 2.81 (t, <i>J</i> = 7.9 Hz, 2H); LCMS (ESI) <i>m</i>/<i>z</i> 365 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>20</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 365.1721, found 365.1727; HPLC purity 90%.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-Cyclopentyl-1-methyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Yield, 72%; mp >250 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (s, 1H), 8.40 (s, 1H), 7.88 (d, <i>J</i> = 7.8 Hz, 1H), 7.69−7.71 (m, 2H), 7.28−7.32 (m, 2H), 6.94−6.98 (m, 1H), 4.33 (s, 3H), 4.17−4.25 (m, 1H), 2.98 (t, <i>J</i> = 7.8 Hz, 2H), 2.81 (t, <i>J</i> = 7.8 Hz, 2H), 1.50−1.89 (m, 8H); LCMS (ESI) <i>m</i>/<i>z</i> 389 (M + H)<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-Methyl-<i>N</i>-phenyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>20</b>)</h3><div class="NLM_p last">Yield, 60%; mp >250 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.07 (s, 1H), 9.53 (s, 1H), 8.43 (s, 1H), 7.80−7.83 (m, 2H), 7.70−7.73 (m, 2H), 7.30−7.35 (m, 4H), 7.06−7.10 (m, 1H), 6.95−6.99 (m, 1H), 4.41 (s, 3H), 3.05 (t, <i>J</i> = 7.9 Hz, 2H), 2.86 (t, <i>J</i> = 7.9 Hz, 2H); LCMS (ESI) <i>m</i>/<i>z</i> 397 (M + H)<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-Benzyl-1-methyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>21</b>)</h3><div class="NLM_p last">Yield, 68%; mp 202 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 8.69 (t, <i>J</i> = 6.3 Hz, 1H), 8.40 (s, 1H), 7.69−7.71 (m, 2H), 7.22−7.32 (m, 5H), 7.28−7.32 (m, 2H), 6.94−6.98 (m, 1H), 4.42 (d, <i>J</i> = 6.3 Hz, 2H), 4.35 (s, 3H), 3.00 (t, <i>J</i> = 7.9 Hz, 2H), 2.82 (t, <i>J</i> = 7.9 Hz, 2H); LCMS (ESI) <i>m</i>/<i>z</i> 411 (M + H)<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1,4,4-Trimethyl-8-phenylamino-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>26</b>)</h3><div class="NLM_p last">To a suspension of <b>11b</b> (0.50 g, 1.32 mmol) in anhydrous ethanol (25 mL), 1.5 M KOH in 95% ethanol (2.64 mL, 3.96 mmol) was added under good stirring, and the mixture was left at room temperature overnight. After the mixture was cooled in an ice bath, 1 N HCl was added until neutral pH was attained. Water was added, and the resulting precipitate was collected by filtration (420 mg, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (s, 1H), 9.51 (s, 1H), 8.40 (s, 1H), 7.68−7.71 (m, 2H), 7.28−7.32 (m, 2H), 6.94−6.98 (m, 1H), 4.34 (s, 3H), 2.71 (s, 2H), 1.33 (s, 6H). A solution of the above carboxylic acid (349 mg, 1.0 mmol) in anhydrous DMF (10 mL) was treated with <i>N</i>,<i>N</i>-diisopropylethylamine (0.349 mL, 2.0 mmol) and EDC (269 mg, 1.4 mmol). The mixture was treated with HOBt·NH<sub>3</sub> (213 mg, 1.4 mmol). The mixture was kept at room temperature for 5 h. The mixture was diluted with water and the resulting precipitate was collected by filtration to afford <b>26</b> (320 mg, 92%) as a yellow solid: mp 158 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (s, 1H), 8.39 (s, 1H), 7.68−7.71 (m, 2H), 7.55 (bs, 1H), 7.28−7.31 (m, 2H), 7.29 (bs, 1H), 6.94−6.98 (m, 1H), 4.31 (s, 3H), 2.69 (s, 2H), 1.33 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 349 (M + H)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>20</sub>N<sub>6</sub>O) C, H, N.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Ethyl 8-Amino-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>12a</b>)</h3><div class="NLM_p last">Potassium carbonate (7.87 g, 57 mmol) and guanidine hydrochloride (5.44 g, 57 mmol) were added to a solution of compound <b>6a</b> (16.0 g, 57 mmol) in DMF (60 mL), and the mixture was stirred at 110 °C for 6 h. After cooling, the mixture was poured into water (300 mL) and the resulting precipitate was collected by filtration and dried to give <b>12a</b> (14.33 g, 92% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 1H), 6.55 (bs, 2H), 4.32 (s, 3H), 4.30 (q, <i>J</i> = 7.1 Hz, 2H), 2.91 (t, <i>J</i> = 7.7 Hz, 2H), 2.74 (t, <i>J</i> = 7.7 Hz, 2H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 274 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>13</sub>H<sub>15</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 274.1298, found 274.1299.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Ethyl 8-Amino-1,4,4-trimethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>12b</b>)</h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>6b</b>, the compound <b>12b</b> was prepared. Yield, 93%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 6.56 (bs, 2H), 4.31 (s, 3H), 4.29 (q, <i>J</i> = 7.1 Hz, 2H), 2.62 (s, 2H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H), 1.29 (s, 6 H); LCMS (ESI) <i>m</i>/<i>z</i> 302 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>15</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 302.1611, found 302.1615.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Ethyl 8-Iodo-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>13a</b>)</h3><div class="NLM_p last">To a well stirred suspension of <b>12a</b> (8.8 g, 32 mmol) in dimethoxyethane (1.2 L) maintained in an inert atmosphere of argon, cesium iodide (9.13 g, 35 mmol), iodine (4.45 g, 18 mmol), copper(I) iodide (2.01 g, 10 mmol), and isopentyl nitrite (7.00 mL, 52 mmol) were added in sequence. The reaction mixture was stirred vigorously at 65 °C for 18 h. After the mixture was cooled in an ice−water bath, the solid was filtered off and the filtrate was diluted with dichloromethane (2.0 L), washed with 30% ammonium hydroxide (150 mL), sodium thiosulphate (300 mL), brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Concentrating to a volume of about 100 mL of dimethoxyethane, the crude <b>13a</b> precipitated. It was then filtered and washed with dimethoxyethane. Flash chromatography on silica gel (eluant, dichloromethane/methanol, 98/2) yielded the title compound (5.65 g, 46%). <sup>1</sup>H NMR (400 MHz), DMSO-<i>d</i><sub>6</sub>), δ 8.48 (s, 1H), 4.29 (q, <i>J</i> = 7.1 Hz, 2H), 4.26 (s, 3H), 3.01 (m, 2H), 2.93 (m, 2H), 1.31 (t, <i>J</i> = 7.1 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 385 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>13</sub>H<sub>13</sub>IN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 385.0156, found 385.0154.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Ethyl 8-Iodo-1,4,4-trimethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (13b)</h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>12b</b>, compound <b>13b</b> was prepared. Yield, 40%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.48 (s, 1H), 4.30 (q, <i>J</i> = 7.2 Hz, 2H), 4.26 (s, 3H), 2.81 (s, 2H), 1.32 (s, 6H), 1.31 (t, <i>J</i> = 7.2 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 413 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>15</sub>H<sub>17</sub>IN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 413.0469, found 413.0472.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 8-Iodo-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>14a</b>)</h3><div class="NLM_p last">To a suspension of <b>13a</b> (384 mg, 1.0 mmol) in anhydrous ethanol (10 mL), 1.5 M KOH in 95% ethanol (2.0 mL, 3.0 mmol) was added under good stirring, and the mixture was left at room temperature overnight. After the mixture was cooled in an ice bath, the resulting precipitate was collected by filtration and used without further purification. A suspension of the above carboxylic acid potassium salt in anhydrous DMF (10 mL) was treated with EDC (269 mg, 1.4 mmol). HOBt·NH<sub>3</sub> (213 mg, 1.4 mmol) was added, and the mixture was kept at room temperature overnight and then diluted with water. The resulting precipitate was collected by filtration to afford <b>14a</b> (220 mg, 62%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (s, 1H), 7.51 (bs, 1H), 7.29 (bs, 1H), 4.23 (s, 3H), 3.01 (t, <i>J</i> = 8.0 Hz, 2H), 2.89 (t, <i>J</i> = 8.0 Hz, 2H); LCMS (ESI) <i>m</i>/<i>z</i> 356 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>11</sub>H<sub>10</sub>IN<sub>5</sub>O + H<sup>+</sup> 356.0003, found 356.0005.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 8-Iodo-<i>N</i>,1-dimethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>15a</b>)</h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>13a</b> and using methylamine, compound <b>15a</b> was prepared. Yield, 75%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (s, 1H), 8.12 (q, <i>J</i> = 4.8 Hz, 1H), 4.23 (s, 3H), 3.02 (dd, <i>J</i> = 7.6, 6.6 Hz, 2H), 2.89 (dd <i>J</i> = 7.6, 6.6 Hz, 2H), 2.73 (d, <i>J</i> = 4.8 Hz, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 370 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>12</sub>IN<sub>5</sub>O + H<sup>+</sup> 370.0160, found 370.0170.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 8-Iodo-1,4,4-trimethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>14b</b>)</h3><div class="NLM_p last">Potassium carbonate (1.38 g, 10 mmol) in water (10 mL) was added to a solution of compound <b>13b</b> (1.03 g, 2.5 mmol) in dioxane (20 mL), and the mixture was stirred under reflux for 30 h. After cooling, the mixture was poured into water (100 mL) and extracted with ethyl acetate (2 × 100 mL). The aqueous phase was acidified with 2 N HCl (12 mL), and the resulting precipitate was collected by filtration, washed with water, dried, and used without further purification. To a solution of the above carboxylic acid in anhydrous DMF (10 mL) were added <i>N</i>,<i>N</i>-diisopropylethylamine (0.51 mL, 3.0 mmol), EDC (572 mg, 3.0 mmol), and HOBt·NH<sub>3</sub> (456 mg, 3.0 mmol). The mixture was kept at room temperature overnight and then diluted with water. The resulting precipitate was collected by filtration and washed with water to afford <b>14b</b> (536 mg, 56%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.48 (s, 1H), 7.51 (bs, 1H), 7.30 (bs, 1H), 4.25 (s, 3H), 2.78 (s, 2H), 1.33 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 384 (M + H)<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 8-Iodo-<i>N</i>,1,4,4-tetramethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>15b</b>)</h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>13b</b> and using methylamine, compound <b>15b</b> was prepared. Yield, 65%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (s, 1H), 8.20 (q, <i>J</i> = 4.6 Hz, 1H), 4.22 (s, 3H), 2.78 (s, 2H), 2.75 (d, <i>J</i> = 4.6 Hz, 3H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 398 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>14</sub>H<sub>16</sub>IN<sub>5</sub>O + H<sup>+</sup> 398.0473, found 398.0476.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-Methyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Pd(OAc)<sub>2</sub> (20 mg, 0.09 mmol), (±)-BINAP (55 mg, 0.09 mmol), and DMF (5 mL) were charged in a round-bottom flask flushed with argon. The flask was evacuated and backfilled with argon. The mixture was stirred under argon for 30 min and added to a mixture of <b>14a</b> (319 mg, 0.9 mmol), 4-(4-methylpiperazin-1-yl)phenylamine (515 mg, 2.7 mmol), and potassium carbonate (1.24 g, 9.0 mmol) in DMF (10 mL). The resulting mixture was stirred at 80 °C for 3 h under argon. After cooling to room temperature, the reaction mixture was filtered on a pad of Celite. The solvent was concentrated, and the crude solid was purified by flash chromatography on silica gel (eluant, dichloromethane/methanol, 95/5) to afford <b>22</b> (230 mg, 61%): mp 211 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (bs, 1H), 8.33 (s, 1H), 7.52 (m, 2H), 7.46 (bs, 1H), 7.25 (bs, 1H), 6.90 (m, 2H), 4.31 (s, 3H), 3.05−3.07 (m, 4H), 2.97 (t, <i>J</i> = 7.9 Hz, 2H), 2.78 (t, <i>J</i> = 7.9 Hz, 2H), 2.46−2.48 (m, 4H), 2.23 (s, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 419 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>26</sub>N<sub>8</sub>O + H<sup>+</sup> 419.2303, found 419.2297.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>,1-dimethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>23</b>)</h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>15a</b>, compound <b>23</b> was prepared. Yield, 65%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.27 (s, 1H), 8.34 (s, 1H), 8.08 (q, <i>J</i> = 4.7 Hz, 1H), 7.55 (m, 9.2 Hz, 2H), 6.93 (d, <i>J</i> = 9.2 Hz, 2H), 4.33 (s, 3H), 3.04−3.08 (m, 4H), 2.97 (t, <i>J</i> = 7.9 Hz, 2H), 2.78 (t, <i>J</i> = 7.9 Hz, 2H), 2.75 (d, <i>J</i> = 4.7 Hz, 3H), 2.45−2.50 (m, 4H), 2.24 (s, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 433 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>N<sub>8</sub>O + H<sup>+</sup> 433.2459, found 433.2459.</div></div><div id="sec24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Compounds <b>24</b> and <b>25</b></h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>14a</b> and using the suitable substituted aniline, compounds <b>24</b> and <b>25</b> were prepared.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-Methyl-8-{[3-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>24</b>)</h3><div class="NLM_p last"> Yield, 52%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.34 (bs, 1H), 8.39 (s, 1H), 7.43 (bs, 1H), 7.26−7.28 (m, 2H), 7.26 (bs, 1H), 7.15 (t, <i>J</i> = 8.0 Hz, 1H), 6.60 (d, <i>J</i> = 8.4 Hz, 1H), 4.33 (s, 3H), 3.0−3.5 (bs obscured by water signal, 4H), 2.98 (t, <i>J</i> = 7.8 Hz, 2H), 2.85−2.95 (bs, 4H), 2.80 (t, <i>J</i> = 7.8 Hz, 2H), 2.52−2.59 (bs, 3H); LCMS (ESI) <i>m</i>/<i>z</i> 419 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>26</sub>N<sub>8</sub>O + H<sup>+</sup> 419.2303, found 419.2306.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-Methyl-8-[(4-morpholin-4-ylphenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>25</b>)</h3><div class="NLM_p last">Yield, 60%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (bs, 1H), 8.34 (s, 1H), 7.52−7.56 (m, 2H), 7.44 (bs, 1H), 7.23 (bs, 1H), 6.89−6.93 (m, 2H), 4.31 (s, 3H), 3.73−3.77 (m, 4H), 3.03−3.05 (m, 4H), 2.97 (t, <i>J</i> = 7.8 Hz, 2H), 2.78 (t, <i>J</i> = 7.8 Hz, 2H); LCMS (ESI) <i>m</i>/<i>z</i> 406 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 406.1986, found 406.1991; HPLC purity 90%.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1,4,4-Trimethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>27</b>)</h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>14b</b> and using the suitable substituted aniline, tcompound <b>27</b> was prepared. Yield, 54%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.23 (bs, 1H), 8.32 (s, 1H), 7.53 (bs, 1H), 7.49−7.53 (m, 2H), 7.27 (bs, 1H), 6.87−6.91 (m, 2H), 4.29 (s, 3H), 3.06−3.08 (m, 4H), 2.66 (s, 2H), 2.48−2.55 (m partially obscured by DMSO, 4H), 2.24 (s, 3H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 447 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>24</sub>H<sub>30</sub>N<sub>8</sub>O + H<sup>+</sup> 447.2616, found 447.2616.</div></div><div id="sec28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Compounds <b>28</b>−<b>41</b></h3><div class="NLM_p last">By employment of the above-described procedure, starting from <b>15b</b> and using the suitable substituted aniline, the compounds <b>28</b>−<b>41</b> were prepared.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>28</b>)</h3><div class="NLM_p last"> Yield, 65%; mp 190 °C; <sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>) δ 9.24 (bs, 1H), 8.32 (s, 1H), 8.13 (q, <i>J</i> = 4.8 Hz, 1H), 7.49−7.54 (m, 2H), 6.88−6.92 (m, 2H), 4.29 (s, 3H), 3.05−3.10 (m, 4H), 2.74 (d, <i>J</i> = 4.8 Hz, 3H), 2.66 (bs, 2H), 2.44−2.54 (m obscured by DMSO, 4H), 2.26 (bs, 3H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 461 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>25</sub>H<sub>32</sub>N<sub>8</sub>O +H<sup>+</sup> 461.2772, found 461.2772. Anal. (C<sub>25</sub>H<sub>32</sub>N<sub>8</sub>O) C, H, N.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>,1,4,4-Tetramethyl-8-{[3-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>29</b>)</h3><div class="NLM_p last">Yield, 61%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.30 (s, 1H), 8.37 (s, 1H), 8.14 (q, <i>J</i> = 4.9 Hz, 1H), 7.24 (dd, <i>J</i> = 8.0, 2.2 Hz, 1H), 7.21 (t, <i>J</i> = 2.2 Hz, 1H), 7.12 (t, <i>J</i> = 8.0 Hz, 1H), 6.56 (dd, <i>J</i> = 8.0, 2,2 Hz, 1H), 4.31 (s, 3H) 3.09−3.13 (m, 4H), 2.74 (d, <i>J</i> = 4.9 Hz, 3H), 2.67 (bs, 2H) 2.50−2.54 (m obscured by DMSO, 4H), 2.25 (bs, 3H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 461 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>25</sub>H<sub>32</sub>N<sub>8</sub>O + H<sup>+</sup> 461.2772, found 461.2780.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>,1,4,4-Tetramethyl-8-[(4-morpholin-4-ylphenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>30</b>)</h3><div class="NLM_p last">Yield, 61%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (s, 1H), 8.33 (s, 1H), 8.13 (q, <i>J</i> = 4.9 Hz, 1H), 7.52−7.56 (m, 2H), 6.89−6.93 (m, 2H), 4.29 (s, 3H), 3.73−3.75 (m, 4H), 3.03−3.05 (m, 4H), 2.74 (d, <i>J</i> = 4.9 Hz, 3H), 2.66 (s, 2H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 448 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>24</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 448.2456, found 448.2455.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>,1,4,4-Tetramethyl-8-[(3-morpholin-4-ylphenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>31</b>)</h3><div class="NLM_p last">Yield, 71%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.33 (s, 1H), 8.38 (s, 1H), 8.14 (q, <i>J</i> = 4.6 Hz, 1H), 7.28 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.21 (t, <i>J</i> = 2.0 Hz, 1H), 7.14 (t, <i>J</i> = 8.0 Hz, 1H), 6.57 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 4.31 (s, 3H), 3.73−3.75 (m, 4H), 3.07−3.09 (m, 4H), 2.74 (d, <i>J</i> = 4.6 Hz, 3H), 2.68 (s, 2H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 448 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>24</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 448.2456, found 448.2454.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>,1,4,4-Tetramethyl-8-({4-[(1-methylpiperidin-4-yl)oxy]phenyl}amino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>32</b>)</h3><div class="NLM_p last">Yield, 36%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.32 (s, 1H), 8.34 (s, 1H), 8.13 (q, <i>J</i> = 4.8 Hz, 1H), 7.54−7.58 (m, 2H), 6.90−6.94 (m, 2H), 4.34−4.41 (m, 1H), 4.28 (s, 3H), 2.82−2.93 (bs, 2H), 2.74 (d, <i>J</i> = 4.8 Hz, 3H), 2.67 (s, 2H), 2.37−2.47 (bs, 5H), 1.93−2.02 (bs, 2H), 1.66−1.81 (bs, 2H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 476 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>26</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 476.2768, found 476.2767; HPLC purity 95%.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>,1,4,4-Tetramethyl-8-({3-[(1-methylpiperidin-4-yl)oxy]phenyl}amino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>33</b>)</h3><div class="NLM_p last">Yield, 30%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (s, 1H), 8.40 (s, 1H), 8.14 (q, <i>J</i> = 4.80 Hz, 1H), 7.40 (t, <i>J</i> = 2.1 Hz, 1H), 7.26 (ddd, <i>J</i> = 8.2, 2.1, 0.7 Hz, 1 H), 7.17 (t, <i>J</i> = 8.2 Hz, 1H), 6.55 (ddd, <i>J</i> = 8.2, 2.1, 0.7 Hz, 1 H), 4.33 (s, 3H), 4.28−4.34 (m, 1H), 2.74 (d, <i>J</i> = 4.8 Hz, 3H), 2.69 (s, 2H), 2.58−2.66 (m, 2H), 2.18−2.25 (bs, 2H), 2.20 (s, 3H), 1.91−1.99 (m, 2H), 1.60−1.70 (m, 2H), 1.33 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 476 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>26</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 476.2768, found 476.2776.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>,1,4,4-Tetramethyl-8-({4-[(4-methylpiperazin-1-yl)methyl]phenyl}amino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>34</b>)</h3><div class="NLM_p last">Yield, 55%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.48 (s, 1H), 8.38 (s, 1H), 8.15 (q, <i>J</i> = 4.8 Hz, 1H), 7.62−7.65 (m, 2H), 7.19−7.22 (m, 2H), 4.31 (s, 3H), 3.40 (s, 2H), 2.75 (d, <i>J</i> = 4.8 Hz, 3H), 2.69 (s, 2H), 2.26−2.45 (bs, 8H), 2.18 (bs, 3H), 1.33 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 475 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>26</sub>H<sub>34</sub>N<sub>8</sub>O + H<sup>+</sup> 475.2928, found 475.2932.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>,1,4,4-Tetramethyl-8-({3-[(4-methylpiperazin-1-yl)methyl]phenyl}amino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>35</b>)</h3><div class="NLM_p last">Yield, 62%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 8.39 (s, 1H), 8.14 (q, <i>J</i> = 4.8 Hz, 1H), 7.73 (bs, 1H), 7.55 (d, <i>J</i> = 7.8, Hz, 1H), 7.22 (t, <i>J</i> = 7.8 Hz, 1H), 6.87 (d, <i>J</i> = 7.8 Hz, 1H), 4.33 (s, 3H), 3.41 (s, 2H), 2.75 (d, <i>J</i> = 4.8 Hz, 3H), 2.69 (s, 2H), 2.26−2.47 (bs, 8H), 2.17 (bs, 3H), 1.33 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 475 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>26</sub>H<sub>34</sub>N<sub>8</sub>O + H<sup>+</sup> 475.2928, found 475.2931.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>,1,4,4-Tetramethyl-8-{[4-(morpholin-4-ylmethyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>36</b>)</h3><div class="NLM_p last">Yield, 64%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1H), 8.38 (s, 1H), 8.14 (q, <i>J</i> = 4.9 Hz, 1H), 7.63−7.68 (m, 2H), 7.19−7.25 (m, 2H), 4.31 (s, 3H), 3.56−3.61 (m, 4H), 3.40 (s, 2H), 2.74 (d, <i>J</i> = 4.9 Hz, 3H), 2.69 (s, 2H), 2.30−2.37 (bs, 4H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 462 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>25</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 462.2612, found 462.2621.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>,1,4,4-Tetramethyl-8-{[3-(morpholin-4-ylmethyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>37</b>)</h3><div class="NLM_p last">Yield, 60%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.52 (s, 1H), 8.40 (s, 1H), 8.14 (q, <i>J</i> = 4.8 Hz, 1H), 7.74 (bs, 1H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.23 (t, <i>J</i> = 7.8 Hz, 1H), 6.89 (d, <i>J</i> = 7.8 Hz, 1H), 4.34 (s, 3H), 3.54−3.60 (bs, 4H), 3.42 (bs, 2H), 2.74 (d, <i>J</i> = 4.8 Hz, 3H), 2.69 (s,2H), 2.33−2.40 (bs, 4H), 1.33 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 462 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>25</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 462.2612, found 462.2618; HPLC purity 95%.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 8-{[4-(Dimethylamino)phenyl]amino}-<i>N</i>,1,4,4-tetramethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>38</b>)</h3><div class="NLM_p last">Yield, 44%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 8.40 (s, 1H), 8.16 (q, <i>J</i> = 4.8 Hz, 1H), 7.55 (d, <i>J</i> = 9.2 Hz, 2H), 6.93 (d, <i>J</i> = 9.2 Hz, 2H), 4.33 (s, 3H), 2.88 (s, 6H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H), 2.67 (s, 2H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 406 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>N<sub>7</sub>O + H<sup>+</sup> 406.2350, found 406.2349.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 8-{[3-(Dimethylamino)phenyl]amino}-<i>N</i>,1,4,4-tetramethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>39</b>)</h3><div class="NLM_p last">Yield, 52%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (s, 1H), 8.37 (s, 1H), 8.14 (q, <i>J</i> = 4.8 Hz, 1H), 7.18 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 7.09 (t, <i>J</i> = 8.2 Hz, 1H), 6.97 (t, <i>J</i> = 2.1 Hz, 1H), 6.37 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 4.32 (s, 3H), 2.88 (s, 6H), 2.74 (d, <i>J</i> = 4.8 Hz, 3H), 2.68 (s, 2H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 406 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>N<sub>7</sub>O + H<sup>+</sup> 406.2350, found 406.2346; HPLC purity 90%.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 8-({4-[(Dimethylamino)methyl]phenyl}amino)-<i>N</i>,1,4,4-tetramethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>40</b>)</h3><div class="NLM_p last">Yield, 54%; mp 161 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (bs, 1H), 8.39 (s, 1H), 8.15 (q, <i>J</i> = 4.8 Hz, 1H), 7.64−7.68 (m, 2H), 7.20−7.25 (m, 2H), 4.32 (s, 3H), 3.43 (bs, 2H), 2.74 (d, <i>J</i> = 4.8 Hz, 3H), 2.69 (s, 2H), 2.21 (bs, 6H), 1.32 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 420 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>7</sub>O + H<sup>+</sup> 420.2506, found 420.2509.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 8-({3-[(Dimethylamino)methyl]phenyl}amino)-<i>N</i>,1,4,4-tetramethyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>41</b>)</h3><div class="NLM_p last">Yield, 62%; mp 181 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 8.39 (s, 1H), 8.14 (q, <i>J</i> = 4.8 Hz, 1H), 7.76 (s, 1H), 7.53 (d, <i>J</i> = 7.8 Hz, 1H), 7.23 (t, <i>J</i> = 7.8 Hz, 1H), 6.88 (d, <i>J</i> = 7.8 Hz, 1H), 4.33 (s, 3H), 3.34−3.38 (s obscured by water, 2H), 2.75 (d, <i>J</i> = 4.8 Hz, 3H), 2.69 (s, 2H), 2.17 (s, 6H), 1.33 (s, 6H); LCMS (ESI) <i>m</i>/<i>z</i> 420 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>7</sub>O + H<sup>+</sup> 420.2506, found 420.2498.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Registry Numbers (RN)</h3><div class="NLM_p last">1,2-Cyclohexanedione (RN, 765-87-7), 5,5-dimethyl-1,3-cyclohexanedione (RN, 126-81-8), phenylguanidine carbonate (RN, 14018-90-7), guanidine hydrochloride (RN, 50-01-1), 4-(4-methylpiperazin-1-yl)aniline (RN, 16153-81-4), 3-(4-methylpiperazin-1-yl)aniline (RN, 148546-99-0), 4-morpholin-4-ylaniline (RN, 2524-67-6), 3-morpholin-4-ylaniline (RN, 159724-40-0), 4-[(1-methylpiperidin-4-yl)oxy]aniline (RN, 358789-72-7), 3-[(1-methylpiperidin-4-yl)oxy]aniline (RN, 790667-66-2), 4-[(4-methylpiperazin-1-yl)methyl]aniline (RN, 70261-82-4), 3-[(4-methylpiperazin-1-yl)methyl]aniline (RN, 198281-55-9), 4-(morpholin-4-ylmethyl)aniline (RN, 51013-67-3), 3-(morpholin-4-ylmethyl)aniline (RN, 123207-48-7), <i>N</i>,<i>N</i>-dimethylbenzene-1,4-diamine (RN, 536-46-9), <i>N</i>,<i>N</i>-dimethylbenzene-1,3-diamine (RN, 3575-32-4), 4-[(dimethylamino)methyl]aniline (RN, 6406-74-2), 3-[(dimethylamino)methyl]aniline (RN, 27958-77-6).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Crystallographic Methods</h3><div class="NLM_p last">Expression, purification, crystallization, and soaking procedures of the CDK2/cyclin A complexes were carried out as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Kinase Assays</h3><div class="NLM_p last">Kinase assays were performed as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The panel includes c-ABL, AKT1, ALK, Aur-A, Aur-B, CDC7, CDK2/A, CDK1/B, CDK2/E, CDK4/D1, CDK5/p25, CDK7/H, CHK1, CK2, EGFR, ERK2, FGFR1, GSK3β, IGF1R, IKKi, IKK2, IR, C-KIT, LCK, LYN, MAPKAPK2, MET, NEK-6, NIM, PAK4, PDGFR, PDK1, PKAα, PKCβ, PLK1, P38α, P38β, RET, STLK2, SULU1, TRKA, VEGFR2, VEGFR3, and ZAP-70.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> In Vitro Pharmacology. A2780 Cells Proliferation Assay</h3><div class="NLM_p last">Cells were seeded into 96- or 384-well plates at final concentration ranging from 10 000 to 30 000 cells per cm<sup>2</sup> in appropriate medium plus 10% FCS. After 24 h cells were treated using serial dilution of compounds in two replicates. At 72 h after treatment the amount of cells were evaluated using the Cell Titer_Glo assay (Promega). IC<sub>50</sub> values were calculated using a sigmoidal fitting (Assay Explorer MDL). Experiments were replicated at least two times.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Flow Cytometry Analysis and BrdU Incorporation</h3><div class="NLM_p last">A2780 cells (human adenocarcinoma ovary, from ECACC) were seeded in T-75 tissue culture flasks, 25 000 cells/cm<sup>2</sup> in RPMI 1640, pH 7.4, 10% FBS, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 1× penicillin−streptomycin, and maintained in 5% CO<sub>2</sub> at 37 °C with 96% relative humidity. After 24 h, cells were treated with compounds at 1 μM for 24 h. Cells in the supernatant and adherent cells were collected using 0.25% trypsin and 0.02% EDTA. Cells were washed with PBS and were divided into three samples for flow cytometry analysis and for immunoblot and BrdU incorporation, as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> In Vivo Pharmacology</h3><div class="NLM_p last">Evaluation of antitumor efficacy was performed as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> High-Throughput Solubility</h3><div class="NLM_p last">Solubility at pH 7 was performed as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Metabolic Stability</h3><div class="NLM_p last">Compounds were dissolved in DMSO at 10 μM. Human cDNA expressed cytochrome P450 isoforms (supersomes) were purchased from Gentest (Woburn, MA). All chemicals used were of analytical grade and commercially available. The potential inhibitory effect was investigated against cDNA expressed human CYP4503A4 supersome using typical substrates incubated at their respective <i>K</i><sub>m</sub> concentration. The known inhibitor ketoconazole was included to check the inhibition response. Analysis of both substrate and metabolite was done by LC/MS/MS.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Plasma Protein Binding</h3><div class="NLM_p last">Plasma protein binding was performed as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> In Vivo Pharmacokinetics</h3><div class="NLM_p last">The pharmacokinetic profiles of the compounds were investigated in overnight fasted male Nu/Nu mice following a single dose given intravenously (iv) or orally (po). The vehicle used was 5% dextrose solution. A total of six mice were treated (three for each leg). Blood samples of each mouse were collected from the saphenous vein at predose, 0.083, 0.5, 1, 6, and 24 h postdosing following iv dosing, and at predose, 0.25, 0.5, 1, 6, and 24 h following oral dosing. Samples were centrifuged at 10000<i>g</i> for 3 min at 4 °C, and the plasma was stored at −80 °C until analysis. Samples were analyzed by LC/MS/MS technique.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/jm9006559">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic studies of compounds <b>2</b> and <b>28</b>; elemental analyses results of compounds <b>1</b>, <b>2</b>, <b>17</b>, <b>26</b>, <b>28</b>; kinase selective profile of compound <b>28</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9006559/suppl_file/jm9006559_si_001.pdf">jm9006559_si_001.pdf (52.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm9006559" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Gabriella Brasca</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#caadaba8b8a3afa6a6abe4a8b8abb9a9ab8aa4afb8bca3aba4a5a7b9e4a9a5a7"><span class="__cf_email__" data-cfemail="e08781829289858c8c81ce829281938381a08e85929689818e8f8d93ce838f8d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nadia Amboldi</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dario Ballinari</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Cameron</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Casale</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Cervi</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maristella Colombo</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Colotta</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valter Croci</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto D’Alessio</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Fiorentini</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonella Isacchi</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ciro Mercurio</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Moretti</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Achille Panzeri</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wilma Pastori</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Pevarello</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesca Quartieri</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fulvia Roletto</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriella Traquandi</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Vianello</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Vulpetti</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Ciomei</span> - <span class="hlFld-Affiliation affiliation">Business Unit Oncology, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Antonio Longo, Fabrizio Orzi, and Marcellino Tibolla for their skilled synthetic chemistry support. We thank Daniela Borghi for skillful assistance in NMR spectra recording and interpretation, and Clara Albanese for her support in flow cytometric analysis. We are also grateful to Nilla Avanzi and the group of Assay Development.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0lhams_3yImeJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">To cycle or not to cycle: a critical decision in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1038%2F35106065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=11902577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=222-231&author=M.+Malumbresauthor=M.+Barbacid&title=To+cycle+or+not+to+cycle%3A+a+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Milestones in cell division: to cycle or not to cycle: a critical decision in cancer</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells undergo uncontrolled proliferation, yet tumors most often originate from adult tissues, in which most cells are quiescent.  So, the proliferative advantage of tumor cells arises from their ability to bypass quiescence.  This can be due to increased mitogenic signaling and/or alterations that lower the threshold required for cell-cycle commitment.  Understanding the mol. mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2EOLFB2ULbVg90H21EOLACvtfcHk0lhA2BEwNnSx7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D&md5=2bd8961854332a30c814f8ac2f9bd6f4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35106065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106065%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%2520a%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span> </span><span class="NLM_article-title">Alvocidib: Orphan Drug Status</span>. Presented at the U.S. Food and Drug Administration, Committee for Orphan Medicinal Products, 84th Plenary Meeting,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alvocidib%3A+Orphan+Drug+Status.+Presented+at+the+U.S.+Food+and+Drug+Administration%2C+Committee+for+Orphan+Medicinal+Products%2C+84th+Plenary+Meeting%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DAlvocidib%253A%2520Orphan%2520Drug%2520Status%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Meijer, L.; Bettayeb, K.; Galons, H.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-Roscovitine (CYC202, Seliciclib)</span>. In  <span class="citation_source-book">Inhibitors of Cyclin-Dependent Kinases as Anti-Tumor Agents</span>; <span class="NLM_publisher-name">CRC</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">187</span>− <span class="NLM_lpage">225</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=187-225&author=L.+Meijer&author=K.+Bettayeb&author=H.+Galons&title=Inhibitors+of+Cyclin-Dependent+Kinases+as+Anti-Tumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3D%2528R%2529-Roscovitine%2520%2528CYC202%252C%2520Seliciclib%2529%26btitle%3DInhibitors%2520of%2520Cyclin-Dependent%2520Kinases%2520as%2520Anti-Tumor%2520Agents%26pub%3DCRC%26date%3D2007%26spage%3D187%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roongta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranadive, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0305568" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1719-1728&author=R.+N.+Misraauthor=H.+Xiaoauthor=K.+S.+Kimauthor=S.+Luauthor=W.+Hanauthor=S.+A.+Barbosaauthor=J.+T.+Huntauthor=D.+B.+Rawlinsauthor=W.+Shanauthor=S.+Z.+Ahmedauthor=L.+Qianauthor=B.+Chenauthor=R.+Zhaoauthor=M.+S.+Bednarzauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=R.+Batorskyauthor=U.+Roongtaauthor=A.+Kamathauthor=P.+Maratheauthor=S.+A.+Ranadiveauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=N.+P.+Pavletichauthor=F.+Y.+F.+Leeauthor=K.+R.+Websterauthor=S.+D.+Kimball&title=N-%28Cycloalkylamino%29acyl-2-aminothiazole+inhibitors+of+cyclin-dependent+kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+highly+efficacious+and+selective+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm0305568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0305568%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DBarbosa%26aufirst%3DS.%2BA.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DBednarz%26aufirst%3DM.%2BS.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DBatorsky%26aufirst%3DR.%26aulast%3DRoongta%26aufirst%3DU.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DRanadive%26aufirst%3DS.%2BA.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26atitle%3DN-%2528Cycloalkylamino%2529acyl-2-aminothiazole%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25202.%2520N-%255B5-%255B%255B%255B5-%25281%252C1-Dimethylethyl%2529-2-oxazolyl%255Dmethyl%255Dthio%255D-2-thiazolyl%255D-4-piperidinecarboxamide%2520%2528BMS-387032%2529%252C%2520a%2520highly%2520efficacious%2520and%2520selective%2520antitumor%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1719%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0lhA2BEwNnSx7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goelzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span> </span><span class="NLM_article-title">Discovery of [4-amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6549</span><span class="NLM_x">–</span> <span class="NLM_lpage">6560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0606138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6549-6560&author=X.+J.+Chuauthor=W.+DePintoauthor=D.+Bartkovitzauthor=S.+S.+Soauthor=B.+T.+Vuauthor=K.+Packmanauthor=C.+Lukacsauthor=Q.+Dingauthor=N.+Jiangauthor=K.+Wangauthor=P.+Goelzerauthor=X.+Yinauthor=M.+A.+Smithauthor=B.+X.+Higginsauthor=Y.+Chenauthor=Q.+Xiangauthor=J.+Moliterniauthor=G.+Kaplanauthor=B.+Gravesauthor=A.+Loveyauthor=N.+Fotouhi&title=Discovery+of+%5B4-amino-2-%281-methanesulfonylpiperidin-4-ylamino%29pyrimidin-5-yl%5D%282%2C3-difluoro-6-+methoxyphenyl%29methanone+%28R547%29%2C+a+potent+and+selective+cyclin-dependent+kinase+inhibitor+with+significant+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0606138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0606138%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DDePinto%26aufirst%3DW.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DGoelzer%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DHiggins%26aufirst%3DB.%2BX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DMoliterni%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DG.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DFotouhi%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520%255B4-amino-2-%25281-methanesulfonylpiperidin-4-ylamino%2529pyrimidin-5-yl%255D%25282%252C3-difluoro-6-%2520methoxyphenyl%2529methanone%2520%2528R547%2529%252C%2520a%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520with%2520significant%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6549%26epage%3D6560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Parry, D.; Guzi, T.; Seghezzi, W.; Paruch, K.; Doll, R.; Nomeir, A.; Wang, Y.; Oft, M.; Kirschmeier, P.; Chen, T.; Lees, E.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Characterization of SCH-727965, a Novel Potent Cyclin Dependent Kinase Inhibitor</span>. Presented at the AACR Conference, Los Angeles, CA, April 14−18,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Poster 4371.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=D.+Parry&author=T.+Guzi&author=W.+Seghezzi&author=K.+Paruch&author=R.+Doll&author=A.+Nomeir&author=Y.+Wang&author=M.+Oft&author=P.+Kirschmeier&author=T.+Chen&author=E.+Lees&title=In+Vitro+and+in+Vivo+Characterization+of+SCH-727965%2C+a+Novel+Potent+Cyclin+Dependent+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Characterization%2520of%2520SCH-727965%252C%2520a%2520Novel%2520Potent%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.-A.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%27Brienauthor=M.+O%27Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+A.+Seaversauthor=D.-M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.-A.+Woolford&title=Identification+of+N-%284-piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+novel+cyclin+dependent+kinase+inhibitor+using+fragment-based+X-ray+crystallography+and+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%2527Brien%26aufirst%3DM.%2BA.%26aulast%3DO%2527Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%2BA.%26aulast%3DSmith%26aufirst%3DD.-M.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26atitle%3DIdentification%2520of%2520N-%25284-piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520novel%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520using%2520fragment-based%2520X-ray%2520crystallography%2520and%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddick, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span> </span><span class="NLM_article-title">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1016%2Fj.bmcl.2008.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=18996007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6369-6373&author=C.+D.+Jonesauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=K.+Bladesauthor=P.+Dauntauthor=S.+Eastauthor=C.+Gehauthor=M.+A.+Grahamauthor=K.+M.+Johnsonauthor=S.+A.+Loddickauthor=H.+M.+McFarlandauthor=A.+McGregorauthor=L.+Mossauthor=D.+A.+Rudgeauthor=P.+B.+Simpsonauthor=M.+L.+Swainauthor=K.+Y.+Tamauthor=J.+A.+Tuckerauthor=M.+Walker&title=The+discovery+of+AZD5597%2C+a+potent+imidazole+pyrimidine+amide+CDK+inhibitor+suitable+for+intravenous+dosing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span></div><div class="casAuthors">Jones, Clifford D.; Andrews, David M.; Barker, Andrew J.; Blades, Kevin; Daunt, Paula; East, Simon; Geh, Catherine; Graham, Mark A.; Johnson, Keith M.; Loddick, Sarah A.; McFarland, Heather M.; McGregor, Alexandra; Moss, Louise; Rudge, David A.; Simpson, Peter B.; Swain, Michael L.; Tam, Kin Y.; Tucker, Julie A.; Walker, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6369-6373</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of a novel series of imidazole pyrimidine amides as cyclin-dependent kinase (CDK) inhibitors is described.  Optimization of inhibitory potency against multiple CDK's (1, 2 and 9) resulted in imidazole pyrimidine amides with potent in vitro anti-proliferative effects against a range of cancer cell lines.  Excellent physiochem. properties and large margins against inhibition of CYP isoforms and the hERG ion channel were achieved by modification of lipophilicity and amine basicity.  A candidate with disease model activity in human cancer cell line xenografts and with suitable physiochem. and pharmacokinetic profiles for i.v. (iv) dosing was selected for further development as AZD5597 (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnX9-GP03dzbVg90H21EOLACvtfcHk0lgxAyv3S1TNiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP&md5=084ed54076134c7173953ebbdb23fd86</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DDaunt%26aufirst%3DP.%26aulast%3DEast%26aufirst%3DS.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DLoddick%26aufirst%3DS.%2BA.%26aulast%3DMcFarland%26aufirst%3DH.%2BM.%26aulast%3DMcGregor%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DL.%26aulast%3DRudge%26aufirst%3DD.%2BA.%26aulast%3DSimpson%26aufirst%3DP.%2BB.%26aulast%3DSwain%26aufirst%3DM.%2BL.%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DM.%26atitle%3DThe%2520discovery%2520of%2520AZD5597%252C%2520a%2520potent%2520imidazole%2520pyrimidine%2520amide%2520CDK%2520inhibitor%2520suitable%2520for%2520intravenous%2520dosing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6369%26epage%3D6373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">D'Alessio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargiotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span> </span><span class="NLM_article-title">Benzodipyrazoles: a new class of potent CDK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1315-1319&author=R.+D%27Alessioauthor=A.+Bargiottiauthor=S.+Metzauthor=M.+G.+Brascaauthor=A.+Cameronauthor=A.+Ermoliauthor=A.+Marsiglioauthor=P.+Polucciauthor=F.+Rolettoauthor=M.+Tibollaauthor=M.+L.+Vazquezauthor=A.+Vulpettiauthor=P.+Pevarello&title=Benzodipyrazoles%3A+a+new+class+of+potent+CDK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Alessio%26aufirst%3DR.%26aulast%3DBargiotti%26aufirst%3DA.%26aulast%3DMetz%26aufirst%3DS.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DErmoli%26aufirst%3DA.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DTibolla%26aufirst%3DM.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DPevarello%26aufirst%3DP.%26atitle%3DBenzodipyrazoles%253A%2520a%2520new%2520class%2520of%2520potent%2520CDK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1315%26epage%3D1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Traquandi, G.; Brasca, M. G.; D'Alessio, R.; Polucci, P.; Roletto, F.; Vulpetti, A.; Pevarello, P.; Panzeri, A.; Quartieri, F.; Ferguson, R.; Vianello, P.; Fancelli, D.</span><span> </span><span class="NLM_article-title">Pyrazolo-quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors</span>. Patent WO2004/104007,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Traquandi&author=M.+G.+Brasca&author=R.+D%27Alessio&author=P.+Polucci&author=F.+Roletto&author=A.+Vulpetti&author=P.+Pevarello&author=A.+Panzeri&author=F.+Quartieri&author=R.+Ferguson&author=P.+Vianello&author=D.+Fancelli&title=Pyrazolo-quinazoline+Derivatives%2C+Process+for+Their+Preparation+and+Their+Use+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTraquandi%26aufirst%3DG.%26atitle%3DPyrazolo-quinazoline%2520Derivatives%252C%2520Process%2520for%2520Their%2520Preparation%2520and%2520Their%2520Use%2520as%2520Kinase%2520Inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span> </span><span class="NLM_article-title">An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=561-573&author=A.+Vulpettiauthor=P.+Pevarello&title=An+analysis+of+the+binding+modes+of+ATP-competitive+CDK2+inhibitors+as+revealed+by+X-ray+structures+of+protein-inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DPevarello%26aufirst%3DP.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520modes%2520of%2520ATP-competitive%2520CDK2%2520inhibitors%2520as%2520revealed%2520by%2520X-ray%2520structures%2520of%2520protein-inhibitor%2520complexes%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2005%26volume%3D5%26spage%3D561%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fancelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi-Sirtori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span> </span><span class="NLM_article-title">6-Substituted pyrrolo[3,4-<i>c</i>]pyrazoles: an improved class of CDK2 inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=841-852&author=M.+G.+Brascaauthor=C.+Albaneseauthor=R.+Amiciauthor=D.+Ballinariauthor=L.+Cortiauthor=V.+Crociauthor=D.+Fancelliauthor=F.+Fiorentiniauthor=M.+Nesiauthor=P.+Orsiniauthor=F.+Orziauthor=W.+Pastoriauthor=E.+Perroneauthor=E.+Pesentiauthor=P.+Pevarelloauthor=F.+Riccardi-Sirtoriauthor=F.+Rolettoauthor=P.+Rousselauthor=M.+Varasiauthor=A.+Vulpettiauthor=C.+Mercurio&title=6-Substituted+pyrrolo%5B3%2C4-c%5Dpyrazoles%3A+an+improved+class+of+CDK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DOrzi%26aufirst%3DF.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DPerrone%26aufirst%3DE.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DRiccardi-Sirtori%26aufirst%3DF.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DRoussel%26aufirst%3DP.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3D6-Substituted%2520pyrrolo%255B3%252C4-c%255Dpyrazoles%253A%2520an%2520improved%2520class%2520of%2520CDK2%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D6%26spage%3D841%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chang, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarohia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1016%2FS1074-5521%2899%2980048-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=10375538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=361-375&author=Y.-T.+Changauthor=N.+S.+Grayauthor=G.+R.+Rosaniaauthor=D.+P.+Sutherlinauthor=S.+Kwonauthor=T.+C.+Normanauthor=R.+Sarohiaauthor=M.+Leostauthor=L.+Meijerauthor=P.+G.+Schultz&title=Synthesis+and+application+of+functionally+diverse+2%2C6%2C9-trisubstituted+purine+libraries+as+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span></div><div class="casAuthors">Chang, Young-Tae; Gray, Nathanael S.; Rosania, Gustavo R.; Sutherlin, Daniel P.; Kwon, Soojin; Norman, Thea C.; Sarohia, Radhika; Leost, Maryse; Meijer, Laurent; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">361-375</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Purines constitute a structural class of protein ligands involved in mediating an astonishing array of metabolic processes and signal pathways in all living organisms.  Synthesis of purine derivs. targeting specific purine-binding proteins in vivo could lead to versatile lead compds. for use as biol. probes or drug candidates.  We synthesized several libraries of 2,6,9-trisubstituted purines using both soln.- and solid-phase chem., and screened the compds. for inhibition of cyclin-dependent kinase (CDK) activity and human leukemic cell growth.  Lead compds. were optimized by iterative synthesis based on structure-activity relationships (SARs), as well as anal. of several CDK-inhibitor cocrystal structures, to afford several interesting compds. including one of the most potent CDK inhibitors known to date.  Unexpectedly, some compds. with similar CDK inhibitory activity arrested cellular proliferation at distinctly different phases of the cell cycle, and another inhibitor directly induced apoptosis, bypassing cell-cycle arrest.  Some of these compds. selectively inhibited growth of cells derived from specific tumors.  2,6,9-Trisubstituted purines have various and potent biol. activities, despite high concns. of competing endogenous purine ligands in living cells.  Purine libraries constitute a versatile source of small mols. that affect distinct biochem. pathways mediating different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromOmpUr_CvbVg90H21EOLACvtfcHk0lh0KSsfyrV_kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D&md5=67311217da8fecdddf96b9908a20c906</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980048-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980048-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.-T.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DRosania%26aufirst%3DG.%2BR.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DSarohia%26aufirst%3DR.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520application%2520of%2520functionally%2520diverse%25202%252C6%252C9-trisubstituted%2520purine%2520libraries%2520as%2520CDK%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D361%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Papatsoris, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liolitsa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deliveliotis, C.</span><span> </span><span class="NLM_article-title">Manipulation of the nerve growth factor network in prostate cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=303-309&author=A.+G.+Papatsorisauthor=D.+Liolitsaauthor=C.+Deliveliotis&title=Manipulation+of+the+nerve+growth+factor+network+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapatsoris%26aufirst%3DA.%2BG.%26aulast%3DLiolitsa%26aufirst%3DD.%26aulast%3DDeliveliotis%26aufirst%3DC.%26atitle%3DManipulation%2520of%2520the%2520nerve%2520growth%2520factor%2520network%2520in%2520prostate%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D303%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimahara, Y.</span><span> </span><span class="NLM_article-title">Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=15944784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Churg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=161-171&author=Y.+Zhangauthor=C.+Dangauthor=Q.+Maauthor=Y.+Shimahara&title=Expression+of+nerve+growth+factor+receptors+and+their+prognostic+value+in+human+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer</span></div><div class="casAuthors">Zhang, Yong; Dang, Chengxue; Ma, Qingyong; Shimahara, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF), the prototypic member of the neurotrophin family of growth factors, exerts both stimulatory and inhibitory effects on neuronal and certain non-neuronal tumors, depending on the type of tumor.  It has been reported that two types of NGF receptors, high-affinity receptor, TrkA, and low-affinity receptor, p75NGFR, play important roles in this process.  Moreover, it has also been detected that high levels of TrkA expression have a more favorable overall survival prognosis in breast cancer patients, but the relationships between the two receptors according to the prognosis in pancreatic cancer patients are unknown.  We investigated the expression of NGF receptors (NGFRs: TrkA and p75NGFR) mRNA in 56 human primary pancreatic cancers, using real-time quant. reverse transcription-PCR.  Moreover, pancreatic cancer cell lines were used to validate if the effects of NGF on pancreatic cancer cell growth are dependent on the expression levels and the balance of TrkA and P75 receptors.  NGFRs were found in all of the tumor specimens and cell lines.  It appears that in pancreatic cancer cells the growth effects of NGF depend on the expression levels and the ratio of TrkA and p75NGFR.  TrkA and p75NGFR neg. correlated and were both assocd. with abdominal or back pain and perineural invasion.  Regarding this, high TrkA expression levels exhibited more frequent perineural invasion and a higher degree of pain, whereas the results of p75NGFR are on the contrary.  For Cox univariate analyses in the OS study, high expression of p75NGFR was assocd. with longer overall survival yet TrkA exhibited opposite effects and included the effect of pain.  HPG, tumor size, node involvement, and perineural invasion were not prognostic factors.  In Cox multivariate analyses, TrkA and p75NGFR were both prognostic parameters.  In conclusion, our study found that the expression of TrkA in pancreatic cancer is a marker of tumor aggressiveness.  Conversely, we also found that elevated p75NGFR expression is assocd. with a favorable prognosis; we demonstrated that NGF exerts both stimulatory and inhibitory effects on pancreatic cancers with the effect based on the expression levels and the ratio of TrkA and p75NGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_8Sb8xVndsbVg90H21EOLACvtfcHk0li8n-3eYHUpgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Churg%253D&md5=228c5c6855483ef20ab86cc8d3eb13cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShimahara%26aufirst%3DY.%26atitle%3DExpression%2520of%2520nerve%2520growth%2520factor%2520receptors%2520and%2520their%2520prognostic%2520value%2520in%2520human%2520pancreatic%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2005%26volume%3D14%26spage%3D161%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dollé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriaenssens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazidi-Belkoura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bourhis, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurcombe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hondermarck, H.</span><span> </span><span class="NLM_article-title">Nerve growth factor receptors and signaling in breast cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.2174%2F1568009043332853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=15379632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotV2ltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=463-470&author=L.+Doll%C3%A9author=E.+Adriaenssensauthor=I.+El+Yazidi-Belkouraauthor=X.+Le+Bourhisauthor=V.+Nurcombeauthor=H.+Hondermarck&title=Nerve+growth+factor+receptors+and+signaling+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor receptors and signaling in breast cancer</span></div><div class="casAuthors">Dolle, Laurent; Adriaenssens, Eric; El Yazidi-Belkoura, Ikram; le Bourhis, Xuefen; Nurcombe, Victor; Hondermarck, Hubert</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nerve growth factor (NGF) has long been known for its effects on neuronal cell survival and differentiation.  This prototypical neurotrophic factor stimulates neurons through two distinct classes of membrane receptors: the TrkA tyrosine kinase receptor, and the tumor necrosis factor receptor family member p75NTR, also known as the common neurotrophin receptor.  Somewhat surprisingly, there is a growing body of evidence indicating that NGF is also a major stimulator of breast cancer cell growth.  Both the survival and proliferation of breast cancer cells are strongly stimulated by NGF, mediated by TrkA and p75NTR resp., utilizing signaling pathways similar to those described for neurons.  In addn., although NGF is produced by breast cancer cells, it is not in normal breast epithelial cells, giving rise to an autocrine stimulation of tumor growth.  Therefore, NGF receptors and signaling are thus looking increasingly promising as potential drug targets for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplSJYKr5_U9bVg90H21EOLACvtfcHk0li8n-3eYHUpgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotV2ltbY%253D&md5=02285808da6ed364796cef7ff42e6fc5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568009043332853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009043332853%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%25C3%25A9%26aufirst%3DL.%26aulast%3DAdriaenssens%26aufirst%3DE.%26aulast%3DEl%2BYazidi-Belkoura%26aufirst%3DI.%26aulast%3DLe%2BBourhis%26aufirst%3DX.%26aulast%3DNurcombe%26aufirst%3DV.%26aulast%3DHondermarck%26aufirst%3DH.%26atitle%3DNerve%2520growth%2520factor%2520receptors%2520and%2520signaling%2520in%2520breast%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2004%26volume%3D4%26spage%3D463%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi-Sirtori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span> </span><span class="NLM_article-title">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1002%2Frcm.1368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=14966861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-517&author=M.+Colomboauthor=F.+Riccardi-Sirtoriauthor=V.+Rizzo&title=A+fully+automated+method+for+accurate+mass+determination+using+high-performance+liquid+chromatography+with+a+quadrupole%2Forthogonal+acceleration+time-of-flight+mass+spectrometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span></div><div class="casAuthors">Colombo, Maristella; Sirtori, Federico Riccardi; Rizzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A generic LC/ESI(+)-oaTOFMS method has been developed for routine automated high accuracy mass detns. of different classes of substances.  The system makes use of micro-high-performance liq. chromatog. and a hybrid quadrupole/orthogonal acceleration time-of-flight (Q-oaTOF) mass spectrometer.  Reproducible and accurate mass measurements were obtained using an electrospray dual sprayer with reserpine as ref. compd., introduced into the mass spectrometer alternating with the samples.  Expts. were performed to optimize analyte/ref. response ratio, statistical algorithm correction setting, and analyte concn.  In these expts., a clear dependence of the mass measurement error on the analyte/ref. response ratio was obsd.  The dependence of av. mass error vs. different dead time correction algorithm settings (Np factors) was also explored.  In the final automated procedure, verified for a statistically significant set of compds. (∼550) obtained from a medicinal chem. department, about 70% of the analyzed samples satisfied the acceptance criteria fixed at a max. error of ±5 ppm (mass range 150-800 Da).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5JNVhGdzjrVg90H21EOLACvtfcHk0li9WLGLvV1OUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D&md5=6f1f93c5e2fb4e24257b77f5ce6dfa37</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Frcm.1368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1368%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DRiccardi-Sirtori%26aufirst%3DF.%26aulast%3DRizzo%26aufirst%3DV.%26atitle%3DA%2520fully%2520automated%2520method%2520for%2520accurate%2520mass%2520determination%2520using%2520high-performance%2520liquid%2520chromatography%2520with%2520a%2520quadrupole%252Forthogonal%2520acceleration%2520time-of-flight%2520mass%2520spectrometer%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D18%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span> </span><span class="NLM_article-title">TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1016%2Fj.chembiol.2006.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=16793518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=607-614&author=M.+Grollauthor=M.+Goetzauthor=M.+Kaiserauthor=E.+Weyherauthor=L.+Moroder&title=TMC-95-based+inhibitor+design+provides+evidence+for+the+catalytic+versatility+of+the+proteasome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">TMC-95-Based Inhibitor Design Provides Evidence for the Catalytic Versatility of the Proteasome</span></div><div class="casAuthors">Groll, Michael; Goetz, Marion; Kaiser, Markus; Weyher, Elisabeth; Moroder, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-614</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">TMC-95's natural cyclic tripeptide metabolites represent potent competitive proteasome inhibitors.  The constrained conformation of TMC-95 proteasomal inhibitors provides the driving force for entropically high-affinity binding.  Based on the crystal structure of the proteasome:TMC-95A complex, the synthetically challenging TMC-95 core structure was used for the design and synthesis of less demanding biphenyl-ether macrocycles, in which the biphenyl-ether moiety functions as an endocyclic clamp restricting its tripeptide backbone.  These simplified analogs allowed us to identify high plasticity of the proteasomal tryptic-like specificity pocket.  Biphenyl-ether compds. extended with an amide group were hydrolyzed by the proteasome, although the crystal structure of such proteasome:biphenyl-ether complexes revealed quenching of proteolysis at the acyl-enzyme intermediate.  Our data reveal that biphenyl-ether derivs. bind noncovalently to the proteasomal tryptic-like active site in a reversible substrate-like manner without allosteric changes of active site residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOZ7dfuNzscLVg90H21EOLACvtfcHk0li9WLGLvV1OUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqsLw%253D&md5=35abcd4d64ea6d8ad0b94204abe14e3e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWeyher%26aufirst%3DE.%26aulast%3DMoroder%26aufirst%3DL.%26atitle%3DTMC-95-based%2520inhibitor%2520design%2520provides%2520evidence%2520for%2520the%2520catalytic%2520versatility%2520of%2520the%2520proteasome%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D607%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piutti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritzen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warpehoski, M. A.</span><span> </span><span class="NLM_article-title">3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3367</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031145u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3367-3380&author=P.+Pevarelloauthor=M.+G.+Brascaauthor=R.+Amiciauthor=P.+Orsiniauthor=G.+Traquandiauthor=L.+Cortiauthor=C.+Piuttiauthor=P.+Sansonnaauthor=M.+Villaauthor=B.+S.+Pierceauthor=M.+Puliciauthor=P.+Giordanoauthor=K.+Martinaauthor=E.+L.+Fritzenauthor=R.+A.+Nugentauthor=E.+Casaleauthor=A.+Cameronauthor=M.+Ciomeiauthor=F.+Rolettoauthor=A.+Isacchiauthor=G.+Fogliattoauthor=E.+Pesentiauthor=W.+Pastoriauthor=A.+Marsiglioauthor=K.+L.+Leachauthor=P.+M.+Clareauthor=F.+Fiorentiniauthor=M.+Varasiauthor=A.+Vulpettiauthor=M.+A.+Warpehoski&title=3-Aminopyrazole+inhibitors+of+CDK2%2Fcyclin%E2%80%89A+as+antitumor+agents.+1.+Lead+finding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm031145u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031145u%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DPiutti%26aufirst%3DC.%26aulast%3DSansonna%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DPulici%26aufirst%3DM.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DFritzen%26aufirst%3DE.%2BL.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DP.%2BM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DWarpehoski%26aufirst%3DM.%2BA.%26atitle%3D3-Aminopyrazole%2520inhibitors%2520of%2520CDK2%252Fcyclin%25E2%2580%2589A%2520as%2520antitumor%2520agents.%25201.%2520Lead%2520finding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3367%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 77 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Solomon Tadesse, Elizabeth C. Caldon, Wayne Tilley, <span class="NLM_string-name hlFld-ContribAuthor">Shudong Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4233-4251. <a href="https://doi.org/10.1021/acs.jmedchem.8b01469" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01469%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclin-Dependent%252BKinase%252B2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BAn%252BUpdate%26aulast%3DTadesse%26aufirst%3DSolomon%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D20092018%26date%3D20122018%26date%3D13122018%26volume%3D62%26issue%3D9%26spage%3D4233%26epage%3D4251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q. McDonald, Fengping Lv, Naresh Gunaganti, Brendan Frett, <span class="NLM_string-name hlFld-ContribAuthor">Hong-yu Li</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1731-1760. <a href="https://doi.org/10.1021/acs.jmedchem.8b01092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252BCurrent%252BTropomyosin%252BReceptor%252BKinase%252B%252528TRK%252529%252BInhibitors%25253A%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYan%26aufirst%3DWei%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D19092018%26date%3D06092018%26volume%3D62%26issue%3D4%26spage%3D1731%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radek Jorda, Denisa Hendrychová, Jiří Voller, Eva Řezníčková, Tomáš Gucký, <span class="NLM_string-name hlFld-ContribAuthor">Vladimír Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9105-9120. <a href="https://doi.org/10.1021/acs.jmedchem.8b00049" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BSelective%252BAre%252BPharmacological%252BInhibitors%252Bof%252BCell-Cycle-Regulating%252BCyclin-Dependent%252BKinases%25253F%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31012018%26date%3D05102018%26date%3D20092018%26volume%3D61%26issue%3D20%26spage%3D9105%26epage%3D9120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexandre
A. Mikhailine, Gabriela A. Grasa Mannino, <span class="NLM_string-name hlFld-ContribAuthor">Thomas J. Colacot</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Directed Chemoselective Double Amination of Bromo-chloro(hetero)arenes: A Synthetic Route toward Advanced Amino-aniline Intermediates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (8)
                                     , 2301-2305. <a href="https://doi.org/10.1021/acs.orglett.8b00646" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b00646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b00646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b00646%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalyst-Directed%252BChemoselective%252BDouble%252BAmination%252Bof%252BBromo-chloro%252528hetero%252529arenes%25253A%252BA%252BSynthetic%252BRoute%252Btoward%252BAdvanced%252BAmino-aniline%252BIntermediates%26aulast%3DMikhailine%26aufirst%3DAlexandre%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23022018%26date%3D05042018%26volume%3D20%26issue%3D8%26spage%3D2301%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Yi  Zhu</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Cuellar</span>, <span class="hlFld-ContribAuthor ">Norbert  Berndt</span>, <span class="hlFld-ContribAuthor ">Hee Eun  Lee</span>, <span class="hlFld-ContribAuthor ">Sanne H.  Olesen</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Jensen</span>, <span class="hlFld-ContribAuthor ">Gunda I.  Georg</span>, and <span class="hlFld-ContribAuthor ">Ernst  Schönbrunn</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (18)
                                     , 7863-7875. <a href="https://doi.org/10.1021/acs.jmedchem.7b00996" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00996</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00996%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BBasis%252Bof%252BWee%252BKinases%252BFunctionality%252Band%252BInactivation%252Bby%252BDiverse%252BSmall%252BMolecule%252BInhibitors%26aulast%3DZhu%26aufirst%3DJin-Yi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06072017%26date%3D14092017%26date%3D28092017%26date%3D09082017%26volume%3D60%26issue%3D18%26spage%3D7863%26epage%3D7875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priya  Mahajan</span>, <span class="hlFld-ContribAuthor ">Gousia  Chashoo</span>, <span class="hlFld-ContribAuthor ">Monika  Gupta</span>, <span class="hlFld-ContribAuthor ">Amit  Kumar</span>, <span class="hlFld-ContribAuthor ">Parvinder Pal  Singh</span>, and <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>  . </span><span class="cited-content_cbyCitation_article-title">Fusion of Structure and Ligand Based Methods for Identification of Novel CDK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (8)
                                     , 1957-1969. <a href="https://doi.org/10.1021/acs.jcim.7b00293" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00293%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFusion%252Bof%252BStructure%252Band%252BLigand%252BBased%252BMethods%252Bfor%252BIdentification%252Bof%252BNovel%252BCDK2%252BInhibitors%26aulast%3DMahajan%26aufirst%3DPriya%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22052017%26date%3D03082017%26date%3D28082017%26date%3D19072017%26volume%3D57%26issue%3D8%26spage%3D1957%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Babinski</span>, <span class="hlFld-ContribAuthor ">Hector R.  Aguilar</span>, <span class="hlFld-ContribAuthor ">Raymond  Still</span>, and <span class="hlFld-ContribAuthor ">Doug E.  Frantz</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Substituted Pyrazoles via Tandem Cross-Coupling/Electrocyclization of Enol Triflates and Diazoacetates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (15)
                                     , 5915-5923. <a href="https://doi.org/10.1021/jo201042c" title="DOI URL">https://doi.org/10.1021/jo201042c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo201042c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo201042c%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BSubstituted%252BPyrazoles%252Bvia%252BTandem%252BCross-Coupling%25252FElectrocyclization%252Bof%252BEnol%252BTriflates%252Band%252BDiazoacetates%26aulast%3DBabinski%26aufirst%3DDavid%2BJ.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D25052011%26date%3D27062011%26date%3D05082011%26date%3D18062011%26volume%3D76%26issue%3D15%26spage%3D5915%26epage%3D5923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis S.  Vizirianakis</span>, <span class="hlFld-ContribAuthor ">Maria  Chatzopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis D.  Bonovolias</span>, <span class="hlFld-ContribAuthor ">Ioannis  Nicolaou</span>, <span class="hlFld-ContribAuthor ">Vassilis J.  Demopoulos</span>, and <span class="hlFld-ContribAuthor ">Asterios S.  Tsiftsoglou</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward the Development of Innovative Bifunctional Agents To Induce Differentiation and To Promote Apoptosis in Leukemia: Clinical Candidates and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 6779-6810. <a href="https://doi.org/10.1021/jm100189a" title="DOI URL">https://doi.org/10.1021/jm100189a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100189a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100189a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252Bthe%252BDevelopment%252Bof%252BInnovative%252BBifunctional%252BAgents%252BTo%252BInduce%252BDifferentiation%252Band%252BTo%252BPromote%252BApoptosis%252Bin%252BLeukemia%25253A%252BClinical%252BCandidates%252Band%252BPerspectives%26aulast%3DVizirianakis%26aufirst%3DIoannis%2BS.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D12022010%26date%3D20072010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D6779%26epage%3D6810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Italo  Beria</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Jay Aaron  Bertrand</span>, <span class="hlFld-ContribAuthor ">Daniela  Borghi</span>, <span class="hlFld-ContribAuthor ">Roberto Tiberio  Bossi</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Paolo  Cappella</span>, <span class="hlFld-ContribAuthor ">Michele  Caruso</span>, <span class="hlFld-ContribAuthor ">Walter  Ceccarelli</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciavolella</span>, <span class="hlFld-ContribAuthor ">Cinzia  Cristiani</span>, <span class="hlFld-ContribAuthor ">Valter  Croci</span>, <span class="hlFld-ContribAuthor ">Anna  De Ponti</span>, <span class="hlFld-ContribAuthor ">Gabriele  Fachin</span>, <span class="hlFld-ContribAuthor ">Ronald Dale  Ferguson</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Lansen</span>, <span class="hlFld-ContribAuthor ">Jurgen Karl  Moll</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Helena  Posteri</span>, <span class="hlFld-ContribAuthor ">Rita  Perego</span>, <span class="hlFld-ContribAuthor ">Maurizio  Rocchetti</span>, <span class="hlFld-ContribAuthor ">Paola  Storici</span>, <span class="hlFld-ContribAuthor ">Daniele  Volpi</span> and <span class="hlFld-ContribAuthor ">Barbara  Valsasina</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (9)
                                     , 3532-3551. <a href="https://doi.org/10.1021/jm901713n" title="DOI URL">https://doi.org/10.1021/jm901713n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901713n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901713n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252B4%25252C5-Dihydro-1H-pyrazolo%25255B4%25252C3-h%25255Dquinazoline%252BDerivatives%252Bas%252Ba%252BNew%252BClass%252Bof%252BOrally%252Band%252BSelective%252BPolo-Like%252BKinase%252B1%252BInhibitors%26aulast%3DBeria%26aufirst%3DItalo%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D19112009%26date%3D16042010%26date%3D13052010%26volume%3D53%26issue%3D9%26spage%3D3532%26epage%3D3551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriella  Traquandi</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Nicoletta  Colombo</span>, <span class="hlFld-ContribAuthor ">Valter  Croci</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Antonio  Longo</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Wilma  Pastori</span>, <span class="hlFld-ContribAuthor ">Paolo  Pevarello</span>, <span class="hlFld-ContribAuthor ">Daniele  Volpi</span>, <span class="hlFld-ContribAuthor ">Patrick  Roussel</span>, <span class="hlFld-ContribAuthor ">Anna  Vulpetti</span> and <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Potent Pyrazolo[4,3-h]quinazoline-3-carboxamides as Multi-Cyclin-Dependent Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2171-2187. <a href="https://doi.org/10.1021/jm901710h" title="DOI URL">https://doi.org/10.1021/jm901710h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901710h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901710h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotent%252BPyrazolo%25255B4%25252C3-h%25255Dquinazoline-3-carboxamides%252Bas%252BMulti-Cyclin-Dependent%252BKinase%252BInhibitors%26aulast%3DTraquandi%26aufirst%3DGabriella%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D18112009%26date%3D08022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2171%26epage%3D2187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mala  Sharma</span>, <span class="hlFld-ContribAuthor ">Neha  Sharma</span>, <span class="hlFld-ContribAuthor ">Mohd  Muddassir</span>, <span class="hlFld-ContribAuthor ">Qazi Inamur  Rahman</span>, <span class="hlFld-ContribAuthor ">U. N.  Dwivedi</span>, <span class="hlFld-ContribAuthor ">Salman  Akhtar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>24 </em>, 1-18. <a href="https://doi.org/10.1080/07391102.2021.1936178" title="DOI URL">https://doi.org/10.1080/07391102.2021.1936178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1936178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1936178%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DStructure-based%252Bpharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%252Band%252Bsimulation%252Bstudies%252Bfor%252Bthe%252Bidentification%252Bof%252Bpotent%252Banticancerous%252Bphytochemical%252Blead%252Btargeting%252Bcyclin-dependent%252Bkinase%252B2%26aulast%3DSharma%26aufirst%3DMala%26date%3D2021%26date%3D2021%26volume%3D24%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandra  Martínez-Chávez</span>, <span class="hlFld-ContribAuthor ">Jelle  Broeders</span>, <span class="hlFld-ContribAuthor ">Maria C.  Lebre</span>, <span class="hlFld-ContribAuthor ">Matthijs T.  Tibben</span>, <span class="hlFld-ContribAuthor ">Hilde  Rosing</span>, <span class="hlFld-ContribAuthor ">Jos H.  Beijnen</span>, <span class="hlFld-ContribAuthor ">Alfred H.  Schinkel</span>. </span><span class="cited-content_cbyCitation_article-title">The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>159 </em>, 105740. <a href="https://doi.org/10.1016/j.ejps.2021.105740" title="DOI URL">https://doi.org/10.1016/j.ejps.2021.105740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2021.105740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2021.105740%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DThe%252Brole%252Bof%252Bdrug%252Befflux%252Band%252Buptake%252Btransporters%252BABCB1%252B%252528P-gp%252529%25252C%252BABCG2%252B%252528BCRP%252529%252Band%252BOATP1A%25252F1B%252Band%252Bof%252BCYP3A4%252Bin%252Bthe%252Bpharmacokinetics%252Bof%252Bthe%252BCDK%252Binhibitor%252Bmilciclib%26aulast%3DMart%25C3%25ADnez-Ch%25C3%25A1vez%26aufirst%3DAlejandra%26date%3D2021%26volume%3D159%26spage%3D105740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Lin</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Li</span>, <span class="hlFld-ContribAuthor ">Liping  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanqing  Li</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113281. <a href="https://doi.org/10.1016/j.ejmech.2021.113281" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113281%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B4-benzoylamino-1H-pyrazole-3-carboxamide%252Bderivatives%252Bas%252Bpotent%252BCDK2%252Binhibitors%26aulast%3DLin%26aufirst%3DTingting%26date%3D2021%26volume%3D215%26spage%3D113281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mona O.  Sarhan</span>, <span class="hlFld-ContribAuthor ">Somaia S.  Abd El-Karim</span>, <span class="hlFld-ContribAuthor ">Manal M.  Anwar</span>, <span class="hlFld-ContribAuthor ">Raghda H.  Gouda</span>, <span class="hlFld-ContribAuthor ">Wafaa A.  Zaghary</span>, <span class="hlFld-ContribAuthor ">Mohammed A.  Khedr</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D QSAR, Molecular Dynamics, In Vitro Cytotoxicity, Radioiodination, and Biodistribution Studies. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (8)
                                     , 2273. <a href="https://doi.org/10.3390/molecules26082273" title="DOI URL">https://doi.org/10.3390/molecules26082273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26082273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26082273%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BNew%252BCoumarin-Based%252BLead%252Bwith%252BPotential%252BAnticancer%25252C%252BCDK4%252BInhibition%252Band%252BSelective%252BRadiotheranostic%252BEffect%25253A%252BSynthesis%25252C%252B2D%252B%252526%252B3D%252BQSAR%25252C%252BMolecular%252BDynamics%25252C%252BIn%252BVitro%252BCytotoxicity%25252C%252BRadioiodination%25252C%252Band%252BBiodistribution%252BStudies%26aulast%3DSarhan%26aufirst%3DMona%2BO.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D8%26spage%3D2273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Łukasik</span>, <span class="hlFld-ContribAuthor ">Irena  Baranowska-Bosiacka</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kulczycka</span>, <span class="hlFld-ContribAuthor ">Izabela  Gutowska</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (6)
                                     , 2806. <a href="https://doi.org/10.3390/ijms22062806" title="DOI URL">https://doi.org/10.3390/ijms22062806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22062806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22062806%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DInhibitors%252Bof%252BCyclin-Dependent%252BKinases%25253A%252BTypes%252Band%252BTheir%252BMechanism%252Bof%252BAction%26aulast%3D%25C5%2581ukasik%26aufirst%3DPawe%25C5%2582%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D6%26spage%3D2806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Jiang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Liu</span>, <span class="hlFld-ContribAuthor ">Lu  Feng</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 355-372. <a href="https://doi.org/10.1016/j.apsb.2020.05.004" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDevelopment%252Bof%252Bsmall-molecule%252Btropomyosin%252Breceptor%252Bkinase%252B%252528TRK%252529%252Binhibitors%252Bfor%252BNTRK%252Bfusion%252Bcancers%26aulast%3DJiang%26aufirst%3DTingting%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D355%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Borgenvik</span>, <span class="hlFld-ContribAuthor ">Matko  Čančer</span>, <span class="hlFld-ContribAuthor ">Sonja  Hutter</span>, <span class="hlFld-ContribAuthor ">Fredrik J.  Swartling</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting MYCN in Molecularly Defined Malignant Brain Tumors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.626751" title="DOI URL">https://doi.org/10.3389/fonc.2020.626751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.626751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.626751%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DTargeting%252BMYCN%252Bin%252BMolecularly%252BDefined%252BMalignant%252BBrain%252BTumors%26aulast%3DBorgenvik%26aufirst%3DAnna%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yizhe  Yan</span>, <span class="hlFld-ContribAuthor ">Shaoqing  Li</span>, <span class="hlFld-ContribAuthor ">Jianyong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative Alkoxylation/Dehydrogenation of Unactivated Cyclic Ketones with Simple Alcohols: Direct Route to α‐Alkoxy Cycloenones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (41)
                                     , 6474-6477. <a href="https://doi.org/10.1002/ejoc.202001140" title="DOI URL">https://doi.org/10.1002/ejoc.202001140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001140%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOxidative%252BAlkoxylation%25252FDehydrogenation%252Bof%252BUnactivated%252BCyclic%252BKetones%252Bwith%252BSimple%252BAlcohols%25253A%252BDirect%252BRoute%252Bto%252B%2525CE%2525B1%2525E2%252580%252590Alkoxy%252BCycloenones%26aulast%3DYan%26aufirst%3DYizhe%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D41%26spage%3D6474%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingkai  Du</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojiao  Luo</span>, <span class="hlFld-ContribAuthor ">Rong  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Yiwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>, <span class="hlFld-ContribAuthor ">Jun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships of Wee1 inhibitors: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112524. <a href="https://doi.org/10.1016/j.ejmech.2020.112524" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112524%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationships%252Bof%252BWee1%252Binhibitors%25253A%252BA%252Breview%26aulast%3DDu%26aufirst%3DXingkai%26date%3D2020%26volume%3D203%26spage%3D112524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandra  Martínez-Chávez</span>, <span class="hlFld-ContribAuthor ">Matthijs M.  Tibben</span>, <span class="hlFld-ContribAuthor ">Jelle  Broeders</span>, <span class="hlFld-ContribAuthor ">Hilde  Rosing</span>, <span class="hlFld-ContribAuthor ">Alfred H.  Schinkel</span>, <span class="hlFld-ContribAuthor ">Jos H.  Beijnen</span>. </span><span class="cited-content_cbyCitation_article-title">Development and validation of an LC-MS/MS method for the quantitative analysis of milciclib in human and mouse plasma, mouse tissue homogenates and tissue culture medium. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2020,</strong> <em>190 </em>, 113516. <a href="https://doi.org/10.1016/j.jpba.2020.113516" title="DOI URL">https://doi.org/10.1016/j.jpba.2020.113516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2020.113516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2020.113516%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DDevelopment%252Band%252Bvalidation%252Bof%252Ban%252BLC-MS%25252FMS%252Bmethod%252Bfor%252Bthe%252Bquantitative%252Banalysis%252Bof%252Bmilciclib%252Bin%252Bhuman%252Band%252Bmouse%252Bplasma%25252C%252Bmouse%252Btissue%252Bhomogenates%252Band%252Btissue%252Bculture%252Bmedium%26aulast%3DMart%25C3%25ADnez-Ch%25C3%25A1vez%26aufirst%3DAlejandra%26date%3D2020%26volume%3D190%26spage%3D113516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harri M.  Itkonen</span>, <span class="hlFld-ContribAuthor ">Ninu  Poulose</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Steele</span>, <span class="hlFld-ContribAuthor ">Sara E.S.  Martin</span>, <span class="hlFld-ContribAuthor ">Zebulon G.  Levine</span>, <span class="hlFld-ContribAuthor ">Damien Y.  Duveau</span>, <span class="hlFld-ContribAuthor ">Ryan  Carelli</span>, <span class="hlFld-ContribAuthor ">Reema  Singh</span>, <span class="hlFld-ContribAuthor ">Alfonso  Urbanucci</span>, <span class="hlFld-ContribAuthor ">Massimo  Loda</span>, <span class="hlFld-ContribAuthor ">Craig J.  Thomas</span>, <span class="hlFld-ContribAuthor ">Ian G.  Mills</span>, <span class="hlFld-ContribAuthor ">Suzanne  Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2020,</strong> <em>18 </em>
                                    (10)
                                     , 1512-1521. <a href="https://doi.org/10.1158/1541-7786.MCR-20-0339" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-20-0339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-20-0339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-20-0339%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DInhibition%252Bof%252BO-GlcNAc%252BTransferase%252BRenders%252BProstate%252BCancer%252BCells%252BDependent%252Bon%252BCDK9%26aulast%3DItkonen%26aufirst%3DHarri%2BM.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D10%26spage%3D1512%26epage%3D1521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik B  Faber</span>, <span class="hlFld-ContribAuthor ">Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Gunda I  Georg</span>. </span><span class="cited-content_cbyCitation_article-title">Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†. </span><span class="cited-content_cbyCitation_journal-name">Biology of Reproduction</span><span> <strong>2020,</strong> <em>103 </em>
                                    (2)
                                     , 357-367. <a href="https://doi.org/10.1093/biolre/ioaa107" title="DOI URL">https://doi.org/10.1093/biolre/ioaa107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/biolre/ioaa107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbiolre%2Fioaa107%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520of%2520Reproduction%26atitle%3DReview%252Bof%252Brationale%252Band%252Bprogress%252Btoward%252Btargeting%252Bcyclin-dependent%252Bkinase%252B2%252B%252528CDK2%252529%252Bfor%252Bmale%252Bcontraception%2525E2%252580%2525A0%26aulast%3DFaber%26aufirst%3DErik%2BB%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D2%26spage%3D357%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yihui  Shi</span>, <span class="hlFld-ContribAuthor ">Walter  Bray</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Smith</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Joy  Calaoagan</span>, <span class="hlFld-ContribAuthor ">Chandraiah  Lagisetti</span>, <span class="hlFld-ContribAuthor ">Lidia  Sambucetti</span>, <span class="hlFld-ContribAuthor ">Phillip  Crews</span>, <span class="hlFld-ContribAuthor ">R. Scott  Lokey</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Webb</span>, . </span><span class="cited-content_cbyCitation_article-title">An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2020,</strong> <em>15 </em>
                                    (5)
                                     , e0233672. <a href="https://doi.org/10.1371/journal.pone.0233672" title="DOI URL">https://doi.org/10.1371/journal.pone.0233672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0233672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0233672%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DAn%252Bexon%252Bskipping%252Bscreen%252Bidentifies%252Bantitumor%252Bdrugs%252Bthat%252Bare%252Bpotent%252Bmodulators%252Bof%252Bpre-mRNA%252Bsplicing%25252C%252Bsuggesting%252Bnew%252Btherapeutic%252Bapplications%26aulast%3DShi%26aufirst%3DYihui%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D5%26spage%3De0233672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Hu</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunlei  Tang</span>, <span class="hlFld-ContribAuthor ">Bainian  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in Synthesis and Bioactivity Evaluation of Pyrazoloquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (2)
                                     , 104-113. <a href="https://doi.org/10.2174/1570180815666181017120100" title="DOI URL">https://doi.org/10.2174/1570180815666181017120100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180815666181017120100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180815666181017120100%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DProgress%252Bin%252BSynthesis%252Band%252BBioactivity%252BEvaluation%252Bof%252BPyrazoloquinazolines%26aulast%3DZhao%26aufirst%3DHui%26date%3D2020%26volume%3D17%26issue%3D2%26spage%3D104%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeanluc  Bertrand</span>, <span class="hlFld-ContribAuthor ">Hana  Dostálová</span>, <span class="hlFld-ContribAuthor ">Vladimir  Krystof</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Alejandro  Castro</span>, <span class="hlFld-ContribAuthor ">Jaime  Mella</span>, <span class="hlFld-ContribAuthor ">Christian  Espinosa-Bustos</span>, <span class="hlFld-ContribAuthor ">Ana  María Zarate</span>, <span class="hlFld-ContribAuthor ">Cristian O.  Salas</span>. </span><span class="cited-content_cbyCitation_article-title">New 2,6,9-trisubstituted purine derivatives as Bcr-Abl and Btk inhibitors and as promising agents against leukemia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103361. <a href="https://doi.org/10.1016/j.bioorg.2019.103361" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103361%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNew%252B2%25252C6%25252C9-trisubstituted%252Bpurine%252Bderivatives%252Bas%252BBcr-Abl%252Band%252BBtk%252Binhibitors%252Band%252Bas%252Bpromising%252Bagents%252Bagainst%252Bleukemia%26aulast%3DBertrand%26aufirst%3DJeanluc%26date%3D2020%26volume%3D94%26spage%3D103361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Concepción  Sánchez-Martínez</span>, <span class="hlFld-ContribAuthor ">María José  Lallena</span>, <span class="hlFld-ContribAuthor ">Sonia Gutiérrez  Sanfeliciano</span>, <span class="hlFld-ContribAuthor ">Alfonso  de Dios</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126637. <a href="https://doi.org/10.1016/j.bmcl.2019.126637" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126637%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCyclin%252Bdependent%252Bkinase%252B%252528CDK%252529%252Binhibitors%252Bas%252Banticancer%252Bdrugs%25253A%252BRecent%252Badvances%252B%2525282015%2525E2%252580%2525932019%252529%26aulast%3DS%25C3%25A1nchez-Mart%25C3%25ADnez%26aufirst%3DConcepci%25C3%25B3n%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shutao  Wang</span>, <span class="hlFld-ContribAuthor ">Muxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengnan  Jiang</span>, <span class="hlFld-ContribAuthor ">Junli  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaguo  Li</span>, <span class="hlFld-ContribAuthor ">Chenchen  Li</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 247-268. <a href="https://doi.org/10.1016/j.ejmech.2019.04.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bdesign%252Band%252Banticancer%252Bactivities%252Bof%252Bsmall-molecule%252Bmonopolar%252Bspindle%252B1%252Binhibitors%25253A%252BA%252BMedicinal%252Bchemistry%252Bperspective%26aulast%3DWang%26aufirst%3DShutao%26date%3D2019%26volume%3D175%26spage%3D247%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Miao</span>, <span class="hlFld-ContribAuthor ">Kun  Ma</span>, <span class="hlFld-ContribAuthor ">Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoxing  Wu</span>, <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting tropomyosin receptor kinase for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 129-148. <a href="https://doi.org/10.1016/j.ejmech.2019.04.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Btropomyosin%252Breceptor%252Bkinase%252Bfor%252Bcancer%252Btherapy%26aulast%3DMiao%26aufirst%3DQi%26date%3D2019%26volume%3D175%26spage%3D129%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirill  Gorshkov</span>, <span class="hlFld-ContribAuthor ">Ni  Sima</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Billy  Lu</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Jameson  Travers</span>, <span class="hlFld-ContribAuthor ">Carleen  Klumpp-Thomas</span>, <span class="hlFld-ContribAuthor ">Samuel G.  Michael</span>, <span class="hlFld-ContribAuthor ">Tuan  Xu</span>, <span class="hlFld-ContribAuthor ">Ruili  Huang</span>, <span class="hlFld-ContribAuthor ">Emily M.  Lee</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Cheng</span>, <span class="hlFld-ContribAuthor ">Wei  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (3)
                                     , 441-452. <a href="https://doi.org/10.1016/j.tranon.2018.11.016" title="DOI URL">https://doi.org/10.1016/j.tranon.2018.11.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tranon.2018.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tranon.2018.11.016%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DQuantitative%252BChemotherapeutic%252BProfiling%252Bof%252BGynecologic%252BCancer%252BCell%252BLines%252BUsing%252BApproved%252BDrugs%252Band%252BBioactive%252BCompounds%26aulast%3DGorshkov%26aufirst%3DKirill%26date%3D2019%26volume%3D12%26issue%3D3%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 386-453. <a href="https://doi.org/10.1002/cmdc.201800755" title="DOI URL">https://doi.org/10.1002/cmdc.201800755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnpacking%252Bthe%252BPathogen%252BBox%2525E2%252580%252594An%252BOpen%252BSource%252BTool%252Bfor%252BFighting%252BNeglected%252BTropical%252BDisease%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D386%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiyan  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Yang</span>, <span class="hlFld-ContribAuthor ">Suhua  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Han  Wei</span>, <span class="hlFld-ContribAuthor ">Xin  Tian</span>, <span class="hlFld-ContribAuthor ">Quancheng  Kan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 615-639. <a href="https://doi.org/10.1016/j.ejmech.2019.01.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopment%252Bof%252BCDK%252Binhibitors%25253A%252BAn%252Boverview%252Bof%252BCDK%25252Finhibitor%252Bco-crystal%252Bstructures%26aulast%3DCheng%26aufirst%3DWeiyan%26date%3D2019%26volume%3D164%26spage%3D615%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  De Donato</span>, <span class="hlFld-ContribAuthor ">Benedetta  Righino</span>, <span class="hlFld-ContribAuthor ">Flavia  Filippetti</span>, <span class="hlFld-ContribAuthor ">Alessandra  Battaglia</span>, <span class="hlFld-ContribAuthor ">Marco  Petrillo</span>, <span class="hlFld-ContribAuthor ">Davide  Pirolli</span>, <span class="hlFld-ContribAuthor ">Giovanni  Scambia</span>, <span class="hlFld-ContribAuthor ">Maria Cristina  De Rosa</span>, <span class="hlFld-ContribAuthor ">Daniela  Gallo</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-34471-y" title="DOI URL">https://doi.org/10.1038/s41598-018-34471-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-34471-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-34471-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIdentification%252Band%252Bantitumor%252Bactivity%252Bof%252Ba%252Bnovel%252Binhibitor%252Bof%252Bthe%252BNIMA-related%252Bkinase%252BNEK6%26aulast%3DDe%2BDonato%26aufirst%3DMarta%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryosuke  Okamura</span>, <span class="hlFld-ContribAuthor ">Amélie  Boichard</span>, <span class="hlFld-ContribAuthor ">Shumei  Kato</span>, <span class="hlFld-ContribAuthor ">Jason K.  Sicklick</span>, <span class="hlFld-ContribAuthor ">Lyudmila  Bazhenova</span>, <span class="hlFld-ContribAuthor ">Razelle  Kurzrock</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of
              NTRK
              Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">JCO Precision Oncology</span><span> <strong>2018,</strong> <em> </em>
                                    (2)
                                     , 1-20. <a href="https://doi.org/10.1200/PO.18.00183" title="DOI URL">https://doi.org/10.1200/PO.18.00183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/PO.18.00183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FPO.18.00183%26sid%3Dliteratum%253Aachs%26jtitle%3DJCO%2520Precision%2520Oncology%26atitle%3DAnalysis%252Bof%252BNTRK%252BAlterations%252Bin%252BPan-Cancer%252BAdult%252Band%252BPediatric%252BMalignancies%25253A%252BImplications%252Bfor%252BNTRK-Targeted%252BTherapeutics%26aulast%3DOkamura%26aufirst%3DRyosuke%26date%3D2018%26issue%3D2%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Hu</span>, <span class="hlFld-ContribAuthor ">Kai  Cao</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Kuantao  Zhao</span>, <span class="hlFld-ContribAuthor ">Chunlei  Tang</span>, <span class="hlFld-ContribAuthor ">Bainian  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as potent and selective CDK4/6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 935-945. <a href="https://doi.org/10.1016/j.ejmech.2018.08.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252B4%25252C5-dihydro-1H-pyrazolo%25255B4%25252C3-h%25255Dquinazoline%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BCDK4%25252F6%252Binhibitors%26aulast%3DZhao%26aufirst%3DHui%26date%3D2018%26volume%3D157%26spage%3D935%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiting  Wang</span>, <span class="hlFld-ContribAuthor ">Yanmei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Cheng</span>, <span class="hlFld-ContribAuthor ">Ke  Zhang</span>, <span class="hlFld-ContribAuthor ">Hangyu  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Jinhui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrimidine derivatives as novel CDK2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3491-3501. <a href="https://doi.org/10.1016/j.bmc.2018.05.024" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrimidine%252Bderivatives%252Bas%252Bnovel%252BCDK2%252Binhibitors%252Bthat%252Binduce%252Bapoptosis%252Band%252Bcell%252Bcycle%252Barrest%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DWang%26aufirst%3DYiting%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3491%26epage%3D3501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Alagarsamy</span>, <span class="hlFld-ContribAuthor ">K.  Chitra</span>, <span class="hlFld-ContribAuthor ">G.  Saravanan</span>, <span class="hlFld-ContribAuthor ">V. Raja  Solomon</span>, <span class="hlFld-ContribAuthor ">M.T.  Sulthana</span>, <span class="hlFld-ContribAuthor ">B.  Narendhar</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of quinazolines: Pharmacological significance and recent developments. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 628-685. <a href="https://doi.org/10.1016/j.ejmech.2018.03.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bquinazolines%25253A%252BPharmacological%252Bsignificance%252Band%252Brecent%252Bdevelopments%26aulast%3DAlagarsamy%26aufirst%3DV.%26date%3D2018%26volume%3D151%26spage%3D628%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Bolin</span>, <span class="hlFld-ContribAuthor ">Anna  Borgenvik</span>, <span class="hlFld-ContribAuthor ">Camilla U.  Persson</span>, <span class="hlFld-ContribAuthor ">Anders  Sundström</span>, <span class="hlFld-ContribAuthor ">Jun  Qi</span>, <span class="hlFld-ContribAuthor ">James E.  Bradner</span>, <span class="hlFld-ContribAuthor ">William A.  Weiss</span>, <span class="hlFld-ContribAuthor ">Yoon-Jae  Cho</span>, <span class="hlFld-ContribAuthor ">Holger  Weishaupt</span>, <span class="hlFld-ContribAuthor ">Fredrik J.  Swartling</span>. </span><span class="cited-content_cbyCitation_article-title">Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2018,</strong> <em>37 </em>
                                    (21)
                                     , 2850-2862. <a href="https://doi.org/10.1038/s41388-018-0135-1" title="DOI URL">https://doi.org/10.1038/s41388-018-0135-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-018-0135-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-018-0135-1%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DCombined%252BBET%252Bbromodomain%252Band%252BCDK2%252Binhibition%252Bin%252BMYC-driven%252Bmedulloblastoma%26aulast%3DBolin%26aufirst%3DSara%26date%3D2018%26date%3D2018%26volume%3D37%26issue%3D21%26spage%3D2850%26epage%3D2862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clement  Opoku-Temeng</span>, <span class="hlFld-ContribAuthor ">Neetu  Dayal</span>, <span class="hlFld-ContribAuthor ">Delmis E.  Hernandez</span>, <span class="hlFld-ContribAuthor ">N.  Naganna</span>, <span class="hlFld-ContribAuthor ">Herman O.  Sintim</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydro-3
              H
              -pyrazolo[4,3-
              a
              ]phenanthridine-based CDK inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (36)
                                     , 4521-4524. <a href="https://doi.org/10.1039/C8CC01154K" title="DOI URL">https://doi.org/10.1039/C8CC01154K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC01154K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC01154K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTetrahydro-3%252BH%252B-pyrazolo%25255B4%25252C3-%252Ba%252B%25255Dphenanthridine-based%252BCDK%252Binhibitor%26aulast%3DOpoku-Temeng%26aufirst%3DClement%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D36%26spage%3D4521%26epage%3D4524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yousry A.  Ammar</span>, <span class="hlFld-ContribAuthor ">Eman A.  Fayed</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Bayoumi</span>, <span class="hlFld-ContribAuthor ">Rogy R.  Ezz</span>, <span class="hlFld-ContribAuthor ">Mansour S.  Alsaid</span>, <span class="hlFld-ContribAuthor ">Aiten M.  Soliman</span>, <span class="hlFld-ContribAuthor ">Mostafa M.  Ghorab</span>. </span><span class="cited-content_cbyCitation_article-title">New chalcones bearing isatin scaffold: synthesis, molecular modeling and biological evaluation as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (12)
                                     , 6765-6786. <a href="https://doi.org/10.1007/s11164-017-3019-z" title="DOI URL">https://doi.org/10.1007/s11164-017-3019-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-017-3019-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-017-3019-z%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DNew%252Bchalcones%252Bbearing%252Bisatin%252Bscaffold%25253A%252Bsynthesis%25252C%252Bmolecular%252Bmodeling%252Band%252Bbiological%252Bevaluation%252Bas%252Banticancer%252Bagents%26aulast%3DAmmar%26aufirst%3DYousry%2BA.%26date%3D2017%26date%3D2017%26volume%3D43%26issue%3D12%26spage%3D6765%26epage%3D6786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Müller</span>, <span class="hlFld-ContribAuthor ">Adriana  Aguado</span>, <span class="hlFld-ContribAuthor ">Benoît  Laleu</span>, <span class="hlFld-ContribAuthor ">Vreni  Balmer</span>, <span class="hlFld-ContribAuthor ">Dominic  Ritler</span>, <span class="hlFld-ContribAuthor ">Andrew  Hemphill</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology</span><span> <strong>2017,</strong> <em>47 </em>
                                    (12)
                                     , 801-809. <a href="https://doi.org/10.1016/j.ijpara.2017.06.002" title="DOI URL">https://doi.org/10.1016/j.ijpara.2017.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpara.2017.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpara.2017.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%26atitle%3DIn%252Bvitro%252Bscreening%252Bof%252Bthe%252Bopen%252Bsource%252BPathogen%252BBox%252Bidentifies%252Bnovel%252Bcompounds%252Bwith%252Bprofound%252Bactivities%252Bagainst%252BNeospora%252Bcaninum%26aulast%3DM%25C3%25BCller%26aufirst%3DJoachim%26date%3D2017%26volume%3D47%26issue%3D12%26spage%3D801%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Kristen  Farrell</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>. </span><span class="cited-content_cbyCitation_article-title">Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 –
              Part II. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (7)
                                     , 831-849. <a href="https://doi.org/10.1080/13543776.2017.1297797" title="DOI URL">https://doi.org/10.1080/13543776.2017.1297797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1297797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1297797%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTropomyosin%252Breceptor%252Bkinase%252Binhibitors%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252Bfor%252B2010-2016%252B%2525E2%252580%252593%252BPart%252BII%26aulast%3DBailey%26aufirst%3DJustin%2BJ.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D831%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Aspeslagh</span>, <span class="hlFld-ContribAuthor ">Kunwar  Shailubhai</span>, <span class="hlFld-ContribAuthor ">Rastilav  Bahleda</span>, <span class="hlFld-ContribAuthor ">Anas  Gazzah</span>, <span class="hlFld-ContribAuthor ">Andréa  Varga</span>, <span class="hlFld-ContribAuthor ">Antoine  Hollebecque</span>, <span class="hlFld-ContribAuthor ">Christophe  Massard</span>, <span class="hlFld-ContribAuthor ">Anna  Spreafico</span>, <span class="hlFld-ContribAuthor ">Michele  Reni</span>, <span class="hlFld-ContribAuthor ">Jean-Charles  Soria</span>. </span><span class="cited-content_cbyCitation_article-title">Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2017,</strong> <em>79 </em>
                                    (6)
                                     , 1257-1265. <a href="https://doi.org/10.1007/s00280-017-3303-z" title="DOI URL">https://doi.org/10.1007/s00280-017-3303-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-017-3303-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-017-3303-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DPhase%252BI%252Bdose-escalation%252Bstudy%252Bof%252Bmilciclib%252Bin%252Bcombination%252Bwith%252Bgemcitabine%252Bin%252Bpatients%252Bwith%252Brefractory%252Bsolid%252Btumors%26aulast%3DAspeslagh%26aufirst%3DSandrine%26date%3D2017%26date%3D2017%26volume%3D79%26issue%3D6%26spage%3D1257%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorota  Lubanska</span>, <span class="hlFld-ContribAuthor ">Lisa  Porter</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme. </span><span class="cited-content_cbyCitation_journal-name">Drugs in R&D</span><span> <strong>2017,</strong> <em>17 </em>
                                    (2)
                                     , 255-263. <a href="https://doi.org/10.1007/s40268-017-0180-1" title="DOI URL">https://doi.org/10.1007/s40268-017-0180-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40268-017-0180-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40268-017-0180-1%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520in%2520R%2526D%26atitle%3DRevisiting%252BCDK%252BInhibitors%252Bfor%252BTreatment%252Bof%252BGlioblastoma%252BMultiforme%26aulast%3DLubanska%26aufirst%3DDorota%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D2%26spage%3D255%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jérémy  Thireau</span>, <span class="hlFld-ContribAuthor ">Cédric  Schneider</span>, <span class="hlFld-ContribAuthor ">Christine  Baudequin</span>, <span class="hlFld-ContribAuthor ">Sandrine  Gaurrand</span>, <span class="hlFld-ContribAuthor ">Patrick  Angibaud</span>, <span class="hlFld-ContribAuthor ">Lieven  Meerpoel</span>, <span class="hlFld-ContribAuthor ">Vincent  Levacher</span>, <span class="hlFld-ContribAuthor ">Olivier  Querolle</span>, <span class="hlFld-ContribAuthor ">Christophe  Hoarau</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselective Palladium-Catalyzed Direct C-H Arylation of 5-Carboxyimidazoles: Unparalleled Access to Fused Imidazole-Based Tricycles Containing Six-, Seven- or Eight-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (17)
                                     , 2491-2494. <a href="https://doi.org/10.1002/ejoc.201700297" title="DOI URL">https://doi.org/10.1002/ejoc.201700297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201700297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201700297%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DChemoselective%252BPalladium-Catalyzed%252BDirect%252BC-H%252BArylation%252Bof%252B5-Carboxyimidazoles%25253A%252BUnparalleled%252BAccess%252Bto%252BFused%252BImidazole-Based%252BTricycles%252BContaining%252BSix-%25252C%252BSeven-%252Bor%252BEight-Membered%252BRings%26aulast%3DThireau%26aufirst%3DJ%25C3%25A9r%25C3%25A9my%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D17%26spage%3D2491%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven R.  Whittaker</span>, <span class="hlFld-ContribAuthor ">Aurélie  Mallinger</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of cyclin-dependent kinases as cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2017,</strong> <em>173 </em>, 83-105. <a href="https://doi.org/10.1016/j.pharmthera.2017.02.008" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2017.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2017.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2017.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DInhibitors%252Bof%252Bcyclin-dependent%252Bkinases%252Bas%252Bcancer%252Btherapeutics%26aulast%3DWhittaker%26aufirst%3DSteven%2BR.%26date%3D2017%26volume%3D173%26spage%3D83%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tinghan  Li</span>, <span class="hlFld-ContribAuthor ">Tianwei  Weng</span>, <span class="hlFld-ContribAuthor ">Minzan  Zuo</span>, <span class="hlFld-ContribAuthor ">Zhihui  Wei</span>, <span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress of cyclin-dependent kinase inhibitors as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (17)
                                     , 2047-2076. <a href="https://doi.org/10.4155/fmc-2016-0129" title="DOI URL">https://doi.org/10.4155/fmc-2016-0129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0129%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bof%252Bcyclin-dependent%252Bkinase%252Binhibitors%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DLi%26aufirst%3DTinghan%26date%3D2016%26volume%3D8%26issue%3D17%26spage%3D2047%26epage%3D2076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Di Giovanni</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Adriana  Chilin</span>, <span class="hlFld-ContribAuthor ">Antonio  Lavecchia</span>, <span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2016,</strong> <em>25 </em>
                                    (10)
                                     , 1215-1230. <a href="https://doi.org/10.1080/13543784.2016.1234603" title="DOI URL">https://doi.org/10.1080/13543784.2016.1234603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2016.1234603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2016.1234603%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bdrugs%252Btargeting%252Bcyclin-dependent%252Bkinases%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%25253A%252Ban%252Bupdate%252Bon%252Brecent%252Bfindings%252B%2525282013-2016%252529%26aulast%3DDi%2BGiovanni%26aufirst%3DCarmen%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D10%26spage%3D1215%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dingkong  Liang</span>, <span class="hlFld-ContribAuthor ">Si  Shi</span>, <span class="hlFld-ContribAuthor ">Jin  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Qin</span>, <span class="hlFld-ContribAuthor ">Shunrong  Ji</span>, <span class="hlFld-ContribAuthor ">Wenyan  Xu</span>, <span class="hlFld-ContribAuthor ">Jiang  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Jiang  Long</span>, <span class="hlFld-ContribAuthor ">Quanxing  Ni</span>, <span class="hlFld-ContribAuthor ">Xianjun  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">New insights into perineural invasion of pancreatic cancer: More than pain. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2016,</strong> <em>1865 </em>
                                    (2)
                                     , 111-122. <a href="https://doi.org/10.1016/j.bbcan.2016.01.002" title="DOI URL">https://doi.org/10.1016/j.bbcan.2016.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2016.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2016.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DNew%252Binsights%252Binto%252Bperineural%252Binvasion%252Bof%252Bpancreatic%252Bcancer%25253A%252BMore%252Bthan%252Bpain%26aulast%3DLiang%26aufirst%3DDingkong%26date%3D2016%26volume%3D1865%26issue%3D2%26spage%3D111%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ladislava  Vymětalová</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Clinical Uses of CDK Inhibitors: Lessons from Synthetic Lethality Screens. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (6)
                                     , 1156-1174. <a href="https://doi.org/10.1002/med.21354" title="DOI URL">https://doi.org/10.1002/med.21354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21354%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DPotential%252BClinical%252BUses%252Bof%252BCDK%252BInhibitors%25253A%252BLessons%252Bfrom%252BSynthetic%252BLethality%252BScreens%26aulast%3DVym%25C4%259Btalov%25C3%25A1%26aufirst%3DLadislava%26date%3D2015%26date%3D2015%26volume%3D35%26issue%3D6%26spage%3D1156%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Concepción  Sánchez-Martínez</span>, <span class="hlFld-ContribAuthor ">Lawrence M.  Gelbert</span>, <span class="hlFld-ContribAuthor ">María José  Lallena</span>, <span class="hlFld-ContribAuthor ">Alfonso  de Dios</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin dependent kinase (CDK) inhibitors as anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3420-3435. <a href="https://doi.org/10.1016/j.bmcl.2015.05.100" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.05.100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.05.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.05.100%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCyclin%252Bdependent%252Bkinase%252B%252528CDK%252529%252Binhibitors%252Bas%252Banticancer%252Bdrugs%26aulast%3DS%25C3%25A1nchez-Mart%25C3%25ADnez%26aufirst%3DConcepci%25C3%25B3n%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3420%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mansi  Garg</span>, <span class="hlFld-ContribAuthor ">Monika  Chauhan</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Jimi Marin  Alex</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazoloquinazolines: Synthetic strategies and bioactivities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 444-461. <a href="https://doi.org/10.1016/j.ejmech.2014.11.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.11.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.11.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazoloquinazolines%25253A%252BSynthetic%252Bstrategies%252Band%252Bbioactivities%26aulast%3DGarg%26aufirst%3DMansi%26date%3D2015%26volume%3D97%26spage%3D444%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Fares</span>, <span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Sahar M.  Abou-Seri</span>, <span class="hlFld-ContribAuthor ">Hatem A.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Mohamed H.  Aly</span>, <span class="hlFld-ContribAuthor ">Mai F.  Tolba</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and
              In Vitro
              Antiproliferative Activity of Novel Isatin-Quinazoline Hybrids. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (2)
                                     , 144-154. <a href="https://doi.org/10.1002/ardp.201400337" title="DOI URL">https://doi.org/10.1002/ardp.201400337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400337%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BIn%252BVitro%252BAntiproliferative%252BActivity%252Bof%252BNovel%252BIsatin-Quinazoline%252BHybrids%26aulast%3DFares%26aufirst%3DMohamed%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D2%26spage%3D144%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaiprakash N.  Sangshetti</span>, <span class="hlFld-ContribAuthor ">Deepak K.  Lokwani</span>, <span class="hlFld-ContribAuthor ">Rashmi S.  Chouthe</span>, <span class="hlFld-ContribAuthor ">Ashok  Ganure</span>, <span class="hlFld-ContribAuthor ">Bhuvan  Raval</span>, <span class="hlFld-ContribAuthor ">Firoz A. Kalam  Khan</span>, <span class="hlFld-ContribAuthor ">Devanand B.  Shinde</span>. </span><span class="cited-content_cbyCitation_article-title">Green synthesis and biological evaluation of some new benzothiazolo [2,3-b] quinazolin-1-ones as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (11)
                                     , 4893-4900. <a href="https://doi.org/10.1007/s00044-014-1044-7" title="DOI URL">https://doi.org/10.1007/s00044-014-1044-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1044-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1044-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DGreen%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252Bnew%252Bbenzothiazolo%252B%25255B2%25252C3-b%25255D%252Bquinazolin-1-ones%252Bas%252Banticancer%252Bagents%26aulast%3DSangshetti%26aufirst%3DJaiprakash%2BN.%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D11%26spage%3D4893%26epage%3D4900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Bao-Xiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 311-340. <a href="https://doi.org/10.1016/j.ejmech.2014.07.102" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.102%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bof%252Bthe%252Bsynthesis%252Bof%252Bcondensed%252Bpyrazole%252Bderivatives%252B%252528from%252B2010%252Bto%252Bmid-2013%252529%26aulast%3DLi%26aufirst%3DMeng%26date%3D2014%26volume%3D85%26spage%3D311%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simpal  Kumari</span>, <span class="hlFld-ContribAuthor ">Sarvesh  Paliwal</span>, <span class="hlFld-ContribAuthor ">Rajani  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Pyrazole Derivatives Possessing Anticancer Activity: Current Status. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (11)
                                     , 1521-1578. <a href="https://doi.org/10.1080/00397911.2013.828757" title="DOI URL">https://doi.org/10.1080/00397911.2013.828757</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2013.828757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2013.828757%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Bof%252BPyrazole%252BDerivatives%252BPossessing%252BAnticancer%252BActivity%25253A%252BCurrent%252BStatus%26aulast%3DKumari%26aufirst%3DSimpal%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D11%26spage%3D1521%26epage%3D1578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simpal  Chauhan</span>, <span class="hlFld-ContribAuthor ">Sarvesh  Paliwal</span>, <span class="hlFld-ContribAuthor ">Rajani  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Activity of Pyrazole via Different Biological Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (10)
                                     , 1333-1374. <a href="https://doi.org/10.1080/00397911.2013.837186" title="DOI URL">https://doi.org/10.1080/00397911.2013.837186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2013.837186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2013.837186%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DAnticancer%252BActivity%252Bof%252BPyrazole%252Bvia%252BDifferent%252BBiological%252BMechanisms%26aulast%3DChauhan%26aufirst%3DSimpal%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D10%26spage%3D1333%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santiago  Diaz-Moralli</span>, <span class="hlFld-ContribAuthor ">Míriam  Tarrado-Castellarnau</span>, <span class="hlFld-ContribAuthor ">Anibal  Miranda</span>, <span class="hlFld-ContribAuthor ">Marta  Cascante</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting cell cycle regulation in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2013,</strong> <em>138 </em>
                                    (2)
                                     , 255-271. <a href="https://doi.org/10.1016/j.pharmthera.2013.01.011" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2013.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2013.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2013.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTargeting%252Bcell%252Bcycle%252Bregulation%252Bin%252Bcancer%252Btherapy%26aulast%3DDiaz-Moralli%26aufirst%3DSantiago%26date%3D2013%26volume%3D138%26issue%3D2%26spage%3D255%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C  Albanese</span>, <span class="hlFld-ContribAuthor ">R  Alzani</span>, <span class="hlFld-ContribAuthor ">N  Amboldi</span>, <span class="hlFld-ContribAuthor ">A  Degrassi</span>, <span class="hlFld-ContribAuthor ">C  Festuccia</span>, <span class="hlFld-ContribAuthor ">F  Fiorentini</span>, <span class="hlFld-ContribAuthor ">GL  Gravina</span>, <span class="hlFld-ContribAuthor ">C  Mercurio</span>, <span class="hlFld-ContribAuthor ">W  Pastori</span>, <span class="hlFld-ContribAuthor ">MG  Brasca</span>, <span class="hlFld-ContribAuthor ">E  Pesenti</span>, <span class="hlFld-ContribAuthor ">A  Galvani</span>, <span class="hlFld-ContribAuthor ">M  Ciomei</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>169 </em>
                                    (1)
                                     , 156-166. <a href="https://doi.org/10.1111/bph.12112" title="DOI URL">https://doi.org/10.1111/bph.12112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12112%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DAnti-tumour%252Befficacy%252Bon%252Bglioma%252Bmodels%252Bof%252BPHA-848125%25252C%252Ba%252Bmulti-kinase%252Binhibitor%252Bable%252Bto%252Bcross%252Bthe%252Bblood-brain%252Bbarrier%26aulast%3DAlbanese%26aufirst%3DC%26date%3D2013%26date%3D2013%26volume%3D169%26issue%3D1%26spage%3D156%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Weimin  Gao</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jinghui  Wang</span>, <span class="hlFld-ContribAuthor ">Jingxiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Yang</span>, <span class="hlFld-ContribAuthor ">Shuwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2013,</strong> <em>9 </em>
                                    (9)
                                     , 2266. <a href="https://doi.org/10.1039/c3mb70186g" title="DOI URL">https://doi.org/10.1039/c3mb70186g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3mb70186g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3mb70186g%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DAn%252Bin%252Bsilico%252Bexploration%252Bof%252Bthe%252Binteraction%252Bmechanism%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Btype%252BCDK2%252Binhibitors%26aulast%3DLi%26aufirst%3DYan%26date%3D2013%26volume%3D9%26issue%3D9%26spage%3D2266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Glen J.  Weiss</span>, <span class="hlFld-ContribAuthor ">Manuel  Hidalgo</span>, <span class="hlFld-ContribAuthor ">Mitesh J.  Borad</span>, <span class="hlFld-ContribAuthor ">Daniel  Laheru</span>, <span class="hlFld-ContribAuthor ">Raoul  Tibes</span>, <span class="hlFld-ContribAuthor ">Ramesh K.  Ramanathan</span>, <span class="hlFld-ContribAuthor ">Lisa  Blaydorn</span>, <span class="hlFld-ContribAuthor ">Gayle  Jameson</span>, <span class="hlFld-ContribAuthor ">Antonio  Jimeno</span>, <span class="hlFld-ContribAuthor ">Jeffrey D.  Isaacs</span>, <span class="hlFld-ContribAuthor ">Angela  Scaburri</span>, <span class="hlFld-ContribAuthor ">Maria Adele  Pacciarini</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Daniel D.  Von Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2012,</strong> <em>30 </em>
                                    (6)
                                     , 2334-2343. <a href="https://doi.org/10.1007/s10637-011-9774-6" title="DOI URL">https://doi.org/10.1007/s10637-011-9774-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-011-9774-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-011-9774-6%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DPhase%252BI%252Bstudy%252Bof%252Bthe%252Bsafety%25252C%252Btolerability%252Band%252Bpharmacokinetics%252Bof%252BPHA-848125AC%25252C%252Ba%252Bdual%252Btropomyosin%252Breceptor%252Bkinase%252BA%252Band%252Bcyclin-dependent%252Bkinase%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Bmalignancies%26aulast%3DWeiss%26aufirst%3DGlen%2BJ.%26date%3D2012%26date%3D2011%26volume%3D30%26issue%3D6%26spage%3D2334%26epage%3D2343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Bing  He</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Qi-Feng  Deng</span>, <span class="hlFld-ContribAuthor ">Wei-Ping  Ma</span>, <span class="hlFld-ContribAuthor ">Chun-Lan  Tang</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Jing-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (23)
                                     , 7237-7242. <a href="https://doi.org/10.1016/j.bmcl.2012.09.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.09.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.09.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.09.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4%25252C4-dimethyl%252Blithocholic%252Bacid%252Bderivatives%252Bas%252Bnovel%252Binhibitors%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252B1B%26aulast%3DHe%26aufirst%3DHai-Bing%26date%3D2012%26volume%3D22%26issue%3D23%26spage%3D7237%26epage%3D7242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simona  Caporali</span>, <span class="hlFld-ContribAuthor ">Ester  Alvino</span>, <span class="hlFld-ContribAuthor ">Lauretta  Levati</span>, <span class="hlFld-ContribAuthor ">Alessia I.  Esposito</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Maria G.  Brasca</span>, <span class="hlFld-ContribAuthor ">Donatella  Del Bufalo</span>, <span class="hlFld-ContribAuthor ">Marianna  Desideri</span>, <span class="hlFld-ContribAuthor ">Enzo  Bonmassar</span>, <span class="hlFld-ContribAuthor ">Ulrich  Pfeffer</span>, <span class="hlFld-ContribAuthor ">Stefania  D’Atri</span>. </span><span class="cited-content_cbyCitation_article-title">Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2012,</strong> <em>84 </em>
                                    (5)
                                     , 598-611. <a href="https://doi.org/10.1016/j.bcp.2012.06.004" title="DOI URL">https://doi.org/10.1016/j.bcp.2012.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2012.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2012.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DDown-regulation%252Bof%252Bthe%252BPTTG1%252Bproto-oncogene%252Bcontributes%252Bto%252Bthe%252Bmelanoma%252Bsuppressive%252Beffects%252Bof%252Bthe%252Bcyclin-dependent%252Bkinase%252Binhibitor%252BPHA-848125%26aulast%3DCaporali%26aufirst%3DSimona%26date%3D2012%26volume%3D84%26issue%3D5%26spage%3D598%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>, <span class="hlFld-ContribAuthor ">Adriano  Guiotto</span>, <span class="hlFld-ContribAuthor ">Adriana  Chilin</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (3)
                                     , 223-252. <a href="https://doi.org/10.1517/13543776.2012.665876" title="DOI URL">https://doi.org/10.1517/13543776.2012.665876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.665876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.665876%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DQuinazoline%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%25253A%252Ba%252Bpatent%252Breview%252B%2525282007%252B%2525E2%252580%252593%252B2010%252529%26aulast%3DMarzaro%26aufirst%3DGiovanni%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D3%26spage%3D223%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Józefa  Węsierska-Gądek</span>, <span class="hlFld-ContribAuthor ">Matthias P  Kramer</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (4)
                                     , 395-424. <a href="https://doi.org/10.4155/fmc.12.12" title="DOI URL">https://doi.org/10.4155/fmc.12.12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.12%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bimpact%252Bof%252BCDK%252Binhibition%252Bin%252Bhuman%252Bmalignancies%252Bassociated%252Bwith%252Bpronounced%252Bdefects%252Bin%252Bapoptosis%25253A%252Badvantages%252Bof%252Bmulti-targeting%252Bsmall%252Bmolecules%26aulast%3DW%25C4%2599sierska-G%25C4%2585dek%26aufirst%3DJ%25C3%25B3zefa%26date%3D2012%26volume%3D4%26issue%3D4%26spage%3D395%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aditi A.  Bapat</span>, <span class="hlFld-ContribAuthor ">Galen  Hostetter</span>, <span class="hlFld-ContribAuthor ">Daniel D.  Von Hoff</span>, <span class="hlFld-ContribAuthor ">Haiyong  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Perineural invasion and associated pain in pancreatic cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2011,</strong> <em>11 </em>
                                    (10)
                                     , 695-707. <a href="https://doi.org/10.1038/nrc3131" title="DOI URL">https://doi.org/10.1038/nrc3131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrc3131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrc3131%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DPerineural%252Binvasion%252Band%252Bassociated%252Bpain%252Bin%252Bpancreatic%252Bcancer%26aulast%3DBapat%26aufirst%3DAditi%2BA.%26date%3D2011%26date%3D2011%26volume%3D11%26issue%3D10%26spage%3D695%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangfang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Ma</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Shanna  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhengtao  Xiao</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonghua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2011,</strong> <em>30 </em>, 67-81. <a href="https://doi.org/10.1016/j.jmgm.2011.06.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2011.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2011.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2011.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DDevelopment%252Bof%252Bin%252Bsilico%252Bmodels%252Bfor%252Bpyrazoles%252Band%252Bpyrimidine%252Bderivatives%252Bas%252Bcyclin-dependent%252Bkinase%252B2%252Binhibitors%26aulast%3DWang%26aufirst%3DFangfang%26date%3D2011%26volume%3D30%26spage%3D67%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Caldarelli</span>, <span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>, <span class="hlFld-ContribAuthor ">Teresa  Disingrini</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Marco  Guanci</span>, <span class="hlFld-ContribAuthor ">Stefano  Nuvoloni</span>, <span class="hlFld-ContribAuthor ">Helena  Posteri</span>, <span class="hlFld-ContribAuthor ">Francesca  Quartieri</span>, <span class="hlFld-ContribAuthor ">Marco  Silvagni</span>, <span class="hlFld-ContribAuthor ">Riccardo  Colombo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (15)
                                     , 4507-4511. <a href="https://doi.org/10.1016/j.bmcl.2011.05.122" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.05.122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.05.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.05.122%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252Bnew%252Bpyrazolo%25255B4%25252C3-h%25255Dquinazoline-3-carboxamide%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BMPS1%252Bkinase%252Binhibitors%26aulast%3DCaldarelli%26aufirst%3DMarina%26date%3D2011%26volume%3D21%26issue%3D15%26spage%3D4507%26epage%3D4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Venkata Mahidhar  Yenugonda</span>, <span class="hlFld-ContribAuthor ">Tushar B.  Deb</span>, <span class="hlFld-ContribAuthor ">Scott C.  Grindrod</span>, <span class="hlFld-ContribAuthor ">Sivanesan  Dakshanamurthy</span>, <span class="hlFld-ContribAuthor ">Yonghong  Yang</span>, <span class="hlFld-ContribAuthor ">Mikell  Paige</span>, <span class="hlFld-ContribAuthor ">Milton L.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (8)
                                     , 2714-2725. <a href="https://doi.org/10.1016/j.bmc.2011.02.052" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.02.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.02.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFluorescent%252Bcyclin-dependent%252Bkinase%252Binhibitors%252Bblock%252Bthe%252Bproliferation%252Bof%252Bhuman%252Bbreast%252Bcancer%252Bcells%26aulast%3DYenugonda%26aufirst%3DVenkata%2BMahidhar%26date%3D2011%26volume%3D19%26issue%3D8%26spage%3D2714%26epage%3D2725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael M.  Miller</span>, <span class="hlFld-ContribAuthor ">Albert J.  DelMonte</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems:. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 393-425. <a href="https://doi.org/10.1016/S0959-6380(11)22013-0" title="DOI URL">https://doi.org/10.1016/S0959-6380(11)22013-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(11)22013-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2811%2922013-0%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%25253A%26aulast%3DMiller%26aufirst%3DMichael%2BM.%26date%3D2011%26spage%3D393%26epage%3D425%26pub%3DElsevier%26date%3D2011%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Lan</span>, <span class="hlFld-ContribAuthor ">Wan-Na  Chen</span>, <span class="hlFld-ContribAuthor ">Gao-Keng  Xiao</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (22)
                                     , 6764-6772. <a href="https://doi.org/10.1016/j.bmcl.2010.08.131" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.08.131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.08.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.08.131%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudies%252Bon%252Bpyrazolo%25255B4%25252C3-h%25255Dqinazoline-3-carboxamides%252Bas%252Bcyclin-dependent%252Bkinase%252B2%252B%252528CDK2%252529%252Binhibitors%26aulast%3DLan%26aufirst%3DPing%26date%3D2010%26volume%3D20%26issue%3D22%26spage%3D6764%26epage%3D6772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Idit  Sagiv-Barfi</span>, <span class="hlFld-ContribAuthor ">Ester  Weiss</span>, <span class="hlFld-ContribAuthor ">Alexander  Levitzki</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (17)
                                     , 6404-6413. <a href="https://doi.org/10.1016/j.bmc.2010.07.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bquinazoline%252BT%252Bcell%252Bproliferation%252Binhibitors%26aulast%3DSagiv-Barfi%26aufirst%3DIdit%26date%3D2010%26volume%3D18%26issue%3D17%26spage%3D6404%26epage%3D6413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F.  Iorio</span>, <span class="hlFld-ContribAuthor ">R.  Bosotti</span>, <span class="hlFld-ContribAuthor ">E.  Scacheri</span>, <span class="hlFld-ContribAuthor ">V.  Belcastro</span>, <span class="hlFld-ContribAuthor ">P.  Mithbaokar</span>, <span class="hlFld-ContribAuthor ">R.  Ferriero</span>, <span class="hlFld-ContribAuthor ">L.  Murino</span>, <span class="hlFld-ContribAuthor ">R.  Tagliaferri</span>, <span class="hlFld-ContribAuthor ">N.  Brunetti-Pierri</span>, <span class="hlFld-ContribAuthor ">A.  Isacchi</span>, <span class="hlFld-ContribAuthor ">D.  di Bernardo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of drug mode of action and drug repositioning from transcriptional responses. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2010,</strong> <em>107 </em>
                                    (33)
                                     , 14621-14626. <a href="https://doi.org/10.1073/pnas.1000138107" title="DOI URL">https://doi.org/10.1073/pnas.1000138107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1000138107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1000138107%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DDiscovery%252Bof%252Bdrug%252Bmode%252Bof%252Baction%252Band%252Bdrug%252Brepositioning%252Bfrom%252Btranscriptional%252Bresponses%26aulast%3DIorio%26aufirst%3DF.%26date%3D2010%26date%3D2010%26volume%3D107%26issue%3D33%26spage%3D14621%26epage%3D14626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clara  Albanese</span>, <span class="hlFld-ContribAuthor ">Rachele  Alzani</span>, <span class="hlFld-ContribAuthor ">Nadia  Amboldi</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Claudio  Festuccia</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Locatelli</span>, <span class="hlFld-ContribAuthor ">Wilma  Pastori</span>, <span class="hlFld-ContribAuthor ">Veronica  Patton</span>, <span class="hlFld-ContribAuthor ">Fulvia  Roletto</span>, <span class="hlFld-ContribAuthor ">Francesco  Colotta</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Jurgen  Moll</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (8)
                                     , 2243-2254. <a href="https://doi.org/10.1158/1535-7163.MCT-10-0190" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-10-0190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-10-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-10-0190%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDual%252BTargeting%252Bof%252BCDK%252Band%252BTropomyosin%252BReceptor%252BKinase%252BFamilies%252Bby%252Bthe%252BOral%252BInhibitor%252BPHA-848125%25252C%252Ban%252BAgent%252Bwith%252BBroad-Spectrum%252BAntitumor%252BEfficacy%26aulast%3DAlbanese%26aufirst%3DClara%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D8%26spage%3D2243%26epage%3D2254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>, <span class="hlFld-ContribAuthor ">Patrizia  Banfi</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Francesco  Casuscelli</span>, <span class="hlFld-ContribAuthor ">Claudio  Fiorelli</span>, <span class="hlFld-ContribAuthor ">Maria B.  Saccardo</span>, <span class="hlFld-ContribAuthor ">Marco  Silvagni</span>, <span class="hlFld-ContribAuthor ">Fabio  Zuccotto</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimization of potent PDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (14)
                                     , 4095-4099. <a href="https://doi.org/10.1016/j.bmcl.2010.05.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.05.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.05.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Boptimization%252Bof%252Bpotent%252BPDK1%252Binhibitors%26aulast%3DAngiolini%26aufirst%3DMauro%26date%3D2010%26volume%3D20%26issue%3D14%26spage%3D4095%26epage%3D4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Locatelli</span>, <span class="hlFld-ContribAuthor ">Roberta  Bosotti</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Maria G.  Brasca</span>, <span class="hlFld-ContribAuthor ">Raffaele  Calogero</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Matteo  Bertolotti</span>, <span class="hlFld-ContribAuthor ">Emanuela  Scacheri</span>, <span class="hlFld-ContribAuthor ">Angela  Scaburri</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Thierry  De Baere</span>, <span class="hlFld-ContribAuthor ">Jean-Charles  Soria</span>, <span class="hlFld-ContribAuthor ">Vladimir  Lazar</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (5)
                                     , 1265-1273. <a href="https://doi.org/10.1158/1535-7163.MCT-09-1163" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-1163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-1163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-1163%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTranscriptional%252BAnalysis%252Bof%252Ban%252BE2F%252BGene%252BSignature%252Bas%252Ba%252BBiomarker%252Bof%252BActivity%252Bof%252Bthe%252BCyclin-Dependent%252BKinase%252BInhibitor%252BPHA-793887%252Bin%252BTumor%252Band%252BSkin%252BBiopsies%252Bfrom%252Ba%252BPhase%252BI%252BClinical%252BStudy%26aulast%3DLocatelli%26aufirst%3DGiuseppe%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D5%26spage%3D1265%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Degrassi</span>, <span class="hlFld-ContribAuthor ">Micaela  Russo</span>, <span class="hlFld-ContribAuthor ">Cristina  Nanni</span>, <span class="hlFld-ContribAuthor ">Veronica  Patton</span>, <span class="hlFld-ContribAuthor ">Rachele  Alzani</span>, <span class="hlFld-ContribAuthor ">Anna M.  Giusti</span>, <span class="hlFld-ContribAuthor ">Stefano  Fanti</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Gemma  Texido</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of PHA-848125, a Cyclin-Dependent Kinase Inhibitor, on the K-Ras
              G12D
              LA2 Lung Adenocarcinoma Transgenic Mouse Model: Evaluation by Multimodality Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (3)
                                     , 673-681. <a href="https://doi.org/10.1158/1535-7163.MCT-09-0726" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-0726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-0726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-0726%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DEfficacy%252Bof%252BPHA-848125%25252C%252Ba%252BCyclin-Dependent%252BKinase%252BInhibitor%25252C%252Bon%252Bthe%252BK-Ras%252BG12D%252BLA2%252BLung%252BAdenocarcinoma%252BTransgenic%252BMouse%252BModel%25253A%252BEvaluation%252Bby%252BMultimodality%252BImaging%26aulast%3DDegrassi%26aufirst%3DAnna%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D3%26spage%3D673%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. From benzodipyrazole series to hit compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylic acid derivative <b>2</b> in complex with CDK2/cyclin A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIP">2WIP</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Adducts <b>6a</b> and <b>6b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>p-</i>TSA cat., toluene, EtOH, reflux, 48 h, 66%; (b) 1 M LiN(TMS)<sub>2</sub> in THF, diethyl oxalate, Et<sub>2</sub>O, −50 °C to room temp, 76%; (c) methylhydrazine, CH<sub>3</sub>COOH, room temp, 6 h, 63%; (d) <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal, DMF, 60 °C, 8 h, 90%; (e) TiCl<sub>4</sub>, MeOH, room temp, 1 h, 92%; (f) 1 M LiAlH<sub>4</sub> in THF, 0 °C to room temp, 4 h; 2 M H<sub>2</sub>SO<sub>4</sub>; H<sub>2</sub>O<sub>2</sub>, 2% NaOH, MeOH, 0−4 °C, 20 h, 78%; (g) KOH, MeOH, room temp, 20 h, 68%; (h) NaH, diethyl oxalate, THF, reflux, 1 h; methylhydrazine, CH<sub>3</sub>COOH, room temp, 12 h, 48%; (i) <i>N</i>,<i>N</i>-dimethylformamide di-<i>tert</i>-butyl acetal, DMF, 60 °C, 2 h, 87%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Final Compounds <b>1</b> and <b>16</b>−<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) phenylguanidine carbonate, DMF, 110 °C, 6 h, 72−90%; (b) 1.5 N KOH in 95% EtOH, room temp; HOBt·NH<sub>3</sub>, EDC, DIPEA, DMF, room temp or R<sup>1</sup>NH<sub>2</sub>, EDC, HOBt, DIPEA, DMF, room temp, 46−83%; (c) guanidine hydrochloride, K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C, 92−93%; (d) isopentyl nitrite, CsI, I<sub>2</sub>, CuI, DME, 65 °C, 40−46%; (e) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, dioxane, reflux; HOBt·NH<sub>3</sub>, EDC, DIPEA, DMF, room temp or R<sup>1</sup>NH<sub>2</sub>, EDC, HOBt, DIPEA, DMF, room temp, 56−65%; (f) substituted aniline, Pd(OAc)<sub>2</sub>, (±)-BINAP, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 30−71%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of compound <b>28</b> (PHA-848125) in complex with CDK2/cyclin A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIH">2WIH</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>28</b> decreases the amount of pRB phosphorylation in treated cells in comparison with untreated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/medium/jm-2009-006559_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>28</b> shows 53%, 76%, and 91% tumor growth inhibition (TGI) against a human ovarian cancer model (A2780) transplanted into nude mice when orally administered respectively at doses of 20 (◼), 30 (▲), and 40 (×) mg/kg b.i.d. for 10 consecutive days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-16/jm9006559/production/images/large/jm-2009-006559_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9006559&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0liCyMG_uF8e6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">To cycle or not to cycle: a critical decision in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1038%2F35106065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=11902577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=222-231&author=M.+Malumbresauthor=M.+Barbacid&title=To+cycle+or+not+to+cycle%3A+a+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Milestones in cell division: to cycle or not to cycle: a critical decision in cancer</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells undergo uncontrolled proliferation, yet tumors most often originate from adult tissues, in which most cells are quiescent.  So, the proliferative advantage of tumor cells arises from their ability to bypass quiescence.  This can be due to increased mitogenic signaling and/or alterations that lower the threshold required for cell-cycle commitment.  Understanding the mol. mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2EOLFB2ULbVg90H21EOLACvtfcHk0lg4HJuJqs_tGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D&md5=2bd8961854332a30c814f8ac2f9bd6f4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35106065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106065%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%2520a%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span> </span><span class="NLM_article-title">Alvocidib: Orphan Drug Status</span>. Presented at the U.S. Food and Drug Administration, Committee for Orphan Medicinal Products, 84th Plenary Meeting,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alvocidib%3A+Orphan+Drug+Status.+Presented+at+the+U.S.+Food+and+Drug+Administration%2C+Committee+for+Orphan+Medicinal+Products%2C+84th+Plenary+Meeting%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DAlvocidib%253A%2520Orphan%2520Drug%2520Status%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Meijer, L.; Bettayeb, K.; Galons, H.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-Roscovitine (CYC202, Seliciclib)</span>. In  <span class="citation_source-book">Inhibitors of Cyclin-Dependent Kinases as Anti-Tumor Agents</span>; <span class="NLM_publisher-name">CRC</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">187</span>− <span class="NLM_lpage">225</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=187-225&author=L.+Meijer&author=K.+Bettayeb&author=H.+Galons&title=Inhibitors+of+Cyclin-Dependent+Kinases+as+Anti-Tumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3D%2528R%2529-Roscovitine%2520%2528CYC202%252C%2520Seliciclib%2529%26btitle%3DInhibitors%2520of%2520Cyclin-Dependent%2520Kinases%2520as%2520Anti-Tumor%2520Agents%26pub%3DCRC%26date%3D2007%26spage%3D187%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roongta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranadive, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0305568" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1719-1728&author=R.+N.+Misraauthor=H.+Xiaoauthor=K.+S.+Kimauthor=S.+Luauthor=W.+Hanauthor=S.+A.+Barbosaauthor=J.+T.+Huntauthor=D.+B.+Rawlinsauthor=W.+Shanauthor=S.+Z.+Ahmedauthor=L.+Qianauthor=B.+Chenauthor=R.+Zhaoauthor=M.+S.+Bednarzauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=R.+Batorskyauthor=U.+Roongtaauthor=A.+Kamathauthor=P.+Maratheauthor=S.+A.+Ranadiveauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=N.+P.+Pavletichauthor=F.+Y.+F.+Leeauthor=K.+R.+Websterauthor=S.+D.+Kimball&title=N-%28Cycloalkylamino%29acyl-2-aminothiazole+inhibitors+of+cyclin-dependent+kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+highly+efficacious+and+selective+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm0305568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0305568%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DBarbosa%26aufirst%3DS.%2BA.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DBednarz%26aufirst%3DM.%2BS.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DBatorsky%26aufirst%3DR.%26aulast%3DRoongta%26aufirst%3DU.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DRanadive%26aufirst%3DS.%2BA.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26atitle%3DN-%2528Cycloalkylamino%2529acyl-2-aminothiazole%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25202.%2520N-%255B5-%255B%255B%255B5-%25281%252C1-Dimethylethyl%2529-2-oxazolyl%255Dmethyl%255Dthio%255D-2-thiazolyl%255D-4-piperidinecarboxamide%2520%2528BMS-387032%2529%252C%2520a%2520highly%2520efficacious%2520and%2520selective%2520antitumor%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1719%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0lg4HJuJqs_tGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goelzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span> </span><span class="NLM_article-title">Discovery of [4-amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6549</span><span class="NLM_x">–</span> <span class="NLM_lpage">6560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0606138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6549-6560&author=X.+J.+Chuauthor=W.+DePintoauthor=D.+Bartkovitzauthor=S.+S.+Soauthor=B.+T.+Vuauthor=K.+Packmanauthor=C.+Lukacsauthor=Q.+Dingauthor=N.+Jiangauthor=K.+Wangauthor=P.+Goelzerauthor=X.+Yinauthor=M.+A.+Smithauthor=B.+X.+Higginsauthor=Y.+Chenauthor=Q.+Xiangauthor=J.+Moliterniauthor=G.+Kaplanauthor=B.+Gravesauthor=A.+Loveyauthor=N.+Fotouhi&title=Discovery+of+%5B4-amino-2-%281-methanesulfonylpiperidin-4-ylamino%29pyrimidin-5-yl%5D%282%2C3-difluoro-6-+methoxyphenyl%29methanone+%28R547%29%2C+a+potent+and+selective+cyclin-dependent+kinase+inhibitor+with+significant+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0606138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0606138%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DDePinto%26aufirst%3DW.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DGoelzer%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DHiggins%26aufirst%3DB.%2BX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DMoliterni%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DG.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DFotouhi%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520%255B4-amino-2-%25281-methanesulfonylpiperidin-4-ylamino%2529pyrimidin-5-yl%255D%25282%252C3-difluoro-6-%2520methoxyphenyl%2529methanone%2520%2528R547%2529%252C%2520a%2520potent%2520and%2520selective%2520cyclin-dependent%2520kinase%2520inhibitor%2520with%2520significant%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6549%26epage%3D6560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Parry, D.; Guzi, T.; Seghezzi, W.; Paruch, K.; Doll, R.; Nomeir, A.; Wang, Y.; Oft, M.; Kirschmeier, P.; Chen, T.; Lees, E.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Characterization of SCH-727965, a Novel Potent Cyclin Dependent Kinase Inhibitor</span>. Presented at the AACR Conference, Los Angeles, CA, April 14−18,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Poster 4371.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=D.+Parry&author=T.+Guzi&author=W.+Seghezzi&author=K.+Paruch&author=R.+Doll&author=A.+Nomeir&author=Y.+Wang&author=M.+Oft&author=P.+Kirschmeier&author=T.+Chen&author=E.+Lees&title=In+Vitro+and+in+Vivo+Characterization+of+SCH-727965%2C+a+Novel+Potent+Cyclin+Dependent+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Characterization%2520of%2520SCH-727965%252C%2520a%2520Novel%2520Potent%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.-A.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%27Brienauthor=M.+O%27Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+A.+Seaversauthor=D.-M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.-A.+Woolford&title=Identification+of+N-%284-piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+novel+cyclin+dependent+kinase+inhibitor+using+fragment-based+X-ray+crystallography+and+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%2527Brien%26aufirst%3DM.%2BA.%26aulast%3DO%2527Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%2BA.%26aulast%3DSmith%26aufirst%3DD.-M.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.-A.%26atitle%3DIdentification%2520of%2520N-%25284-piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520novel%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520using%2520fragment-based%2520X-ray%2520crystallography%2520and%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">East, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddick, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span> </span><span class="NLM_article-title">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1016%2Fj.bmcl.2008.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=18996007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6369-6373&author=C.+D.+Jonesauthor=D.+M.+Andrewsauthor=A.+J.+Barkerauthor=K.+Bladesauthor=P.+Dauntauthor=S.+Eastauthor=C.+Gehauthor=M.+A.+Grahamauthor=K.+M.+Johnsonauthor=S.+A.+Loddickauthor=H.+M.+McFarlandauthor=A.+McGregorauthor=L.+Mossauthor=D.+A.+Rudgeauthor=P.+B.+Simpsonauthor=M.+L.+Swainauthor=K.+Y.+Tamauthor=J.+A.+Tuckerauthor=M.+Walker&title=The+discovery+of+AZD5597%2C+a+potent+imidazole+pyrimidine+amide+CDK+inhibitor+suitable+for+intravenous+dosing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing</span></div><div class="casAuthors">Jones, Clifford D.; Andrews, David M.; Barker, Andrew J.; Blades, Kevin; Daunt, Paula; East, Simon; Geh, Catherine; Graham, Mark A.; Johnson, Keith M.; Loddick, Sarah A.; McFarland, Heather M.; McGregor, Alexandra; Moss, Louise; Rudge, David A.; Simpson, Peter B.; Swain, Michael L.; Tam, Kin Y.; Tucker, Julie A.; Walker, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6369-6373</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of a novel series of imidazole pyrimidine amides as cyclin-dependent kinase (CDK) inhibitors is described.  Optimization of inhibitory potency against multiple CDK's (1, 2 and 9) resulted in imidazole pyrimidine amides with potent in vitro anti-proliferative effects against a range of cancer cell lines.  Excellent physiochem. properties and large margins against inhibition of CYP isoforms and the hERG ion channel were achieved by modification of lipophilicity and amine basicity.  A candidate with disease model activity in human cancer cell line xenografts and with suitable physiochem. and pharmacokinetic profiles for i.v. (iv) dosing was selected for further development as AZD5597 (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnX9-GP03dzbVg90H21EOLACvtfcHk0lgVEGQul9s_fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjs7bP&md5=084ed54076134c7173953ebbdb23fd86</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DA.%2BJ.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DDaunt%26aufirst%3DP.%26aulast%3DEast%26aufirst%3DS.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DK.%2BM.%26aulast%3DLoddick%26aufirst%3DS.%2BA.%26aulast%3DMcFarland%26aufirst%3DH.%2BM.%26aulast%3DMcGregor%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DL.%26aulast%3DRudge%26aufirst%3DD.%2BA.%26aulast%3DSimpson%26aufirst%3DP.%2BB.%26aulast%3DSwain%26aufirst%3DM.%2BL.%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWalker%26aufirst%3DM.%26atitle%3DThe%2520discovery%2520of%2520AZD5597%252C%2520a%2520potent%2520imidazole%2520pyrimidine%2520amide%2520CDK%2520inhibitor%2520suitable%2520for%2520intravenous%2520dosing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6369%26epage%3D6373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">D'Alessio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargiotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span> </span><span class="NLM_article-title">Benzodipyrazoles: a new class of potent CDK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1315-1319&author=R.+D%27Alessioauthor=A.+Bargiottiauthor=S.+Metzauthor=M.+G.+Brascaauthor=A.+Cameronauthor=A.+Ermoliauthor=A.+Marsiglioauthor=P.+Polucciauthor=F.+Rolettoauthor=M.+Tibollaauthor=M.+L.+Vazquezauthor=A.+Vulpettiauthor=P.+Pevarello&title=Benzodipyrazoles%3A+a+new+class+of+potent+CDK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Alessio%26aufirst%3DR.%26aulast%3DBargiotti%26aufirst%3DA.%26aulast%3DMetz%26aufirst%3DS.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DErmoli%26aufirst%3DA.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DTibolla%26aufirst%3DM.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DPevarello%26aufirst%3DP.%26atitle%3DBenzodipyrazoles%253A%2520a%2520new%2520class%2520of%2520potent%2520CDK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1315%26epage%3D1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Traquandi, G.; Brasca, M. G.; D'Alessio, R.; Polucci, P.; Roletto, F.; Vulpetti, A.; Pevarello, P.; Panzeri, A.; Quartieri, F.; Ferguson, R.; Vianello, P.; Fancelli, D.</span><span> </span><span class="NLM_article-title">Pyrazolo-quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors</span>. Patent WO2004/104007,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Traquandi&author=M.+G.+Brasca&author=R.+D%27Alessio&author=P.+Polucci&author=F.+Roletto&author=A.+Vulpetti&author=P.+Pevarello&author=A.+Panzeri&author=F.+Quartieri&author=R.+Ferguson&author=P.+Vianello&author=D.+Fancelli&title=Pyrazolo-quinazoline+Derivatives%2C+Process+for+Their+Preparation+and+Their+Use+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTraquandi%26aufirst%3DG.%26atitle%3DPyrazolo-quinazoline%2520Derivatives%252C%2520Process%2520for%2520Their%2520Preparation%2520and%2520Their%2520Use%2520as%2520Kinase%2520Inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span> </span><span class="NLM_article-title">An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=561-573&author=A.+Vulpettiauthor=P.+Pevarello&title=An+analysis+of+the+binding+modes+of+ATP-competitive+CDK2+inhibitors+as+revealed+by+X-ray+structures+of+protein-inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DPevarello%26aufirst%3DP.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520modes%2520of%2520ATP-competitive%2520CDK2%2520inhibitors%2520as%2520revealed%2520by%2520X-ray%2520structures%2520of%2520protein-inhibitor%2520complexes%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Cancer%2520Agents%26date%3D2005%26volume%3D5%26spage%3D561%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fancelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi-Sirtori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span> </span><span class="NLM_article-title">6-Substituted pyrrolo[3,4-<i>c</i>]pyrazoles: an improved class of CDK2 inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=841-852&author=M.+G.+Brascaauthor=C.+Albaneseauthor=R.+Amiciauthor=D.+Ballinariauthor=L.+Cortiauthor=V.+Crociauthor=D.+Fancelliauthor=F.+Fiorentiniauthor=M.+Nesiauthor=P.+Orsiniauthor=F.+Orziauthor=W.+Pastoriauthor=E.+Perroneauthor=E.+Pesentiauthor=P.+Pevarelloauthor=F.+Riccardi-Sirtoriauthor=F.+Rolettoauthor=P.+Rousselauthor=M.+Varasiauthor=A.+Vulpettiauthor=C.+Mercurio&title=6-Substituted+pyrrolo%5B3%2C4-c%5Dpyrazoles%3A+an+improved+class+of+CDK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DOrzi%26aufirst%3DF.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DPerrone%26aufirst%3DE.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DRiccardi-Sirtori%26aufirst%3DF.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DRoussel%26aufirst%3DP.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DC.%26atitle%3D6-Substituted%2520pyrrolo%255B3%252C4-c%255Dpyrazoles%253A%2520an%2520improved%2520class%2520of%2520CDK2%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D6%26spage%3D841%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chang, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarohia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1016%2FS1074-5521%2899%2980048-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=10375538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=361-375&author=Y.-T.+Changauthor=N.+S.+Grayauthor=G.+R.+Rosaniaauthor=D.+P.+Sutherlinauthor=S.+Kwonauthor=T.+C.+Normanauthor=R.+Sarohiaauthor=M.+Leostauthor=L.+Meijerauthor=P.+G.+Schultz&title=Synthesis+and+application+of+functionally+diverse+2%2C6%2C9-trisubstituted+purine+libraries+as+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span></div><div class="casAuthors">Chang, Young-Tae; Gray, Nathanael S.; Rosania, Gustavo R.; Sutherlin, Daniel P.; Kwon, Soojin; Norman, Thea C.; Sarohia, Radhika; Leost, Maryse; Meijer, Laurent; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">361-375</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Purines constitute a structural class of protein ligands involved in mediating an astonishing array of metabolic processes and signal pathways in all living organisms.  Synthesis of purine derivs. targeting specific purine-binding proteins in vivo could lead to versatile lead compds. for use as biol. probes or drug candidates.  We synthesized several libraries of 2,6,9-trisubstituted purines using both soln.- and solid-phase chem., and screened the compds. for inhibition of cyclin-dependent kinase (CDK) activity and human leukemic cell growth.  Lead compds. were optimized by iterative synthesis based on structure-activity relationships (SARs), as well as anal. of several CDK-inhibitor cocrystal structures, to afford several interesting compds. including one of the most potent CDK inhibitors known to date.  Unexpectedly, some compds. with similar CDK inhibitory activity arrested cellular proliferation at distinctly different phases of the cell cycle, and another inhibitor directly induced apoptosis, bypassing cell-cycle arrest.  Some of these compds. selectively inhibited growth of cells derived from specific tumors.  2,6,9-Trisubstituted purines have various and potent biol. activities, despite high concns. of competing endogenous purine ligands in living cells.  Purine libraries constitute a versatile source of small mols. that affect distinct biochem. pathways mediating different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromOmpUr_CvbVg90H21EOLACvtfcHk0ljxBPwAKampsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D&md5=67311217da8fecdddf96b9908a20c906</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980048-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980048-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.-T.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DRosania%26aufirst%3DG.%2BR.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DSarohia%26aufirst%3DR.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520application%2520of%2520functionally%2520diverse%25202%252C6%252C9-trisubstituted%2520purine%2520libraries%2520as%2520CDK%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D361%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Papatsoris, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liolitsa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deliveliotis, C.</span><span> </span><span class="NLM_article-title">Manipulation of the nerve growth factor network in prostate cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=303-309&author=A.+G.+Papatsorisauthor=D.+Liolitsaauthor=C.+Deliveliotis&title=Manipulation+of+the+nerve+growth+factor+network+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapatsoris%26aufirst%3DA.%2BG.%26aulast%3DLiolitsa%26aufirst%3DD.%26aulast%3DDeliveliotis%26aufirst%3DC.%26atitle%3DManipulation%2520of%2520the%2520nerve%2520growth%2520factor%2520network%2520in%2520prostate%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D303%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimahara, Y.</span><span> </span><span class="NLM_article-title">Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=15944784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1Churg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=161-171&author=Y.+Zhangauthor=C.+Dangauthor=Q.+Maauthor=Y.+Shimahara&title=Expression+of+nerve+growth+factor+receptors+and+their+prognostic+value+in+human+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer</span></div><div class="casAuthors">Zhang, Yong; Dang, Chengxue; Ma, Qingyong; Shimahara, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF), the prototypic member of the neurotrophin family of growth factors, exerts both stimulatory and inhibitory effects on neuronal and certain non-neuronal tumors, depending on the type of tumor.  It has been reported that two types of NGF receptors, high-affinity receptor, TrkA, and low-affinity receptor, p75NGFR, play important roles in this process.  Moreover, it has also been detected that high levels of TrkA expression have a more favorable overall survival prognosis in breast cancer patients, but the relationships between the two receptors according to the prognosis in pancreatic cancer patients are unknown.  We investigated the expression of NGF receptors (NGFRs: TrkA and p75NGFR) mRNA in 56 human primary pancreatic cancers, using real-time quant. reverse transcription-PCR.  Moreover, pancreatic cancer cell lines were used to validate if the effects of NGF on pancreatic cancer cell growth are dependent on the expression levels and the balance of TrkA and P75 receptors.  NGFRs were found in all of the tumor specimens and cell lines.  It appears that in pancreatic cancer cells the growth effects of NGF depend on the expression levels and the ratio of TrkA and p75NGFR.  TrkA and p75NGFR neg. correlated and were both assocd. with abdominal or back pain and perineural invasion.  Regarding this, high TrkA expression levels exhibited more frequent perineural invasion and a higher degree of pain, whereas the results of p75NGFR are on the contrary.  For Cox univariate analyses in the OS study, high expression of p75NGFR was assocd. with longer overall survival yet TrkA exhibited opposite effects and included the effect of pain.  HPG, tumor size, node involvement, and perineural invasion were not prognostic factors.  In Cox multivariate analyses, TrkA and p75NGFR were both prognostic parameters.  In conclusion, our study found that the expression of TrkA in pancreatic cancer is a marker of tumor aggressiveness.  Conversely, we also found that elevated p75NGFR expression is assocd. with a favorable prognosis; we demonstrated that NGF exerts both stimulatory and inhibitory effects on pancreatic cancers with the effect based on the expression levels and the ratio of TrkA and p75NGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_8Sb8xVndsbVg90H21EOLACvtfcHk0liLfFlFbw8jJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1Churg%253D&md5=228c5c6855483ef20ab86cc8d3eb13cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShimahara%26aufirst%3DY.%26atitle%3DExpression%2520of%2520nerve%2520growth%2520factor%2520receptors%2520and%2520their%2520prognostic%2520value%2520in%2520human%2520pancreatic%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2005%26volume%3D14%26spage%3D161%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dollé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriaenssens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazidi-Belkoura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Bourhis, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurcombe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hondermarck, H.</span><span> </span><span class="NLM_article-title">Nerve growth factor receptors and signaling in breast cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.2174%2F1568009043332853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=15379632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotV2ltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=463-470&author=L.+Doll%C3%A9author=E.+Adriaenssensauthor=I.+El+Yazidi-Belkouraauthor=X.+Le+Bourhisauthor=V.+Nurcombeauthor=H.+Hondermarck&title=Nerve+growth+factor+receptors+and+signaling+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor receptors and signaling in breast cancer</span></div><div class="casAuthors">Dolle, Laurent; Adriaenssens, Eric; El Yazidi-Belkoura, Ikram; le Bourhis, Xuefen; Nurcombe, Victor; Hondermarck, Hubert</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nerve growth factor (NGF) has long been known for its effects on neuronal cell survival and differentiation.  This prototypical neurotrophic factor stimulates neurons through two distinct classes of membrane receptors: the TrkA tyrosine kinase receptor, and the tumor necrosis factor receptor family member p75NTR, also known as the common neurotrophin receptor.  Somewhat surprisingly, there is a growing body of evidence indicating that NGF is also a major stimulator of breast cancer cell growth.  Both the survival and proliferation of breast cancer cells are strongly stimulated by NGF, mediated by TrkA and p75NTR resp., utilizing signaling pathways similar to those described for neurons.  In addn., although NGF is produced by breast cancer cells, it is not in normal breast epithelial cells, giving rise to an autocrine stimulation of tumor growth.  Therefore, NGF receptors and signaling are thus looking increasingly promising as potential drug targets for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplSJYKr5_U9bVg90H21EOLACvtfcHk0liLfFlFbw8jJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotV2ltbY%253D&md5=02285808da6ed364796cef7ff42e6fc5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568009043332853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009043332853%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%25C3%25A9%26aufirst%3DL.%26aulast%3DAdriaenssens%26aufirst%3DE.%26aulast%3DEl%2BYazidi-Belkoura%26aufirst%3DI.%26aulast%3DLe%2BBourhis%26aufirst%3DX.%26aulast%3DNurcombe%26aufirst%3DV.%26aulast%3DHondermarck%26aufirst%3DH.%26atitle%3DNerve%2520growth%2520factor%2520receptors%2520and%2520signaling%2520in%2520breast%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2004%26volume%3D4%26spage%3D463%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi-Sirtori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span> </span><span class="NLM_article-title">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1002%2Frcm.1368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=14966861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-517&author=M.+Colomboauthor=F.+Riccardi-Sirtoriauthor=V.+Rizzo&title=A+fully+automated+method+for+accurate+mass+determination+using+high-performance+liquid+chromatography+with+a+quadrupole%2Forthogonal+acceleration+time-of-flight+mass+spectrometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span></div><div class="casAuthors">Colombo, Maristella; Sirtori, Federico Riccardi; Rizzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A generic LC/ESI(+)-oaTOFMS method has been developed for routine automated high accuracy mass detns. of different classes of substances.  The system makes use of micro-high-performance liq. chromatog. and a hybrid quadrupole/orthogonal acceleration time-of-flight (Q-oaTOF) mass spectrometer.  Reproducible and accurate mass measurements were obtained using an electrospray dual sprayer with reserpine as ref. compd., introduced into the mass spectrometer alternating with the samples.  Expts. were performed to optimize analyte/ref. response ratio, statistical algorithm correction setting, and analyte concn.  In these expts., a clear dependence of the mass measurement error on the analyte/ref. response ratio was obsd.  The dependence of av. mass error vs. different dead time correction algorithm settings (Np factors) was also explored.  In the final automated procedure, verified for a statistically significant set of compds. (∼550) obtained from a medicinal chem. department, about 70% of the analyzed samples satisfied the acceptance criteria fixed at a max. error of ±5 ppm (mass range 150-800 Da).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5JNVhGdzjrVg90H21EOLACvtfcHk0liLfFlFbw8jJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D&md5=6f1f93c5e2fb4e24257b77f5ce6dfa37</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Frcm.1368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1368%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DRiccardi-Sirtori%26aufirst%3DF.%26aulast%3DRizzo%26aufirst%3DV.%26atitle%3DA%2520fully%2520automated%2520method%2520for%2520accurate%2520mass%2520determination%2520using%2520high-performance%2520liquid%2520chromatography%2520with%2520a%2520quadrupole%252Forthogonal%2520acceleration%2520time-of-flight%2520mass%2520spectrometer%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D18%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span> </span><span class="NLM_article-title">TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9006559&amp;key=10.1016%2Fj.chembiol.2006.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9006559&amp;key=16793518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9006559&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=607-614&author=M.+Grollauthor=M.+Goetzauthor=M.+Kaiserauthor=E.+Weyherauthor=L.+Moroder&title=TMC-95-based+inhibitor+design+provides+evidence+for+the+catalytic+versatility+of+the+proteasome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">TMC-95-Based Inhibitor Design Provides Evidence for the Catalytic Versatility of the Proteasome</span></div><div class="casAuthors">Groll, Michael; Goetz, Marion; Kaiser, Markus; Weyher, Elisabeth; Moroder, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-614</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">TMC-95's natural cyclic tripeptide metabolites represent potent competitive proteasome inhibitors.  The constrained conformation of TMC-95 proteasomal inhibitors provides the driving force for entropically high-affinity binding.  Based on the crystal structure of the proteasome:TMC-95A complex, the synthetically challenging TMC-95 core structure was used for the design and synthesis of less demanding biphenyl-ether macrocycles, in which the biphenyl-ether moiety functions as an endocyclic clamp restricting its tripeptide backbone.  These simplified analogs allowed us to identify high plasticity of the proteasomal tryptic-like specificity pocket.  Biphenyl-ether compds. extended with an amide group were hydrolyzed by the proteasome, although the crystal structure of such proteasome:biphenyl-ether complexes revealed quenching of proteolysis at the acyl-enzyme intermediate.  Our data reveal that biphenyl-ether derivs. bind noncovalently to the proteasomal tryptic-like active site in a reversible substrate-like manner without allosteric changes of active site residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOZ7dfuNzscLVg90H21EOLACvtfcHk0lj7pabeWEew1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqsLw%253D&md5=35abcd4d64ea6d8ad0b94204abe14e3e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWeyher%26aufirst%3DE.%26aulast%3DMoroder%26aufirst%3DL.%26atitle%3DTMC-95-based%2520inhibitor%2520design%2520provides%2520evidence%2520for%2520the%2520catalytic%2520versatility%2520of%2520the%2520proteasome%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D607%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piutti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritzen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warpehoski, M. A.</span><span> </span><span class="NLM_article-title">3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3367</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031145u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3367-3380&author=P.+Pevarelloauthor=M.+G.+Brascaauthor=R.+Amiciauthor=P.+Orsiniauthor=G.+Traquandiauthor=L.+Cortiauthor=C.+Piuttiauthor=P.+Sansonnaauthor=M.+Villaauthor=B.+S.+Pierceauthor=M.+Puliciauthor=P.+Giordanoauthor=K.+Martinaauthor=E.+L.+Fritzenauthor=R.+A.+Nugentauthor=E.+Casaleauthor=A.+Cameronauthor=M.+Ciomeiauthor=F.+Rolettoauthor=A.+Isacchiauthor=G.+Fogliattoauthor=E.+Pesentiauthor=W.+Pastoriauthor=A.+Marsiglioauthor=K.+L.+Leachauthor=P.+M.+Clareauthor=F.+Fiorentiniauthor=M.+Varasiauthor=A.+Vulpettiauthor=M.+A.+Warpehoski&title=3-Aminopyrazole+inhibitors+of+CDK2%2Fcyclin%E2%80%89A+as+antitumor+agents.+1.+Lead+finding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm031145u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031145u%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DPiutti%26aufirst%3DC.%26aulast%3DSansonna%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DPulici%26aufirst%3DM.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DFritzen%26aufirst%3DE.%2BL.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DP.%2BM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DWarpehoski%26aufirst%3DM.%2BA.%26atitle%3D3-Aminopyrazole%2520inhibitors%2520of%2520CDK2%252Fcyclin%25E2%2580%2589A%2520as%2520antitumor%2520agents.%25201.%2520Lead%2520finding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3367%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIP','PDB','2WIP'); return false;">PDB: 2WIP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WIH','PDB','2WIH'); return false;">PDB: 2WIH</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a href="/doi/suppl/10.1021/jm9006559">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_60078"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic studies of compounds <b>2</b> and <b>28</b>; elemental analyses results of compounds <b>1</b>, <b>2</b>, <b>17</b>, <b>26</b>, <b>28</b>; kinase selective profile of compound <b>28</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9006559/suppl_file/jm9006559_si_001.pdf">jm9006559_si_001.pdf (52.4 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9006559&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm9006559%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-16%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9006559" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799431d2ec53c88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
